1	The	DT	O	the	det	4	SENT_1	[p1l673t81r718b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l737t83r822b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l841t83r1029b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l1048t83r1227b109],
5	of	IN	O	of	_	0	SENT_1	[p1l1247t81r1275b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_1	[p1l1287t83r1486b102],

1	may	MD	O	may	aux	2	SENT_2	[p1l9t329r188b404],
2	require	VB	O	require	_	0	SENT_2	[p1l221t304r527b404],
3	a	DT	O	a	det	6	SENT_2	[p1l565t330r609b382],
4	substantial	JJ	O	substantial	amod	6	SENT_2	[p1l646t303r1123b382],
5	pill	NN	O	pill	nn	6	SENT_2	[p1l1159t303r1300b404],
6	burden	NN	O	burden	dobj	2	SENT_2	[p1l1337t303r1641b382],
7	and	CC	O	and	_	0	SENT_2	[p1l1678t303r1836b382],
8	use	NN	O	use	dobj	2	SENT_2	[p1l1873t330r2013b382],
9	of	IN	O	of	_	0	SENT_2	[p1l2052t303r2152b382],
10	the	DT	O	the	det	13	SENT_2	[p1l10t431r143b510],
11	injectable	JJ	O	injectable	amod	13	SENT_2	[p1l188t431r599b532],
12	drug	NN	O	drug	nn	13	SENT_2	[p1l645t431r849b532],
13	enfuvirtide	NN	O	enfuvirtide	prep_of	6	SENT_2	[p1l893t431r1389b510],
14	.	.	O	.	_	0	SENT_2	[p1l893t431r1389b510],

1	These	DT	O	these	det	2	SENT_3	[p1l1436t431r1687b510],
2	regimens	NNS	O	regimen	nsubj	5	SENT_3	[p1l1733t432r2132b532],
3	can	MD	O	can	aux	5	SENT_3	[p1l10t585r159b638],
4	be	VB	O	be	cop	5	SENT_3	[p1l196t559r292b638],
5	overwhelming	JJ	O	overwhelming	_	0	SENT_3	[p1l330t559r950b660],
6	even	RB	O	even	advmod	5	SENT_3	[p1l984t585r1172b638],
7	for	IN	O	for	_	0	SENT_3	[p1l1208t559r1332b638],
8	the	DT	O	the	det	11	SENT_3	[p1l1365t559r1498b638],
9	most	RBS	O	most	advmod	10	SENT_3	[p1l1535t576r1751b638],
10	motivated	JJ	O	motivated	amod	11	SENT_3	[p1l1782t560r2133b638, p1l10t687r107b766],
11	patient	NN	O	patient	prep_for	5	SENT_3	[p1l144t688r467b788],
12	.	.	O	.	_	0	SENT_3	[p1l144t688r467b788],

1	The	DT	O	the	det	2	SENT_4	[p1l508t687r669b766],
2	fact	NN	O	fact	nsubj	16	SENT_4	[p1l708t687r867b766],
3	that	IN	O	that	complm	7	SENT_4	[p1l902t687r1074b766],
4	integrase	NN	O	integrase	nn	5	SENT_4	[p1l1107t688r1503b788],
5	inhibitors	NNS	O	inhibitor	nsubj	7	SENT_4	[p1l1541t687r1964b766],
6	are	VBP	O	be	aux	7	SENT_4	[p1l2005t713r2133b766],
7	emerging	VBG	O	emerge	dep	2	SENT_4	[p1l10t816r423b916],
8	out	IN	O	out	_	0	SENT_4	[p1l461t832r600b894],
9	of	IN	O	of	_	0	SENT_4	[p1l636t815r737b894],
10	the	DT	O	the	det	11	SENT_4	[p1l760t815r892b894],
11	pipeline	NN	O	pipeline	prep_out_of	7	SENT_4	[p1l932t815r1277b916],
12	and	CC	O	and	_	0	SENT_4	[p1l1318t815r1475b894],
13	into	IN	O	into	dep	2	SENT_4	[p1l1515t816r1685b894],
14	the	DT	O	the	det	15	SENT_4	[p1l1727t815r1860b894],
15	clinic	NN	O	clinic	pobj	13	SENT_4	[p1l1902t815r2135b894],
16	shows	VBZ	O	show	_	0	SENT_4	[p1l11t943r274b1022],
17	that	IN	O	that	complm	25	SENT_4	[p1l331t943r503b1022],
18	persistence	NN	O	persistence	nsubj	31	SENT_4	[p1l551t944r1032b1044],
19	and	CC	O	and	_	0	SENT_4	[p1l1086t943r1244b1022],
20	investment	NN	O	investment	conj_and	18	SENT_4	[p1l1297t944r1775b1022],
21	in	IN	O	in	_	0	SENT_4	[p1l1823t944r1906b1021],
22	new	JJ	O	new	amod	23	SENT_4	[p1l1960t969r2138b1023],
23	agents	NNS	O	agent	prep_in	18	SENT_4	[p1l8t1088r280b1172],
24	can	MD	O	can	aux	25	SENT_4	[p1l319t1097r467b1150],
25	shed	VB	O	shed	ccomp	16	SENT_4	[p1l505t1071r697b1150],
26	light	NN	O	light	dobj	25	SENT_4	[p1l733t1071r931b1172],
27	on	IN	O	on	_	0	SENT_4	[p1l964t1097r1069b1150],
28	basic	JJ	O	basic	amod	29	SENT_4	[p1l1106t1071r1317b1150],
29	science	NN	O	science	prep_on	25	SENT_4	[p1l1355t1072r1676b1167],
30	,	,	O	,	_	0	SENT_4	[p1l1355t1072r1676b1167],
31	open	JJ	O	open	ccomp	16	SENT_4	[p1l1719t1097r1925b1172],
32	new	JJ	O	new	amod	33	SENT_4	[p1l1962t1097r2138b1151],
33	doors	NNS	O	door	dobj	31	SENT_4	[p1l10t1199r249b1278],
34	for	IN	O	for	_	0	SENT_4	[p1l287t1199r410b1278],
35	research	NN	O	research	prep_for	31	SENT_4	[p1l443t1199r828b1295],
36	,	,	O	,	_	0	SENT_4	[p1l443t1199r828b1295],
37	and	CC	O	and	_	0	SENT_4	[p1l869t1199r1027b1278],
38	most	RBS	O	most	advmod	39	SENT_4	[p1l1062t1216r1279b1278],
39	importantly	RB	O	importantly	advmod	41	SENT_4	[p1l1309t1199r1839b1300],
40	,	,	O	,	_	0	SENT_4	[p1l1309t1199r1839b1300],
41	transform	VB	O	transform	ccomp	16	SENT_4	[p1l1881t1216r2133b1278, p1l9t1327r219b1406],
42	approaches	NNS	O	approach	dobj	41	SENT_4	[p1l257t1327r740b1428],
43	to	TO	O	to	_	0	SENT_4	[p1l780t1344r862b1406],
44	HIV	NN	MISC	hiv	nn	45	SENT_4	[p1l900t1335r1075b1406],
45	treatment	NN	O	treatment	prep_to	42	SENT_4	[p1l1110t1344r1555b1406],
46	.	.	O	.	_	0	SENT_4	[p1l1110t1344r1555b1406],

1	No	DT	O	no	det	3	SENT_5	[p1l93t1481r189b1536],
2	potential	JJ	O	potential	amod	3	SENT_5	[p1l216t1476r504b1551],
3	conﬂict	NN	O	conﬂict	nsubj	12	SENT_5	[p1l531t1476r778b1535],
4	of	IN	O	of	_	0	SENT_5	[p1l802t1476r878b1535],
5	interest	NN	O	interest	prep_of	3	SENT_5	[p1l890t1477r1137b1535],
6	relevant	JJ	O	relevant	amod	5	SENT_5	[p1l1160t1476r1418b1536],
7	to	TO	O	to	_	0	SENT_5	[p1l1442t1489r1501b1535],
8	this	DT	O	this	det	9	SENT_5	[p1l1530t1476r1647b1535],
9	article	NN	O	article	prep_to	6	SENT_5	[p1l1675t1476r1873b1535],
10	was	VBD	O	be	cop	12	SENT_5	[p1l1897t1495r2019b1536],
11	re	JJ	O	re	amod	12	SENT_5	[p1l2049t1495r2134b1535],
12	—	NN	O	—	_	0	SENT_5	[p1l2049t1495r2134b1535],

1	ported	VBN	O	port	_	0	SENT_6	[p1l7t1563r237b1638],
2	.	.	O	.	_	0	SENT_6	[p1l7t1563r237b1638],

1	From	IN	O	from	dep	7	SENT_7	[p1l15t1760r180b1816],
2	the	DT	O	the	det	4	SENT_7	[p1l204t1755r309b1816],
3	Department	NNP	O	Department	nn	4	SENT_7	[p1l336t1760r745b1834],
4	ofMedicine	NN	O	ofmedicine	pobj	1	SENT_7	[p1l766t1754r1178b1826],
5	,	,	O	,	_	0	SENT_7	[p1l766t1754r1178b1826],
6	San	NNP	ORGANIZATION	San	nn	7	SENT_7	[p1l1204t1760r1321b1816],
7	Francisco	NNP	ORGANIZATION	Francisco	_	0	SENT_7	[p1l1352t1760r1665b1816],
8	General	NNP	ORGANIZATION	General	nn	9	SENT_7	[p1l1689t1755r1948b1816],
9	Hospital	NNP	ORGANIZATION	Hospital	dep	7	SENT_7	[p1l1979t1760r2134b1816, p1l12t1851r172b1930],
10	,	,	O	,	_	0	SENT_7	[p1l1979t1760r2134b1816, p1l12t1851r172b1930],
11	University	NNP	ORGANIZATION	University	nn	14	SENT_7	[p1l203t1856r540b1930],
12	ofCa	NNP	O	ofCa	nn	14	SENT_7	[p1l563t1850r969b1912],
13	|	NN	O	|	nn	14	SENT_7	[p1l563t1850r969b1912],
14	ifornia	NN	O	ifornium	dep	7	SENT_7	[p1l563t1850r969b1912],
15	at	IN	O	at	_	0	SENT_7	[p1l996t1863r1055b1912],
16	San	NNP	LOCATION	San	nn	17	SENT_7	[p1l1079t1856r1195b1912],
17	Francisco	NNP	LOCATION	Francisco	prep_at	14	SENT_7	[p1l1229t1856r1561b1922],
18	,	,	O	,	_	0	SENT_7	[p1l1229t1856r1561b1922],
19	San	NNP	LOCATION	San	nn	20	SENT_7	[p1l1589t1856r1705b1912],
20	Francisco	NNP	LOCATION	Francisco	dep	7	SENT_7	[p1l1739t1856r2071b1912],
21	.	.	O	.	_	0	SENT_7	[p1l1739t1856r2071b1912],

1	1	LS	NUMBER	1	_	0	SENT_8	[p1l11t1962r60b2013],
2	.	.	O	.	_	0	SENT_8	[p1l11t1962r60b2013],

1	Palella	NNP	PERSON	Palella	_	0	SENT_9	[p1l136t1954r352b2013],
2	F	NN	O	f	nn	4	SENT_9	[p1l371t1960r435b2022],
3	]	CD	NUMBER	]	num	4	SENT_9	[p1l371t1960r435b2022],
4	Jr	NNP	O	Jr	dep	1	SENT_9	[p1l447t1960r516b2026],
5	,	,	O	,	_	0	SENT_9	[p1l447t1960r516b2026],
6	Delaney	NNP	ORGANIZATION	Delaney	nn	7	SENT_9	[p1l541t1954r805b2029],
7	KM	NNP	ORGANIZATION	KM	appos	4	SENT_9	[p1l823t1960r957b2026],
8	,	,	O	,	_	0	SENT_9	[p1l823t1960r957b2026],
9	Moorman	NNP	PERSON	Moorman	nn	10	SENT_9	[p1l981t1960r1306b2013],
10	AC	NN	O	ac	appos	4	SENT_9	[p1l1324t1959r1437b2026],
11	,	,	O	,	_	0	SENT_9	[p1l1324t1959r1437b2026],
12	et	FW	O	et	nn	13	SENT_9	[p1l1462t1967r1521b2013],
13	al.	FW	O	al.	appos	4	SENT_9	[p1l1538t1954r1612b2013],
14	.	.	O	.	_	0	SENT_9	[p1l1538t1954r1612b2013],

1	Declining	VBG	O	decline	amod	2	SENT_10	[p1l1637t1954r1960b2030],
2	morbidity	NN	O	morbidity	_	0	SENT_10	[p1l1979t1973r2134b2013, p1l9t2050r195b2125],
3	and	CC	O	and	_	0	SENT_10	[p1l223t2050r343b2109],
4	mortality	NN	O	mortality	conj_and	2	SENT_10	[p1l374t2050r680b2125],
5	among	IN	O	among	_	0	SENT_10	[p1l708t2069r935b2126],
6	patients	NNS	O	patient	prep_among	4	SENT_10	[p1l963t2051r1222b2125],
7	with	IN	O	with	_	0	SENT_10	[p1l1252t2050r1400b2109],
8	advanced	JJ	O	advanced	amod	14	SENT_10	[p1l1431t2050r1731b2109],
9	human	JJ	O	human	amod	14	SENT_10	[p1l1763t2050r1993b2109],
10	im	NN	O	im	nn	14	SENT_10	[p1l2024t2051r2134b2108],
11	—	NN	O	—	nn	14	SENT_10	[p1l2024t2051r2134b2108],
12	munodeficiency	NN	O	munodeficiency	nn	14	SENT_10	[p1l8t2146r534b2221],
13	virus	NN	O	virus	nn	14	SENT_10	[p1l552t2147r713b2206],
14	infection	NN	O	infection	prep_with	6	SENT_10	[p1l739t2146r1051b2205],
15	.	.	O	.	_	0	SENT_10	[p1l739t2146r1051b2205],

1	N	NN	O	n	nn	2	SENT_11	[p1l1079t2152r1135b2205],
2	EnglJ	NN	O	englj	nsubj	3	SENT_11	[p1l1158t2146r1350b2222],
3	Med	VBD	O	med	_	0	SENT_11	[p1l1371t2146r1513b2205],
4	1998	CD	DATE	1998	dobj	3	SENT_11	[p1l1540t2151r2093b2217],
5	;	:	O	;	_	0	SENT_11	[p1l1540t2151r2093b2217],
6	338:853	CD	NUMBER	338:853	number	7	SENT_11	[p1l1540t2151r2093b2217],
7	—	CD	NUMBER	—	dep	4	SENT_11	[p1l1540t2151r2093b2217],
8	60	CD	NUMBER	60	dep	7	SENT_11	[p1l1540t2151r2093b2217],
9	.	.	O	.	_	0	SENT_11	[p1l1540t2151r2093b2217],

1	2	LS	NUMBER	2	_	0	SENT_12	[p1l8t2251r65b2303],
2	.	.	O	.	_	0	SENT_12	[p1l8t2251r65b2303],

1	Transmission	NNP	O	Transmission	nsubj	8	SENT_13	[p1l137t2244r600b2303],
2	of	IN	O	of	_	0	SENT_13	[p1l641t2243r719b2303],
3	drug-resistant	JJ	O	drug-resistant	amod	4	SENT_13	[p1l745t2244r1227b2320],
4	HIV-1	NN	O	hiv-1	prep_of	1	SENT_13	[p1l1263t2248r1455b2303],
5	in	IN	O	in	_	0	SENT_13	[p1l1495t2244r1560b2302],
6	Europe	NNP	LOCATION	Europe	prep_in	4	SENT_13	[p1l1599t2249r1837b2320],
7	remains	VBZ	O	remain	cop	8	SENT_13	[p1l1877t2244r2149b2303],
8	limited	JJ	O	limited	_	0	SENT_13	[p1l9t2340r248b2398],
9	to	TO	O	to	_	0	SENT_13	[p1l274t2352r336b2398],
10	single	JJ	O	single	amod	11	SENT_13	[p1l365t2340r559b2415],
11	classes	NNS	O	class	prep_to	8	SENT_13	[p1l586t2340r833b2398],
12	.	.	O	.	_	0	SENT_13	[p1l586t2340r833b2398],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_14	[p1l860t2344r1031b2398],
2	2008	CD	DATE	2008	num	1	SENT_14	[p1l1059t2344r1583b2411],
3	;	:	O	;	_	0	SENT_14	[p1l1059t2344r1583b2411],
4	22:625	CD	NUMBER	22:625	number	5	SENT_14	[p1l1059t2344r1583b2411],
5	—	CD	NUMBER	—	dep	1	SENT_14	[p1l1059t2344r1583b2411],
6	35	CD	NUMBER	35	dep	5	SENT_14	[p1l1059t2344r1583b2411],
7	.	.	O	.	_	0	SENT_14	[p1l1059t2344r1583b2411],

1	3	LS	NUMBER	3	_	0	SENT_15	[p1l10t2444r61b2496],
2	.	.	O	.	_	0	SENT_15	[p1l10t2444r61b2496],

1	Hazuda	NNP	O	Hazuda	nn	2	SENT_16	[p1l140t2437r396b2497],
2	DJ	NNP	O	DJ	_	0	SENT_16	[p1l426t2442r517b2509],
3	,	,	O	,	_	0	SENT_16	[p1l426t2442r517b2509],
4	Felock	NNP	PERSON	Felock	nn	5	SENT_16	[p1l553t2437r770b2497],
5	P	NN	PERSON	p	appos	2	SENT_16	[p1l798t2442r848b2509],
6	,	,	O	,	_	0	SENT_16	[p1l798t2442r848b2509],
7	Witmer	NNP	PERSON	Witmer	nn	8	SENT_16	[p1l882t2437r1135b2496],
8	M	NNP	O	M	appos	2	SENT_16	[p1l1162t2442r1245b2509],
9	,	,	O	,	_	0	SENT_16	[p1l1162t2442r1245b2509],
10	et	FW	O	et	nn	11	SENT_16	[p1l1282t2449r1341b2496],
11	al.	FW	O	al.	appos	2	SENT_16	[p1l1370t2437r1444b2496],
12	.	.	O	.	_	0	SENT_16	[p1l1370t2437r1444b2496],

1	Inhibitors	NNS	O	inhibitor	_	0	SENT_17	[p1l1480t2437r1811b2496],
2	of	IN	O	of	_	0	SENT_17	[p1l1844t2436r1921b2496],
3	strand	NN	O	strand	nn	4	SENT_17	[p1l1941t2437r2151b2496],
4	transfer	NN	O	transfer	prep_of	1	SENT_17	[p1l10t2533r273b2593],
5	that	WDT	O	that	nsubj	9	SENT_17	[p1l295t2534r428b2593],
6	prevent	VBP	O	prevent	rcmod	4	SENT_17	[p1l447t2546r693b2610],
7	integration	NN	O	integration	dobj	6	SENT_17	[p1l712t2534r1083b2610],
8	and	CC	O	and	_	0	SENT_17	[p1l1106t2534r1227b2593],
9	inhibit	VBP	O	inhibit	rcmod	4	SENT_17	[p1l1250t2534r1475b2593],
10	HIV-1	NN	MISC	hiv-1	nn	11	SENT_17	[p1l1495t2538r1682b2593],
11	replication	NN	O	replication	dobj	9	SENT_17	[p1l1707t2534r2064b2610],
12	in	IN	O	in	_	0	SENT_17	[p1l2087t2534r2151b2592],
13	cells	NNS	O	cell	prep_in	9	SENT_17	[p1l11t2631r175b2690],
14	.	.	O	.	_	0	SENT_17	[p1l11t2631r175b2690],

1	Science	NNP	O	Science	_	0	SENT_18	[p1l207t2631r448b2690],
2	2000	CD	DATE	2000	num	1	SENT_18	[p1l475t2635r1044b2703],
3	;	:	O	;	_	0	SENT_18	[p1l475t2635r1044b2703],
4	287:646	CD	NUMBER	287:646	number	5	SENT_18	[p1l475t2635r1044b2703],
5	—	CD	NUMBER	—	dep	1	SENT_18	[p1l475t2635r1044b2703],
6	50	CD	NUMBER	50	dep	5	SENT_18	[p1l475t2635r1044b2703],
7	.	.	O	.	_	0	SENT_18	[p1l475t2635r1044b2703],

1	4	LS	NUMBER	4	_	0	SENT_19	[p1l8t2734r62b2785],
2	.	.	O	.	_	0	SENT_19	[p1l8t2734r62b2785],

1	Steigbigel	NNP	ORGANIZATION	Steigbigel	nn	2	SENT_20	[p1l142t2727r465b2802],
2	RT	NN	ORGANIZATION	rt	_	0	SENT_20	[p1l488t2731r594b2798],
3	,	,	O	,	_	0	SENT_20	[p1l488t2731r594b2798],
4	Cooper	NNP	PERSON	Cooper	nn	5	SENT_20	[p1l623t2731r864b2802],
5	DA	NNP	PERSON	DA	appos	2	SENT_20	[p1l886t2732r1004b2798],
6	,	,	O	,	_	0	SENT_20	[p1l886t2732r1004b2798],
7	Kumar	NNP	PERSON	Kumar	nn	8	SENT_20	[p1l1033t2732r1261b2787],
8	PN	NNP	O	PN	appos	2	SENT_20	[p1l1283t2732r1395b2798],
9	,	,	O	,	_	0	SENT_20	[p1l1283t2732r1395b2798],
10	et	FW	O	et	nn	11	SENT_20	[p1l1425t2739r1484b2785],
11	al.	FW	O	al.	appos	2	SENT_20	[p1l1505t2727r1580b2785],
12	.	.	O	.	_	0	SENT_20	[p1l1505t2727r1580b2785],

1	Raltegravir	NN	O	raltegravir	nsubj	3	SENT_21	[p1l1608t2727r1981b2802],
2	with	IN	O	with	prep	1	SENT_21	[p1l2000t2727r2150b2786],
3	optimized	VBN	O	optimize	_	0	SENT_21	[p1l11t2824r351b2900],
4	background	NN	O	background	nn	5	SENT_21	[p1l396t2824r793b2900],
5	therapy	NN	O	therapy	dobj	3	SENT_21	[p1l838t2824r1087b2900],
6	for	IN	O	for	_	0	SENT_21	[p1l1129t2823r1223b2883],
7	resistant	JJ	O	resistant	dep	8	SENT_21	[p1l1267t2824r1555b2883],
8	HIV-1	NN	O	hiv-1	amod	9	SENT_21	[p1l1596t2828r1785b2883],
9	infection	NN	O	infection	prep_for	5	SENT_21	[p1l1830t2823r2147b2883],
10	.	.	O	.	_	0	SENT_21	[p1l1830t2823r2147b2883],

1	N	NN	O	n	nn	2	SENT_22	[p1l8t2925r65b2979],
2	EnglJ	NN	O	englj	nsubj	3	SENT_22	[p1l89t2920r284b2995],
3	Med	VBD	O	med	_	0	SENT_22	[p1l306t2920r450b2978],
4	2008	CD	DATE	2008	dobj	3	SENT_22	[p1l476t2924r1037b2991],
5	;	:	O	;	_	0	SENT_22	[p1l476t2924r1037b2991],
6	359:339	CD	NUMBER	359:339	number	7	SENT_22	[p1l476t2924r1037b2991],
7	—	CD	NUMBER	—	dep	4	SENT_22	[p1l476t2924r1037b2991],
8	54	CD	NUMBER	54	dep	7	SENT_22	[p1l476t2924r1037b2991],
9	.	.	O	.	_	0	SENT_22	[p1l476t2924r1037b2991],

1	5	CD	NUMBER	5	_	0	SENT_23	[p1l11t3023r61b3074],
2	.	.	O	.	_	0	SENT_23	[p1l11t3023r61b3074],

1	Cooper	NNP	ORGANIZATION	Cooper	nn	2	SENT_24	[p1l140t3020r381b3091],
2	DA	NNP	ORGANIZATION	DA	_	0	SENT_24	[p1l415t3021r533b3087],
3	,	,	O	,	_	0	SENT_24	[p1l415t3021r533b3087],
4	Steigbigel	NNP	ORGANIZATION	Steigbigel	nn	5	SENT_24	[p1l577t3016r899b3091],
5	RT	NN	ORGANIZATION	rt	appos	2	SENT_24	[p1l935t3020r1041b3087],
6	,	,	O	,	_	0	SENT_24	[p1l935t3020r1041b3087],
7	Gatell	NNP	O	Gatell	nn	8	SENT_24	[p1l1082t3016r1281b3074],
8	IM	NNP	O	IM	appos	2	SENT_24	[p1l1310t3021r1422b3087],
9	,	,	O	,	_	0	SENT_24	[p1l1310t3021r1422b3087],
10	et	FW	O	et	nn	11	SENT_24	[p1l1464t3028r1523b3074],
11	al.	FW	O	al.	appos	2	SENT_24	[p1l1557t3016r1631b3074],
12	.	.	O	.	_	0	SENT_24	[p1l1557t3016r1631b3074],

1	Subgroup	NN	O	subgroup	nn	4	SENT_25	[p1l1675t3016r1992b3091],
2	and	CC	O	and	_	0	SENT_25	[p1l2030t3016r2150b3074],
3	resistance	NN	O	resistance	nn	4	SENT_25	[p1l10t3113r342b3172],
4	analyses	NNS	O	analysis	_	0	SENT_25	[p1l375t3113r652b3189],
5	of	IN	O	of	_	0	SENT_25	[p1l688t3112r764b3172],
6	raltegravir	NN	O	raltegravir	prep_of	4	SENT_25	[p1l784t3113r1132b3189],
7	for	IN	O	for	_	0	SENT_25	[p1l1163t3112r1258b3172],
8	resistant	JJ	O	resistant	dep	9	SENT_25	[p1l1289t3113r1578b3172],
9	HIV-1	NN	O	hiv-1	amod	10	SENT_25	[p1l1608t3117r1796b3172],
10	infection	NN	O	infection	prep_for	4	SENT_25	[p1l1829t3112r2146b3172],
11	.	.	O	.	_	0	SENT_25	[p1l1829t3112r2146b3172],

1	N	NN	O	n	nn	2	SENT_26	[p1l8t3214r65b3268],
2	EnglJ	NN	O	englj	nsubj	3	SENT_26	[p1l89t3209r284b3284],
3	Med	VBD	O	med	_	0	SENT_26	[p1l306t3209r450b3267],
4	2008	CD	DATE	2008	dobj	3	SENT_26	[p1l476t3213r1036b3280],
5	;	:	O	;	_	0	SENT_26	[p1l476t3213r1036b3280],
6	359:355	CD	NUMBER	359:355	number	7	SENT_26	[p1l476t3213r1036b3280],
7	—	CD	NUMBER	—	dep	4	SENT_26	[p1l476t3213r1036b3280],
8	65	CD	NUMBER	65	dep	7	SENT_26	[p1l476t3213r1036b3280],
9	.	.	O	.	_	0	SENT_26	[p1l476t3213r1036b3280],

1	6	CD	NUMBER	6	_	0	SENT_27	[p1l10t3313r62b3365],
2	.	.	O	.	_	0	SENT_27	[p1l10t3313r62b3365],

1	Hammer	NNP	O	Hammer	nn	2	SENT_28	[p1l140t3311r436b3365],
2	SM	NNP	O	SM	_	0	SENT_28	[p1l474t3310r592b3378],
3	,	,	O	,	_	0	SENT_28	[p1l474t3310r592b3378],
4	Saag	NNP	PERSON	Saag	nn	5	SENT_28	[p1l636t3310r789b3382],
5	MS	NN	O	m	appos	2	SENT_28	[p1l823t3310r945b3378],
6	,	,	O	,	_	0	SENT_28	[p1l823t3310r945b3378],
7	Schechter	NNP	PERSON	Schechter	nn	8	SENT_28	[p1l989t3306r1310b3365],
8	M	NNP	O	M	appos	2	SENT_28	[p1l1344t3311r1426b3378],
9	,	,	O	,	_	0	SENT_28	[p1l1344t3311r1426b3378],
10	et	FW	O	et	nn	11	SENT_28	[p1l1469t3318r1529b3365],
11	al.	FW	O	al.	appos	2	SENT_28	[p1l1562t3306r1638b3365],
12	.	.	O	.	_	0	SENT_28	[p1l1562t3306r1638b3365],

1	Treatment	NN	O	treatment	_	0	SENT_29	[p1l1678t3310r2024b3365],
2	for	IN	O	for	_	0	SENT_29	[p1l2058t3305r2153b3365],
3	adult	JJ	O	adult	amod	5	SENT_29	[p1l10t3402r177b3462],
4	HIV	NN	MISC	hiv	nn	5	SENT_29	[p1l196t3407r330b3461],
5	infection	NN	O	infection	prep_for	1	SENT_29	[p1l349t3401r667b3461],
6	:	:	O	:	_	0	SENT_29	[p1l349t3401r667b3461],
7	2006	CD	DATE	2006	num	8	SENT_29	[p1l692t3406r853b3461],
8	recommendations	NNS	O	recommendation	dep	1	SENT_29	[p1l876t3402r1477b3461],
9	of	IN	O	of	_	0	SENT_29	[p1l1502t3401r1579b3461],
10	the	DT	O	the	det	13	SENT_29	[p1l1588t3402r1690b3461],
11	International	NNP	O	International	nn	13	SENT_29	[p1l1712t3402r2152b3461],
12	AIDS	NNP	O	AIDS	nn	13	SENT_29	[p1l7t3502r178b3556],
13	Society	NNP	O	Society	prep_of	8	SENT_29	[p1l207t3498r626b3573],
14	.	.	O	.	_	0	SENT_29	[p1l207t3498r626b3573],

1	—	NN	O	—	_	0	SENT_30	[p1l207t3498r626b3573],
2	.	.	O	.	_	0	SENT_30	[p1l207t3498r626b3573],

1	USA	NNP	LOCATION	USA	_	0	SENT_31	[p1l207t3498r626b3573],
2	panel	NN	O	panel	dep	1	SENT_31	[p1l648t3498r847b3573],
3	.	.	O	.	_	0	SENT_31	[p1l648t3498r847b3573],

1	JAMA	NNP	O	JAMA	_	0	SENT_32	[p1l870t3503r1068b3566],
2	2006	CD	DATE	2006	num	1	SENT_32	[p1l1092t3502r1656b3569],
3	;	:	O	;	_	0	SENT_32	[p1l1092t3502r1656b3569],
4	296:827	CD	NUMBER	296:827	number	5	SENT_32	[p1l1092t3502r1656b3569],
5	—	CD	NUMBER	—	dep	1	SENT_32	[p1l1092t3502r1656b3569],
6	43	CD	NUMBER	43	dep	5	SENT_32	[p1l1092t3502r1656b3569],
7	.	.	O	.	_	0	SENT_32	[p1l1092t3502r1656b3569],

1	7	CD	NUMBER	7	_	0	SENT_33	[p1l11t3602r56b3654],
2	.	.	O	.	_	0	SENT_33	[p1l11t3602r56b3654],

1	Malet	NNP	PERSON	Malet	nn	2	SENT_34	[p1l138t3595r327b3654],
2	I	NNP	PERSON	I	_	0	SENT_34	[p1l351t3600r391b3667],
3	,	,	O	,	_	0	SENT_34	[p1l351t3600r391b3667],
4	Delelis	NNP	PERSON	Delelis	nn	5	SENT_34	[p1l423t3595r648b3654],
5	O	NNP	PERSON	O	appos	2	SENT_34	[p1l678t3599r746b3667],
6	,	,	O	,	_	0	SENT_34	[p1l678t3599r746b3667],
7	Valantin	NNP	PERSON	Valantin	nn	8	SENT_34	[p1l777t3595r1057b3654],
8	MA	NNP	PERSON	MA	appos	2	SENT_34	[p1l1083t3600r1218b3667],
9	,	,	O	,	_	0	SENT_34	[p1l1083t3600r1218b3667],
10	et	FW	O	et	nn	11	SENT_34	[p1l1251t3607r1310b3654],
11	al.	FW	O	al.	appos	2	SENT_34	[p1l1335t3595r1410b3654],
12	.	.	O	.	_	0	SENT_34	[p1l1335t3595r1410b3654],

1	Mutations	NNS	O	mutation	nsubj	8	SENT_35	[p1l1440t3595r1777b3655],
2	associated	VBN	O	associate	partmod	1	SENT_35	[p1l1807t3595r2151b3654],
3	with	IN	O	with	_	0	SENT_35	[p2l7t20r157b80],
4	failure	NN	O	failure	prep_with	2	SENT_35	[p2l188t19r403b80],
5	of	IN	O	of	_	0	SENT_35	[p2l436t19r512b79],
6	raltegravir	NN	O	raltegravir	nn	7	SENT_35	[p2l530t20r878b96],
7	treatment	NN	O	treatment	prep_of	4	SENT_35	[p2l908t32r1235b79],
8	affect	VBP	O	affect	_	0	SENT_35	[p2l1262t19r1452b79],
9	integrase	NN	O	integrase	nn	10	SENT_35	[p2l1480t20r1786b96],
10	sensitivity	NN	O	sensitivity	dobj	8	SENT_35	[p2l1819t20r2154b96],
11	to	TO	O	to	_	0	SENT_35	[p2l10t128r73b174],
12	the	DT	O	the	det	13	SENT_35	[p2l98t116r200b174],
13	inhibitor	NN	O	inhibitor	prep_to	8	SENT_35	[p2l223t116r519b174],
14	in	FW	O	in	nn	15	SENT_35	[p2l540t116r604b173],
15	vitro	FW	O	vitro	advmod	8	SENT_35	[p2l623t116r795b175],
16	.	.	O	.	_	0	SENT_35	[p2l623t116r795b175],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_36	[p2l820t116r1202b174],
2	Agents	NNPS	O	Agents	nn	3	SENT_36	[p2l1224t121r1452b191],
3	Chemother	NNP	O	Chemother	_	0	SENT_36	[p2l1478t116r1849b174],
4	2008	CD	DATE	2008	dep	3	SENT_36	[p2l1870t120r2148b187],
5	;	:	O	;	_	0	SENT_36	[p2l1870t120r2148b187],
6	52	CD	NUMBER	52	num	8	SENT_36	[p2l1870t120r2148b187],
7	:	:	O	:	_	0	SENT_36	[p2l1870t120r2148b187],
8	1351-8	CD	NUMBER	1351-8	dep	3	SENT_36	[p2l12t217r245b272],
9	.	.	O	.	_	0	SENT_36	[p2l12t217r245b272],

1	Copyright	NN	O	copyright	_	0	SENT_37	[p2l12t299r267b364],
2	©	CD	NUMBER	©	num	6	SENT_37	[p2l292t304r345b359],
3	2008	CD	DATE	2008	num	6	SENT_37	[p2l372t303r507b349],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_37	[p2l530t299r914b349],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_37	[p2l938t299r1148b349],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_37	[p2l1168t301r1366b363],
7	.	.	O	.	_	0	SENT_37	[p2l1168t301r1366b363],

1	Noninvasive	JJ	O	noninvasive	amod	2	SENT_38	[p2l629t513r946b560],
2	Monitoring	NN	O	monitoring	_	0	SENT_38	[p2l968t513r1256b575],
3	of	IN	O	of	_	0	SENT_38	[p2l1272t511r1332b560],
4	Tumors	NNS	O	tumor	prep_of	2	SENT_38	[p2l1337t516r1535b560],

1	Joan	NNP	PERSON	Joan	nn	3	SENT_39	[p2l887t596r965b633],
2	H.	NNP	PERSON	H.	nn	3	SENT_39	[p2l984t596r1019b624],
3	Schiller	NNP	PERSON	Schiller	_	0	SENT_39	[p2l1036t593r1168b629],
4	,	,	O	,	_	0	SENT_39	[p2l1036t593r1168b629],
5	M.D.	NNP	O	M.D.	appos	3	SENT_39	[p2l1187t596r1267b624],

1	The	DT	O	the	det	2	SENT_40	[p2l7t759r168b838],
2	treatment	NN	O	treatment	nsubj	12	SENT_40	[p2l203t776r627b838],
3	of	IN	O	of	_	0	SENT_40	[p2l658t759r757b838],
4	non	JJ	O	non	amod	10	SENT_40	[p2l774t759r1416b838],
5	—	JJ	O	—	amod	10	SENT_40	[p2l774t759r1416b838],
6	small	JJ	O	small	amod	10	SENT_40	[p2l774t759r1416b838],
7	—	NN	O	—	nn	10	SENT_40	[p2l774t759r1416b838],
8	cell	NN	O	cell	nn	10	SENT_40	[p2l774t759r1416b838],
9	lung	NN	O	lung	nn	10	SENT_40	[p2l1450t759r1643b860],
10	cancer	NN	O	cancer	prep_of	2	SENT_40	[p2l1675t785r1956b838],
11	has	VBZ	O	have	aux	12	SENT_40	[p2l1988t759r2132b838],
12	made	VBN	O	make	_	0	SENT_40	[p2l11t887r242b966],
13	limited	JJ	O	limited	amod	17	SENT_40	[p2l287t887r595b966],
14	but	CC	O	but	_	0	SENT_40	[p2l641t887r780b966],
15	clinically	RB	O	clinically	advmod	16	SENT_40	[p2l820t887r1212b988],
16	signiﬁcant	JJ	O	signiﬁcant	conj_but	13	SENT_40	[p2l1254t887r1722b988],
17	progress	NN	O	progress	dobj	12	SENT_40	[p2l1760t913r2131b988],
18	during	IN	O	during	_	0	SENT_40	[p2l11t1015r300b1116],
19	the	DT	DURATION	the	det	22	SENT_40	[p2l333t1015r465b1094],
20	past	JJ	DURATION	past	amod	22	SENT_40	[p2l500t1032r680b1116],
21	two	CD	DURATION	two	num	22	SENT_40	[p2l711t1032r868b1095],
22	decades	NNS	DURATION	decade	prep_during	12	SENT_40	[p2l905t1015r1240b1094],
23	of	IN	O	of	_	0	SENT_40	[p2l1278t1015r1378b1094],
24	clinical	JJ	O	clinical	amod	25	SENT_40	[p2l1395t1015r1708b1094],
25	research	NN	O	research	prep_of	22	SENT_40	[p2l1743t1015r2128b1094],
26	.	.	O	.	_	0	SENT_40	[p2l1743t1015r2128b1094],

1	Through	IN	O	through	_	0	SENT_41	[p2l7t1143r378b1244],
2	carefully	RB	O	carefully	advmod	3	SENT_41	[p2l411t1143r779b1244],
3	designed	VBN	O	design	amod	5	SENT_41	[p2l808t1143r1183b1244],
4	clinical	JJ	O	clinical	amod	5	SENT_41	[p2l1216t1143r1522b1222],
5	trials	NNS	O	trial	prep_through	9	SENT_41	[p2l1554t1143r1792b1239],
6	,	,	O	,	_	0	SENT_41	[p2l1554t1143r1792b1239],
7	investigators	NNS	O	investigator	nsubj	9	SENT_41	[p2l1829t1144r2132b1222, p2l11t1288r271b1372],
8	have	VBP	O	have	aux	9	SENT_41	[p2l328t1271r515b1350],
9	identified	VBN	O	identify	_	0	SENT_41	[p2l571t1271r978b1350],
10	several	JJ	O	several	amod	12	SENT_41	[p2l1035t1271r1321b1351],
11	chemotherapeutic	JJ	O	chemotherapeutic	amod	12	SENT_41	[p2l1376t1271r2135b1372],
12	drugs	NNS	O	drug	dobj	9	SENT_41	[p2l11t1399r246b1500],
13	to	TO	O	to	aux	14	SENT_41	[p2l279t1416r359b1478],
14	combat	VB	O	combat	xcomp	9	SENT_41	[p2l392t1399r701b1478],
15	this	DT	O	this	det	16	SENT_41	[p2l727t1399r880b1478],
16	disease	NN	O	disease	dobj	14	SENT_41	[p2l913t1399r1232b1478],
17	.	.	O	.	_	0	SENT_41	[p2l913t1399r1232b1478],

1	Many	JJ	O	many	amod	2	SENT_42	[p2l1264t1407r1498b1500],
2	questions	NNS	O	question	nsubjpass	7	SENT_42	[p2l1525t1400r1918b1500],
3	have	VBP	O	have	aux	5	SENT_42	[p2l1950t1399r2134b1479],
4	been	VBN	O	be	auxpass	5	SENT_42	[p2l11t1527r213b1606],
5	asked	VBN	O	ask	_	0	SENT_42	[p2l256t1527r498b1607],
6	and	CC	O	and	_	0	SENT_42	[p2l540t1527r698b1606],
7	answered	VBN	O	answer	conj_and	5	SENT_42	[p2l740t1527r1171b1607],
8	.	.	O	.	_	0	SENT_42	[p2l740t1527r1171b1607],

1	Which	WDT	O	which	det	2	SENT_43	[p2l1216t1527r1500b1606],
2	combinations	NNS	O	combination	nsubj	3	SENT_43	[p2l1544t1527r2131b1606],
3	work	VBP	O	work	_	0	SENT_43	[p2l6t1655r228b1734],
4	best	RB	O	best	advmod	3	SENT_43	[p2l263t1652r475b1733],
5	?	.	O	?	_	0	SENT_43	[p2l263t1652r475b1733],

1	How	WRB	O	how	advmod	2	SENT_44	[p2l513t1662r718b1734],
2	frequently	RB	O	frequently	advmod	5	SENT_44	[p2l753t1654r1192b1755],
3	should	MD	O	should	aux	5	SENT_44	[p2l1228t1655r1515b1733],
4	they	PRP	O	they	nsubj	5	SENT_44	[p2l1554t1655r1737b1755],
5	be	VB	O	be	_	0	SENT_44	[p2l1772t1655r1868b1733],
6	given	VBN	O	give	dep	5	SENT_44	[p2l1907t1656r2134b1755],
7	and	CC	O	and	_	0	SENT_44	[p2l10t1783r168b1861],
8	for	IN	O	for	dep	5	SENT_44	[p2l203t1782r326b1861],
9	how	WRB	O	how	advmod	10	SENT_44	[p2l358t1783r543b1862],
10	long	RB	O	long	pobj	8	SENT_44	[p2l572t1780r797b1883],
11	?	.	O	?	_	0	SENT_44	[p2l572t1780r797b1883],

1	And	CC	O	and	dep	6	SENT_45	[p2l829t1783r1007b1861],
2	which	WDT	O	which	dobj	6	SENT_45	[p2l1038t1783r1301b1862],
3	patients	NNS	O	patient	nsubjpass	6	SENT_45	[p2l1335t1784r1676b1883],
4	should	MD	O	should	aux	6	SENT_45	[p2l1715t1783r2002b1862],
5	be	VB	O	be	auxpass	6	SENT_45	[p2l2037t1783r2134b1861],
6	treated	VBN	O	treat	_	0	SENT_45	[p2l11t1908r378b1989],
7	?	.	O	?	_	0	SENT_45	[p2l11t1908r378b1989],

1	1	CD	NUMBER	1	nsubjpass	8	SENT_46	[p2l11t1908r378b1989],
2	Nonetheless	RB	O	nonetheless	advmod	8	SENT_46	[p2l423t1911r974b2006],
3	,	,	O	,	_	0	SENT_46	[p2l423t1911r974b2006],
4	such	JJ	O	such	amod	5	SENT_46	[p2l1028t1911r1221b1990],
5	advances	NNS	O	advance	nsubjpass	8	SENT_46	[p2l1266t1911r1648b1990],
6	have	VBP	O	have	aux	8	SENT_46	[p2l1696t1911r1886b1990],
7	been	VBN	O	be	auxpass	8	SENT_46	[p2l1933t1911r2134b1989],
8	limited	VBN	O	limit	_	0	SENT_46	[p2l10t2039r341b2135],
9	,	,	O	,	_	0	SENT_46	[p2l10t2039r341b2135],
10	and	CC	O	and	_	0	SENT_46	[p2l387t2039r545b2118],
11	the	DT	O	the	det	12	SENT_46	[p2l586t2039r719b2118],
12	prognosis	NN	O	prognosis	nsubj	19	SENT_46	[p2l759t2040r1184b2140],
13	for	IN	O	for	_	0	SENT_46	[p2l1228t2039r1351b2118],
14	patients	NNS	O	patient	prep_for	12	SENT_46	[p2l1388t2040r1729b2140],
15	with	IN	O	with	_	0	SENT_46	[p2l1767t2039r1963b2118],
16	advanced	JJ	O	advanced	amod	17	SENT_46	[p2l2003t2039r2132b2118, p2l6t2167r303b2246],
17	disease	NN	O	disease	prep_with	14	SENT_46	[p2l342t2167r652b2246],
18	remains	VBZ	O	remain	cop	19	SENT_46	[p2l690t2168r1038b2246],
19	grim	JJ	O	grim	conj_and	8	SENT_46	[p2l1078t2168r1310b2268],
20	.	.	O	.	_	0	SENT_46	[p2l1078t2168r1310b2268],

1	Despite	IN	O	despite	_	0	SENT_47	[p2l139t2296r453b2396],
2	the	DT	O	the	det	4	SENT_47	[p2l492t2295r623b2374],
3	modest	JJ	O	modest	amod	4	SENT_47	[p2l662t2295r975b2374],
4	results	NNS	O	result	prep_despite	23	SENT_47	[p2l1010t2295r1286b2374],
5	achieved	VBN	O	achieve	partmod	4	SENT_47	[p2l1326t2295r1686b2374],
6	with	IN	O	with	_	0	SENT_47	[p2l1721t2295r1913b2374],
7	con	NN	O	con	npadvmod	9	SENT_47	[p2l1953t2321r2132b2374],
8	—	CD	NUMBER	—	num	7	SENT_47	[p2l1953t2321r2132b2374],
9	ventional	JJ	O	ventional	amod	12	SENT_47	[p2l6t2423r397b2502],
10	cytotoxic	JJ	O	cytotoxic	amod	12	SENT_47	[p2l430t2424r818b2524],
11	chemotherapeutic	JJ	O	chemotherapeutic	amod	12	SENT_47	[p2l852t2423r1627b2524],
12	agents	NNS	O	agent	prep_with	5	SENT_47	[p2l1660t2440r1961b2524],
13	,	,	O	,	_	0	SENT_47	[p2l1660t2440r1961b2524],
14	the	DT	DATE	the	det	17	SENT_47	[p2l2001t2423r2134b2502],
15	past	JJ	DATE	past	amod	17	SENT_47	[p2l10t2568r187b2652],
16	several	JJ	DATE	several	amod	17	SENT_47	[p2l216t2551r502b2630],
17	decades	NNS	DATE	decade	nsubj	23	SENT_47	[p2l535t2551r862b2630],
18	of	IN	O	of	_	0	SENT_47	[p2l897t2551r996b2630],
19	basic	JJ	O	basic	amod	21	SENT_47	[p2l1011t2551r1222b2630],
20	cancer	NN	O	cancer	nn	21	SENT_47	[p2l1255t2577r1530b2630],
21	research	NN	O	research	prep_of	17	SENT_47	[p2l1560t2551r1914b2630],
22	have	VBP	O	have	aux	23	SENT_47	[p2l1947t2551r2134b2630],
23	started	VBN	O	start	_	0	SENT_47	[p2l12t2679r311b2758],
24	to	TO	O	to	aux	25	SENT_47	[p2l350t2696r432b2758],
25	yield	VB	O	yield	xcomp	23	SENT_47	[p2l468t2679r671b2780],
26	therapeutic	JJ	O	therapeutic	amod	27	SENT_47	[p2l710t2679r1196b2780],
27	results	NNS	O	result	dobj	25	SENT_47	[p2l1234t2679r1517b2758],
28	based	VBN	O	base	_	0	SENT_47	[p2l1560t2679r1805b2758],
29	on	IN	O	on	prepc_based_on	25	SENT_47	[p2l1845t2705r1951b2758],
30	our	PRP$	O	we	poss	31	SENT_47	[p2l1991t2705r2136b2758],
31	understanding	NN	O	understanding	pobj	25	SENT_47	[p2l11t2807r646b2908],
32	of	IN	O	of	_	0	SENT_47	[p2l683t2807r783b2886],
33	cancer	NN	O	cancer	nn	34	SENT_47	[p2l803t2833r1084b2886],
34	biology	NN	O	biology	prep_of	31	SENT_47	[p2l1121t2807r1452b2908],
35	.	.	O	.	_	0	SENT_47	[p2l1121t2807r1452b2908],

1	The	DT	O	the	det	2	SENT_48	[p2l1493t2807r1654b2886],
2	identification	NN	O	identification	nsubj	7	SENT_48	[p2l1692t2807r2132b2886, p2l11t2936r184b3014],
3	of	IN	O	of	_	0	SENT_48	[p2l233t2935r334b3014],
4	“	NN	O	“	nn	6	SENT_48	[p2l368t2935r851b3036],
5	druggable	JJ	O	druggable	amod	6	SENT_48	[p2l368t2935r851b3036],
6	targets	NNS	O	target	prep_of	2	SENT_48	[p2l900t2941r1246b3036],
7	”	VBP	O	”	_	0	SENT_48	[p2l900t2941r1246b3036],
8	has	VBZ	O	have	aux	9	SENT_48	[p2l1299t2935r1445b3014],
9	emerged	VBN	O	emerge	ccomp	7	SENT_48	[p2l1497t2935r1872b3036],
10	from	IN	O	from	_	0	SENT_48	[p2l1921t2935r2134b3014],
11	studies	NNS	O	study	prep_from	9	SENT_48	[p2l12t3063r318b3142],
12	dissecting	VBG	O	dissect	partmod	11	SENT_48	[p2l386t3063r836b3164],
13	the	DT	O	the	det	14	SENT_48	[p2l897t3063r1033b3142],
14	mechanisms	NNS	O	mechanism	dobj	12	SENT_48	[p2l1097t3063r1650b3142],
15	of	IN	O	of	_	0	SENT_48	[p2l1717t3063r1818b3142],
16	tumor	NN	O	tumor	nn	17	SENT_48	[p2l1865t3080r2137b3142],
17	growth	NN	O	growth	prep_of	14	SENT_48	[p2l11t3191r342b3292],
18	,	,	O	,	_	0	SENT_48	[p2l11t3191r342b3292],
19	invasion	NN	O	invasion	appos	17	SENT_48	[p2l387t3192r758b3287],
20	,	,	O	,	_	0	SENT_48	[p2l387t3192r758b3287],
21	and	CC	O	and	_	0	SENT_48	[p2l803t3191r960b3270],
22	metastases	NNS	O	metastase	nsubj	41	SENT_48	[p2l999t3208r1486b3287],
23	;	:	O	;	_	0	SENT_48	[p2l999t3208r1486b3287],
24	the	DT	O	the	det	25	SENT_48	[p2l1531t3191r1662b3270],
25	evasion	NN	O	evasion	dep	22	SENT_48	[p2l1703t3192r2013b3270],
26	of	IN	O	of	_	0	SENT_48	[p2l2054t3191r2153b3270],
27	apoptosis	NN	O	apoptosis	prep_of	25	SENT_48	[p2l10t3320r445b3420],
28	;	:	O	;	_	0	SENT_48	[p2l10t3320r445b3420],
29	self	NN	O	self	nn	31	SENT_48	[p2l503t3319r1157b3420],
30	—	CD	NUMBER	—	num	31	SENT_48	[p2l503t3319r1157b3420],
31	sufficiency	NN	O	sufficiency	dep	25	SENT_48	[p2l503t3319r1157b3420],
32	in	IN	O	in	_	0	SENT_48	[p2l1203t3320r1286b3397],
33	growth	NN	O	growth	nn	34	SENT_48	[p2l1339t3319r1653b3420],
34	signaling	NN	O	signaling	prep_in	31	SENT_48	[p2l1707t3319r2130b3420],
35	;	:	O	;	_	0	SENT_48	[p2l1707t3319r2130b3420],
36	insensitivity	NN	O	insensitivity	dep	25	SENT_48	[p2l10t3448r521b3548],
37	to	TO	O	to	_	0	SENT_48	[p2l557t3464r637b3526],
38	antigrowth	JJ	O	antigrowth	amod	39	SENT_48	[p2l679t3447r1153b3548],
39	signals	NNS	O	signal	prep_to	36	SENT_48	[p2l1195t3447r1512b3548],
40	;	:	O	;	_	0	SENT_48	[p2l1195t3447r1512b3548],
41	sustained	VBD	O	sustain	conj_and	7	SENT_48	[p2l1558t3447r1960b3526],
42	an	DT	O	a	det	44	SENT_48	[p2l2000t3473r2132b3526],
43	—	NN	O	—	nn	44	SENT_48	[p2l2000t3473r2132b3526],
44	giogenesis	NN	O	giogenesis	dobj	41	SENT_48	[p2l11t3576r476b3676],
45	;	:	O	;	_	0	SENT_48	[p2l11t3576r476b3676],
46	and	CC	O	and	_	0	SENT_48	[p2l518t3575r676b3654],
47	limitless	JJ	O	limitless	amod	50	SENT_48	[p2l716t3575r1084b3654],
48	replicative	JJ	O	replicative	amod	50	SENT_48	[p2l1127t3575r1566b3676],
49	potential	JJ	O	potential	amod	50	SENT_48	[p2l1606t3575r1993b3676],
50	—	NN	O	—	dep	53	SENT_48	[p2l2030t3620r2138b3628],
51	the	DT	O	the	det	53	SENT_48	[p2l11t3703r144b3782],
52	classic	JJ	O	classic	amod	53	SENT_48	[p2l182t3703r460b3782],
53	hallmarks	NNS	O	hallmark	conj_and	7	SENT_48	[p2l496t3703r934b3783],
54	of	IN	O	of	_	0	SENT_48	[p2l973t3703r1073b3782],
55	cancer	NN	O	cancer	prep_of	53	SENT_48	[p2l1093t3709r1433b3782],
56	?	.	O	?	_	0	SENT_48	[p2l1093t3709r1433b3782],

1	Some	DT	O	some	det	2	SENT_49	[p2l1473t3709r1704b3782],
2	therapies	NNS	O	therapy	nsubj	19	SENT_49	[p2l1742t3703r2131b3804],
3	that	WDT	O	that	nsubj	4	SENT_49	[p3l11t20r180b99],
4	target	VBP	O	target	rcmod	2	SENT_49	[p3l214t37r464b121],
5	these	DT	O	these	det	6	SENT_49	[p3l497t20r717b99],
6	pathways	NNS	O	pathway	dobj	4	SENT_49	[p3l754t20r1169b121],
7	,	,	O	,	_	0	SENT_49	[p3l754t20r1169b121],
8	such	JJ	O	such	_	0	SENT_49	[p3l1214t20r1405b99],
9	as	IN	O	as	_	0	SENT_49	[p3l1442t47r1526b99],
10	agents	NNS	O	agent	prep_such_as	2	SENT_49	[p3l1566t37r1837b121],
11	inhibiting	VBG	O	inhibit	partmod	10	SENT_49	[p3l1876t20r2132b99, p3l10t149r208b249],
12	angiogenesis	NN	O	angiogenesis	nn	17	SENT_49	[p3l253t149r810b249],
13	and	CC	O	and	_	0	SENT_49	[p3l863t148r1020b227],
14	cell	NN	O	cell	nn	17	SENT_49	[p3l1072t148r1659b249],
15	—	NN	O	—	nn	17	SENT_49	[p3l1072t148r1659b249],
16	signaling	NN	O	signaling	nn	17	SENT_49	[p3l1072t148r1659b249],
17	pathways	NNS	O	pathway	dobj	11	SENT_49	[p3l1704t148r2128b249],
18	,	,	O	,	_	0	SENT_49	[p3l1704t148r2128b249],
19	are	VBP	O	be	_	0	SENT_49	[p3l10t302r139b355],
20	approved	VBN	O	approve	dep	19	SENT_49	[p3l176t276r566b377],
21	and	CC	O	and	_	0	SENT_49	[p3l603t276r761b355],
22	in	IN	O	in	dep	19	SENT_49	[p3l798t277r882b354],
23	the	DT	O	the	det	24	SENT_49	[p3l920t276r1053b355],
24	clinic	NN	O	clinic	pobj	22	SENT_49	[p3l1092t276r1348b355],
25	.	.	O	.	_	0	SENT_49	[p3l1092t276r1348b355],

1	An	DT	O	a	det	2	SENT_50	[p3l136t412r259b482],
2	example	NN	O	example	nsubj	17	SENT_50	[p3l304t404r660b505],
3	of	IN	O	of	_	0	SENT_50	[p3l704t404r805b483],
4	how	WRB	O	how	advmod	12	SENT_50	[p3l830t404r1014b483],
5	an	DT	O	a	det	6	SENT_50	[p3l1054t430r1157b483],
6	understanding	NN	O	understanding	nsubj	12	SENT_50	[p3l1201t404r1836b505],
7	of	IN	O	of	_	0	SENT_50	[p3l1878t404r1978b483],
8	basic	JJ	O	basic	amod	10	SENT_50	[p3l2003t404r2132b483, p3l12t533r120b611],
9	cancer	NN	O	cancer	nn	10	SENT_50	[p3l154t558r429b611],
10	biology	NN	O	biology	prep_of	6	SENT_50	[p3l461t532r774b633],
11	has	VBZ	O	have	aux	12	SENT_50	[p3l804t532r946b611],
12	translated	VBN	O	translate	prepc_of	2	SENT_50	[p3l983t532r1405b611],
13	into	IN	O	into	_	0	SENT_50	[p3l1438t533r1604b611],
14	the	DT	O	the	det	15	SENT_50	[p3l1640t532r1770b611],
15	clinic	NN	O	clinic	prep_into	12	SENT_50	[p3l1806t532r2033b611],
16	is	VBZ	O	be	cop	17	SENT_50	[p3l2066t533r2131b611],
17	that	IN	O	that	_	0	SENT_50	[p3l11t660r180b739],
18	of	IN	O	of	_	0	SENT_50	[p3l213t660r312b739],
19	the	DT	O	the	det	20	SENT_50	[p3l332t660r462b739],
20	pathway	NN	O	pathway	prep_of	17	SENT_50	[p3l498t660r853b761],
21	of	IN	O	of	_	0	SENT_50	[p3l887t660r986b739],
22	the	DT	O	the	det	29	SENT_50	[p3l1005t660r1136b739],
23	epidermal	JJ	O	epidermal	amod	29	SENT_50	[p3l1174t660r1598b761],
24	growth	NN	O	growth	nn	29	SENT_50	[p3l1635t660r1943b761],
25	factor	NN	O	factor	nn	29	SENT_50	[p3l1981t660r2131b739, p3l11t805r131b867],
26	receptor	NN	O	receptor	nn	29	SENT_50	[p3l163t805r519b889],
27	(	CD	NUMBER	(	num	29	SENT_50	[p3l556t794r888b884],
28	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_50	[p3l556t794r888b884],
29	)	NN	O	)	prep_of	20	SENT_50	[p3l556t794r888b884],
30	,	,	O	,	_	0	SENT_50	[p3l556t794r888b884],
31	one	CD	NUMBER	one	appos	29	SENT_50	[p3l929t814r1080b867],
32	of	IN	O	of	_	0	SENT_50	[p3l1117t788r1217b867],
33	the	DT	O	the	det	35	SENT_50	[p3l1235t788r1367b867],
34	four	CD	NUMBER	four	num	35	SENT_50	[p3l1404t788r1583b867],
35	members	NNS	O	member	prep_of	31	SENT_50	[p3l1616t788r2013b867],
36	of	IN	O	of	_	0	SENT_50	[p3l2052t788r2152b867],
37	the	DT	O	the	det	39	SENT_50	[p3l11t916r141b995],
38	HER2/ErbB	NN	O	her2/erbb	nn	39	SENT_50	[p3l179t916r657b1006],
39	family	NN	O	family	prep_of	35	SENT_50	[p3l697t916r967b1017],
40	of	IN	O	of	_	0	SENT_50	[p3l1001t916r1101b995],
41	receptors	NNS	O	receptor	prep_of	39	SENT_50	[p3l1120t933r1530b1017],
42	.	.	O	.	_	0	SENT_50	[p3l1120t933r1530b1017],

1	Ligands	NNS	MISC	ligand	nsubj	2	SENT_51	[p3l1573t916r1903b1017],
2	bind	VBP	O	bind	_	0	SENT_51	[p3l1944t916r2133b995],
3	to	TO	O	to	_	0	SENT_51	[p3l11t1061r93b1123],
4	the	DT	O	the	det	5	SENT_51	[p3l136t1044r270b1123],
5	receptor	NN	O	receptor	prep_to	2	SENT_51	[p3l311t1061r693b1145],
6	,	,	O	,	_	0	SENT_51	[p3l311t1061r693b1145],
7	inducing	VBG	O	induce	xcomp	2	SENT_51	[p3l739t1044r1127b1145],
8	receptor	NN	O	receptor	nn	9	SENT_51	[p3l1164t1061r1528b1145],
9	dimerization	NN	O	dimerization	dobj	7	SENT_51	[p3l1566t1044r2133b1123],
10	and	CC	O	and	_	0	SENT_51	[p3l10t1172r167b1251],
11	subsequent	JJ	O	subsequent	amod	12	SENT_51	[p3l211t1172r696b1273],
12	phosphorylation	NN	O	phosphorylation	dobj	7	SENT_51	[p3l732t1172r1441b1273],
13	of	IN	O	of	_	0	SENT_51	[p3l1484t1172r1583b1251],
14	intracellular	JJ	O	intracellular	amod	15	SENT_51	[p3l1606t1172r2136b1251],
15	tyrosine	NN	O	tyrosine	prep_of	9	SENT_51	[p3l11t1301r357b1401],
16	l	NN	O	l	tmod	7	SENT_51	[p3l396t1300r1074b1401],
17	<	JJR	O	<	dep	2	SENT_51	[p3l396t1300r1074b1401],
18	inase	CD	NUMBER	inase	num	21	SENT_51	[p3l396t1300r1074b1401],
19	—	NN	O	—	nn	21	SENT_51	[p3l396t1300r1074b1401],
20	binding	NN	O	binding	nn	21	SENT_51	[p3l396t1300r1074b1401],
21	sites	NNS	O	site	dep	17	SENT_51	[p3l1110t1301r1320b1396],
22	,	,	O	,	_	0	SENT_51	[p3l1110t1301r1320b1396],
23	leading	VBG	O	lead	partmod	2	SENT_51	[p3l1364t1300r1683b1401],
24	to	TO	O	to	_	0	SENT_51	[p3l1718t1317r1800b1379],
25	the	DT	O	the	det	28	SENT_51	[p3l1841t1300r1973b1379],
26	ac	NN	O	ac	nn	28	SENT_51	[p3l2011t1327r2131b1379],
27	—	NN	O	—	nn	28	SENT_51	[p3l2011t1327r2131b1379],
28	tivation	NN	O	tivation	prep_to	23	SENT_51	[p3l11t1429r335b1507],
29	of	IN	O	of	_	0	SENT_51	[p3l389t1428r488b1507],
30	a	DT	O	a	det	31	SENT_51	[p3l523t1455r567b1507],
31	cascade	NN	O	cascade	prep_of	28	SENT_51	[p3l620t1428r948b1507],
32	of	IN	O	of	_	0	SENT_51	[p3l1003t1428r1102b1507],
33	downstream	JJ	O	downstream	amod	35	SENT_51	[p3l1138t1428r1678b1507],
34	signaling	NN	O	signaling	nn	35	SENT_51	[p3l1733t1428r2136b1529],
35	events	NNS	O	event	prep_of	31	SENT_51	[p3l11t1573r299b1636],
36	.	.	O	.	_	0	SENT_51	[p3l11t1573r299b1636],

1	Activation	NN	O	activation	nsubj	5	SENT_52	[p3l340t1557r777b1635],
2	of	IN	O	of	_	0	SENT_52	[p3l817t1556r917b1635],
3	these	DT	O	these	det	4	SENT_52	[p3l938t1556r1162b1635],
4	pathways	NNS	O	pathway	prep_of	1	SENT_52	[p3l1200t1556r1599b1657],
5	leads	VBZ	O	lead	ccomp	29	SENT_52	[p3l1638t1556r1853b1635],
6	to	TO	O	to	_	0	SENT_52	[p3l1895t1573r1977b1635],
7	increased	VBN	O	increase	amod	9	SENT_52	[p3l2016t1557r2131b1634, p3l11t1684r331b1763],
8	cellular	JJ	O	cellular	amod	9	SENT_52	[p3l366t1684r687b1763],
9	proliferation	NN	O	proliferation	prep_to	5	SENT_52	[p3l716t1684r1283b1785],
10	,	,	O	,	_	0	SENT_52	[p3l716t1684r1283b1785],
11	motility	NN	O	motility	nsubjpass	29	SENT_52	[p3l1323t1684r1680b1785],
12	,	,	O	,	_	0	SENT_52	[p3l1323t1684r1680b1785],
13	adhesion	NN	O	adhesion	conj_and	11	SENT_52	[p3l1719t1684r2127b1780],
14	,	,	O	,	_	0	SENT_52	[p3l1719t1684r2127b1780],
15	invasion	NN	O	invasion	conj_and	11	SENT_52	[p3l10t1813r389b1908],
16	,	,	O	,	_	0	SENT_52	[p3l10t1813r389b1908],
17	angiogenesis	NN	O	angiogenesis	conj_and	11	SENT_52	[p3l443t1813r1025b1913],
18	,	,	O	,	_	0	SENT_52	[p3l443t1813r1025b1913],
19	and	CC	O	and	_	0	SENT_52	[p3l1077t1812r1235b1891],
20	inhibition	NN	O	inhibition	conj_and	11	SENT_52	[p3l1282t1812r1711b1891],
21	of	IN	O	of	_	0	SENT_52	[p3l1760t1812r1859b1891],
22	apop	NN	O	apop	nn	26	SENT_52	[p3l1889t1838r2131b1913],
23	—	NN	O	—	nn	26	SENT_52	[p3l1889t1838r2131b1913],
24	tosis	NN	O	tosis	nn	26	SENT_52	[p3l11t1941r271b2019],
25	.3	NN	NUMBER	.3	nn	26	SENT_52	[p3l11t1941r271b2019],
26	Agents	NNS	O	agent	prep_of	11	SENT_52	[p3l319t1948r615b2041],
27	have	VBP	O	have	aux	29	SENT_52	[p3l666t1940r855b2019],
28	been	VBN	O	be	auxpass	29	SENT_52	[p3l905t1940r1106b2019],
29	developed	VBN	O	develop	_	0	SENT_52	[p3l1156t1940r1583b2041],
30	that	IN	O	that	complm	31	SENT_52	[p3l1632t1940r1805b2019],
31	inhibit	VBP	O	inhibit	conj_or	31	SENT_52	[p3l1848t1940r2138b2019],
32	this	DT	O	this	det	33	SENT_52	[p3l11t2068r171b2147],
33	pathway	NN	O	pathway	dobj	31	SENT_52	[p3l212t2068r573b2169],
34	by	IN	O	by	_	0	SENT_52	[p3l610t2068r707b2169],
35	binding	VBG	O	bind	prep_by	33	SENT_52	[p3l744t2068r1081b2169],
36	to	TO	O	to	_	0	SENT_52	[p3l1119t2085r1200b2147],
37	the	DT	O	the	det	39	SENT_52	[p3l1243t2068r1375b2147],
38	extracellular	JJ	O	extracellular	amod	39	SENT_52	[p3l1417t2068r1955b2147],
39	domain	NN	O	domain	prep_to	31	SENT_52	[p3l1993t2068r2131b2147, p3l11t2197r232b2275],
40	of	IN	O	of	_	0	SENT_52	[p3l270t2196r370b2275],
41	the	DT	O	the	det	42	SENT_52	[p3l388t2196r521b2275],
42	receptor	NN	O	receptor	prep_of	39	SENT_52	[p3l558t2213r931b2297],
43	,	,	O	,	_	0	SENT_52	[p3l558t2213r931b2297],
44	as	IN	O	as	cc	31	SENT_52	[p3l973t2223r1058b2275],
45	in	IN	O	in	_	0	SENT_52	[p3l1096t2197r1180b2274],
46	the	DT	O	the	det	47	SENT_52	[p3l1217t2196r1349b2275],
47	case	NN	O	case	prep_in	31	SENT_52	[p3l1387t2223r1566b2275],
48	of	IN	O	of	_	0	SENT_52	[p3l1604t2196r1703b2275],
49	monoclonal	JJ	O	monoclonal	amod	50	SENT_52	[p3l1722t2196r2131b2275, p3l11t2324r145b2403],
50	antibodies	NNS	O	antibody	prep_of	47	SENT_52	[p3l195t2324r655b2403],
51	such	JJ	O	such	_	0	SENT_52	[p3l709t2324r905b2403],
52	as	IN	O	as	_	0	SENT_52	[p3l955t2351r1042b2403],
53	cetuximab	NN	O	cetuximab	nn	57	SENT_52	[p3l1094t2324r1555b2403],
54	and	CC	O	and	_	0	SENT_52	[p3l1605t2324r1765b2403],
55	panitu	NN	O	panitu	nn	57	SENT_52	[p3l1814t2325r2131b2425],
56	—	NN	O	—	nn	57	SENT_52	[p3l1814t2325r2131b2425],
57	mumab	NN	O	mumab	prep_such_as	50	SENT_52	[p3l11t2452r355b2548],
58	,	,	O	,	_	0	SENT_52	[p3l11t2452r355b2548],
59	or	CC	O	or	_	0	SENT_52	[p3l391t2478r478b2531],
60	by	IN	O	by	_	0	SENT_52	[p3l505t2452r600b2553],
61	binding	VBG	O	bind	prep_by	31	SENT_52	[p3l626t2452r956b2553],
62	to	TO	O	to	_	0	SENT_52	[p3l982t2469r1062b2531],
63	the	DT	O	the	det	67	SENT_52	[p3l1093t2452r1223b2531],
64	intracellular	JJ	O	intracellular	amod	67	SENT_52	[p3l1251t2452r1768b2531],
65	tyrosine	NN	O	tyrosine	nn	67	SENT_52	[p3l1794t2453r2133b2553],
66	kinase	NN	O	kinase	nn	67	SENT_52	[p3l10t2580r289b2659],
67	domain	NN	O	domain	prep_to	61	SENT_52	[p3l332t2580r684b2676],
68	,	,	O	,	_	0	SENT_52	[p3l332t2580r684b2676],
69	such	JJ	O	such	_	0	SENT_52	[p3l733t2580r927b2659],
70	as	IN	O	as	_	0	SENT_52	[p3l968t2607r1053b2659],
71	erlotinib	NN	O	erlotinib	prep_such_as	61	SENT_52	[p3l1098t2580r1487b2676],
72	,	,	O	,	_	0	SENT_52	[p3l1098t2580r1487b2676],
73	gefitinib	NN	O	gefitinib	prep_such_as	61	SENT_52	[p3l1534t2580r1928b2681],
74	,	,	O	,	_	0	SENT_52	[p3l1534t2580r1928b2681],
75	and	CC	O	and	_	0	SENT_52	[p3l1975t2580r2133b2659],
76	lapatinib	NN	O	lapatinib	prep_such_as	61	SENT_52	[p3l9t2708r415b2809],
77	.	.	O	.	_	0	SENT_52	[p3l9t2708r415b2809],

1	However	RB	O	however	advmod	7	SENT_53	[p3l139t2844r518b2932],
2	,	,	O	,	_	0	SENT_53	[p3l139t2844r518b2932],
3	these	DT	O	these	det	4	SENT_53	[p3l560t2836r775b2915],
4	drugs	NNS	O	drug	nsubj	7	SENT_53	[p3l812t2836r1047b2937],
5	do	VBP	O	do	aux	7	SENT_53	[p3l1085t2836r1185b2915],
6	not	RB	O	not	neg	7	SENT_53	[p3l1222t2853r1360b2915],
7	work	VB	O	work	_	0	SENT_53	[p3l1386t2836r1601b2916],
8	in	IN	O	in	_	0	SENT_53	[p3l1631t2837r1712b2914],
9	everyone	NN	O	everyone	prep_in	7	SENT_53	[p3l1749t2862r2128b2937],
10	.	.	O	.	_	0	SENT_53	[p3l1749t2862r2128b2937],

1	Even	RB	O	even	advmod	18	SENT_54	[p3l9t2972r208b3044],
2	though	IN	O	though	dep	18	SENT_54	[p3l248t2964r557b3065],
3	patients	NNS	O	patient	nsubj	18	SENT_54	[p3l595t2965r937b3065],
4	whose	WP$	O	whose	poss	5	SENT_54	[p3l975t2964r1249b3043],
5	tumors	NNS	O	tumor	nsubj	6	SENT_54	[p3l1290t2981r1597b3043],
6	have	VBP	O	have	rcmod	3	SENT_54	[p3l1640t2964r1830b3043],
7	an	DT	O	a	det	9	SENT_54	[p3l1869t2990r1972b3043],
8	ac	NN	O	ac	nn	9	SENT_54	[p3l2011t2991r2131b3043],
9	—	NN	O	—	dobj	6	SENT_54	[p3l2011t2991r2131b3043],
10	tivating	VBG	O	tivate	partmod	9	SENT_54	[p3l11t3093r339b3193],
11	mutation	NN	O	mutation	dobj	10	SENT_54	[p3l374t3093r767b3171],
12	in	IN	O	in	_	0	SENT_54	[p3l805t3093r888b3170],
13	the	DT	O	the	det	16	SENT_54	[p3l928t3092r1061b3171],
14	tyrosine	NN	O	tyrosine	nn	16	SENT_54	[p3l1100t3093r1446b3193],
15	kinase	NN	O	kinase	nn	16	SENT_54	[p3l1485t3092r1764b3172],
16	domain	NN	O	domain	prep_in	11	SENT_54	[p3l1804t3092r2133b3171],
17	are	VBP	O	be	cop	18	SENT_54	[p3l10t3247r141b3299],
18	likely	JJ	O	likely	advcl	37	SENT_54	[p3l198t3220r435b3321],
19	to	TO	O	to	aux	20	SENT_54	[p3l489t3237r572b3299],
20	have	VB	O	have	xcomp	18	SENT_54	[p3l631t3220r825b3299],
21	a	DT	O	a	det	23	SENT_54	[p3l882t3247r927b3299],
22	high	JJ	O	high	amod	23	SENT_54	[p3l983t3220r1181b3321],
23	rate	NN	O	rate	dobj	20	SENT_54	[p3l1239t3237r1402b3299],
24	of	IN	O	of	_	0	SENT_54	[p3l1462t3220r1562b3299],
25	response	NN	O	response	prep_of	23	SENT_54	[p3l1602t3246r1990b3321],
26	to	TO	O	to	_	0	SENT_54	[p3l2049t3237r2131b3299],
27	EGFR	NN	ORGANIZATION	egfr	nn	30	SENT_54	[p3l9t3354r265b3432],
28	tyrosine	NN	O	tyrosine	nn	30	SENT_54	[p3l302t3349r648b3449],
29	kinase	NN	O	kinase	nn	30	SENT_54	[p3l696t3348r974b3428],
30	inhibitors	NNS	O	inhibitor	prep_to	20	SENT_54	[p3l1022t3348r1443b3427],
31	and	CC	O	and	_	0	SENT_54	[p3l1492t3348r1649b3427],
32	prolonged	JJ	O	prolonged	amod	33	SENT_54	[p3l1695t3348r2133b3449],
33	survival	NN	O	survival	conj_and	30	SENT_54	[p3l12t3476r409b3572],
34	,4	CD	NUMBER	,4	num	33	SENT_54	[p3l12t3476r409b3572],
35	these	DT	O	these	det	36	SENT_54	[p3l443t3476r666b3555],
36	patients	NNS	O	patient	nsubj	37	SENT_54	[p3l698t3477r1040b3577],
37	are	VBP	O	be	_	0	SENT_54	[p3l1075t3502r1204b3555],
38	in	IN	O	in	_	0	SENT_54	[p3l1237t3477r1320b3554],
39	the	DT	O	the	det	40	SENT_54	[p3l1355t3476r1487b3555],
40	minority	NN	O	minority	prep_in	37	SENT_54	[p3l1521t3477r1911b3577],
41	.	.	O	.	_	0	SENT_54	[p3l1521t3477r1911b3577],

1	(	NN	O	(	_	0	SENT_55	[p3l1955t3483r2131b3577, p3l9t3604r514b3705],
2	Approximately	RB	O	approximately	quantmod	3	SENT_55	[p3l1955t3483r2131b3577, p3l9t3604r514b3705],
3	10	CD	PERCENT	10	num	4	SENT_55	[p3l547t3609r726b3683],
4	%	NN	PERCENT	%	dep	1	SENT_55	[p3l547t3609r726b3683],
5	of	IN	O	of	_	0	SENT_55	[p3l760t3604r860b3683],
6	patients	NNS	O	patient	prep_of	4	SENT_55	[p3l874t3605r1208b3705],
7	in	IN	O	in	_	0	SENT_55	[p3l1244t3605r1326b3682],
8	Europe	NNP	LOCATION	Europe	prep_in	6	SENT_55	[p3l1359t3612r1657b3705],
9	and	CC	O	and	_	0	SENT_55	[p3l1691t3604r1846b3683],
10	North	NNP	LOCATION	North	conj_and	8	SENT_55	[p3l1878t3604r2133b3683],

1	America	NNP	LOCATION	America	nsubj	2	SENT_56	[p4l7t21r368b98],
2	carry	VBP	O	carry	_	0	SENT_56	[p4l421t46r642b120],
3	activating	VBG	O	activate	xcomp	2	SENT_56	[p4l689t21r1111b120],
4	mutations	NNS	O	mutation	dobj	3	SENT_56	[p4l1161t21r1648b111],
5	.	.	O	.	_	0	SENT_56	[p4l1161t21r1648b111],
6	)	SYM	O	)	dep	2	SENT_56	[p4l1161t21r1648b111],

1	Moreover	RB	O	moreover	advmod	19	SENT_57	[p4l1703t27r2128b115],
2	,	,	O	,	_	0	SENT_57	[p4l1703t27r2128b115],
3	the	DT	O	the	det	4	SENT_57	[p4l11t148r144b227],
4	emergence	NN	O	emergence	nsubjpass	19	SENT_57	[p4l178t174r639b249],
5	of	IN	O	of	_	0	SENT_57	[p4l674t148r774b227],
6	secondary	JJ	O	secondary	amod	8	SENT_57	[p4l791t148r1229b249],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_57	[p4l1256t155r1468b228],
8	mutations	NNS	O	mutation	prep_of	4	SENT_57	[p4l1495t149r1929b227],
9	that	WDT	O	that	nsubj	10	SENT_57	[p4l1966t148r2138b227],
10	inhibit	VBP	O	inhibit	rcmod	8	SENT_57	[p4l10t276r300b355],
11	the	DT	O	the	det	12	SENT_57	[p4l336t276r468b355],
12	binding	NN	O	binding	dobj	10	SENT_57	[p4l509t276r846b377],
13	of	IN	O	of	_	0	SENT_57	[p4l883t276r983b355],
14	tyrosine	NN	O	tyrosine	nn	16	SENT_57	[p4l1005t277r1351b377],
15	kinase	NN	O	kinase	nn	16	SENT_57	[p4l1391t276r1670b356],
16	inhibitors	NNS	O	inhibitor	prep_of	12	SENT_57	[p4l1709t276r2130b355],
17	has	VBZ	O	have	aux	19	SENT_57	[p4l11t404r157b483],
18	been	VBN	O	be	auxpass	19	SENT_57	[p4l211t404r416b483],
19	observed	VBN	O	observe	_	0	SENT_57	[p4l467t404r856b483],
20	in	IN	O	in	_	0	SENT_57	[p4l906t405r991b482],
21	patients	NNS	O	patient	prep_in	19	SENT_57	[p4l1041t405r1390b505],
22	in	IN	O	in	_	0	SENT_57	[p4l1442t405r1527b482],
23	whom	WP	O	whom	rel	29	SENT_57	[p4l1574t404r1848b484],
24	resistance	NN	O	resistance	nsubj	29	SENT_57	[p4l1899t405r2131b483, p4l11t549r244b611],
25	to	TO	O	to	_	0	SENT_57	[p4l292t549r374b611],
26	such	JJ	O	such	amod	27	SENT_57	[p4l424t532r621b611],
27	drugs	NNS	O	drug	prep_to	24	SENT_57	[p4l669t532r916b633],
28	has	VBZ	O	have	aux	29	SENT_57	[p4l965t532r1111b611],
29	developed	VBN	O	develop	rcmod	21	SENT_57	[p4l1161t532r1659b633],
30	.5	CD	NUMBER	.5	dobj	29	SENT_57	[p4l1161t532r1659b633],
31	Thus	RB	O	thus	advmod	29	SENT_57	[p4l1705t532r1945b628],
32	,	,	O	,	_	0	SENT_57	[p4l1705t532r1945b628],
33	the	DT	O	the	appos	21	SENT_57	[p4l1998t532r2133b611],

1	418	CD	NUMBER	418	num	4	SENT_58	[p4l148t708r206b730],
2	N	NN	O	n	nn	4	SENT_58	[p4l934t718r948b733],
3	ENGLJ	NN	O	englj	nn	4	SENT_58	[p4l963t718r1041b740],
4	MED359	NN	O	med359	_	0	SENT_58	[p4l1055t718r1183b740],
5	;	:	O	;	_	0	SENT_58	[p4l1055t718r1183b740],
6	4	CD	NUMBER	4	num	8	SENT_58	[p4l1055t718r1183b740],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_58	[p4l1215t718r1416b740],
8	JULY	NNP	DATE	JULY	dep	4	SENT_58	[p4l1447t718r1505b740],
9	24,2008	CD	DATE	24,2008	num	8	SENT_58	[p4l1515t712r1625b740],

1	The	DT	O	the	det	4	SENT_59	[p4l936t751r987b775],
2	New	NNP	O	New	nn	4	SENT_59	[p4l996t752r1058b775],
3	England	NNP	O	England	nn	4	SENT_59	[p4l1067t751r1178b782],
4	Journal	NNP	O	Journal	_	0	SENT_59	[p4l1187t751r1284b775],
5	of	IN	O	of	_	0	SENT_59	[p4l1294t751r1323b775],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_59	[p4l1330t751r1455b775],

1	Downloaded	VBN	O	download	_	0	SENT_60	[p4l378t792r548b815],
2	from	IN	O	from	_	0	SENT_60	[p4l557t792r622b815],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_60	[p4l630t792r749b822],
4	at	IN	O	at	_	0	SENT_60	[p4l759t796r782b815],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_60	[p4l790t792r973b815],
6	on	IN	O	on	_	0	SENT_60	[p4l982t799r1015b815],
7	January	NNP	DATE	January	prep_on	1	SENT_60	[p4l1023t792r1126b822],
8	5	CD	DATE	5	num	7	SENT_60	[p4l1136t792r1159b819],
9	,	,	DATE	,	_	0	SENT_60	[p4l1136t792r1159b819],
10	2014	CD	DATE	2014	num	7	SENT_60	[p4l1169t792r1242b815],
11	.	.	O	.	_	0	SENT_60	[p4l1169t792r1242b815],

1	For	IN	O	for	_	0	SENT_61	[p4l1252t792r1299b815],
2	personal	JJ	O	personal	amod	3	SENT_61	[p4l1307t792r1419b822],
3	use	NN	O	use	pobj	1	SENT_61	[p4l1428t799r1472b815],
4	only	RB	O	only	advmod	3	SENT_61	[p4l1481t792r1546b822],
5	.	.	O	.	_	0	SENT_61	[p4l1481t792r1546b822],

1	No	DT	O	no	det	3	SENT_62	[p4l1557t792r1596b815],
2	other	JJ	O	other	amod	3	SENT_62	[p4l1606t792r1674b815],
3	uses	NNS	O	use	_	0	SENT_62	[p4l1683t799r1739b815],
4	without	IN	O	without	_	0	SENT_62	[p4l1749t792r1850b815],
5	permission	NN	O	permission	prep_without	3	SENT_62	[p4l1858t792r2011b822],
6	.	.	O	.	_	0	SENT_62	[p4l1858t792r2011b822],

1	Copyright	NN	O	copyright	_	0	SENT_63	[p4l729t833r863b864],
2	©	CD	NUMBER	©	num	6	SENT_63	[p4l872t833r896b857],
3	2008	CD	DATE	2008	num	6	SENT_63	[p4l906t833r970b857],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_63	[p4l980t833r1171b857],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_63	[p4l1181t833r1289b857],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_63	[p4l1300t833r1405b864],
7	.	.	O	.	_	0	SENT_63	[p4l1300t833r1405b864],

1	All	DT	O	all	det	2	SENT_64	[p4l1416t833r1457b857],
2	rights	NNS	O	rights	nsubj	3	SENT_64	[p4l1466t833r1541b864],
3	reserved	VBN	O	reserve	_	0	SENT_64	[p4l1551t833r1669b857],
4	.	.	O	.	_	0	SENT_64	[p4l1551t833r1669b857],

1	EDITORIALS	NNS	O	editorial	_	0	SENT_65	[p4l983t939r1177b958],

1	identification	NN	O	identification	nsubj	14	SENT_66	[p4l11t1152r594b1231],
2	of	IN	O	of	_	0	SENT_66	[p4l635t1152r736b1231],
3	patients	NNS	O	patient	prep_of	1	SENT_66	[p4l756t1153r1098b1253],
4	who	WP	O	who	nsubj	7	SENT_66	[p4l1137t1152r1319b1232],
5	are	VBP	O	be	cop	7	SENT_66	[p4l1361t1178r1490b1231],
6	most	RBS	O	most	advmod	7	SENT_66	[p4l1531t1169r1747b1231],
7	likely	JJ	O	likely	rcmod	3	SENT_66	[p4l1782t1152r2014b1253],
8	to	TO	O	to	aux	9	SENT_66	[p4l2051t1169r2132b1231],
9	benefit	VB	O	benefit	xcomp	7	SENT_66	[p4l12t1280r317b1359],
10	from	IN	O	from	_	0	SENT_66	[p4l351t1280r562b1359],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_66	[p4l600t1286r856b1364],
12	inhibitors	NNS	O	inhibitor	prep_from	9	SENT_66	[p4l885t1280r1307b1359],
13	is	VBZ	O	be	cop	14	SENT_66	[p4l1348t1281r1414b1359],
14	key	JJ	O	key	_	0	SENT_66	[p4l1456t1280r1600b1381],
15	to	TO	O	to	_	0	SENT_66	[p4l1636t1297r1718b1359],
16	the	DT	O	the	det	18	SENT_66	[p4l1760t1280r1893b1359],
17	optimal	JJ	O	optimal	amod	18	SENT_66	[p4l1934t1281r2132b1381, p4l11t1408r174b1487],
18	use	NN	O	use	prep_to	14	SENT_66	[p4l212t1435r353b1487],
19	of	IN	O	of	_	0	SENT_66	[p4l394t1408r493b1487],
20	these	DT	O	these	det	21	SENT_66	[p4l515t1408r738b1487],
21	drugs	NNS	O	drug	prep_of	18	SENT_66	[p4l779t1408r1022b1509],
22	so	IN	O	so	mark	31	SENT_66	[p4l1066t1434r1156b1487],
23	that	IN	O	that	dep	31	SENT_66	[p4l1197t1408r1369b1487],
24	patients	NNS	O	patient	nsubjpass	31	SENT_66	[p4l1402t1409r1744b1509],
25	who	WP	O	who	nsubj	27	SENT_66	[p4l1781t1408r1964b1487],
26	are	VBP	O	be	cop	27	SENT_66	[p4l2004t1435r2133b1487],
27	unlikely	JJ	O	unlikely	rcmod	24	SENT_66	[p4l11t1536r366b1637],
28	to	TO	O	to	_	0	SENT_66	[p4l414t1553r497b1615],
29	benefit	NN	O	benefit	prep_to	27	SENT_66	[p4l551t1536r862b1615],
30	are	VBP	O	be	auxpass	31	SENT_66	[p4l909t1562r1040b1615],
31	spared	VBN	O	spare	advcl	14	SENT_66	[p4l1094t1536r1381b1637],
32	the	DT	O	the	det	34	SENT_66	[p4l1433t1536r1568b1615],
33	side	JJ	O	side	amod	34	SENT_66	[p4l1623t1536r1790b1615],
34	effects	NNS	O	effect	dobj	31	SENT_66	[p4l1843t1536r2130b1615],
35	and	CC	O	and	_	0	SENT_66	[p4l11t1664r168b1743],
36	the	DT	O	the	det	37	SENT_66	[p4l209t1664r342b1743],
37	loss	NN	O	loss	conj_and	34	SENT_66	[p4l382t1664r546b1743],
38	of	IN	O	of	_	0	SENT_66	[p4l590t1664r690b1743],
39	time	NN	O	time	prep_of	37	SENT_66	[p4l713t1665r906b1743],
40	that	WDT	O	that	nsubjpass	44	SENT_66	[p4l947t1664r1120b1743],
41	could	MD	O	could	aux	44	SENT_66	[p4l1156t1664r1390b1743],
42	have	VB	O	have	aux	44	SENT_66	[p4l1431t1664r1621b1743],
43	been	VBN	O	be	auxpass	44	SENT_66	[p4l1663t1664r1864b1743],
44	spent	VBN	O	spend	rcmod	37	SENT_66	[p4l1907t1681r2139b1765],
45	in	IN	O	in	_	0	SENT_66	[p4l11t1793r94b1869],
46	pursuing	VBG	O	pursue	prepc_in	44	SENT_66	[p4l130t1793r522b1892],
47	more	RBR	O	more	advmod	48	SENT_66	[p4l556t1817r775b1870],
48	active	JJ	O	active	amod	49	SENT_66	[p4l813t1793r1053b1871],
49	agents	NNS	O	agent	dobj	46	SENT_66	[p4l1091t1808r1391b1892],
50	.	.	O	.	_	0	SENT_66	[p4l1091t1808r1391b1892],

1	Such	JJ	O	such	amod	2	SENT_67	[p4l142t1920r344b1999],
2	identification	NN	O	identification	nsubj	14	SENT_67	[p4l384t1920r968b1999],
3	of	IN	O	of	_	0	SENT_67	[p4l1010t1920r1110b1999],
4	patients	NNS	O	patient	prep_of	2	SENT_67	[p4l1132t1921r1472b2021],
5	who	WP	O	who	nsubj	7	SENT_67	[p4l1512t1920r1694b1999],
6	are	VBP	O	be	cop	7	SENT_67	[p4l1737t1946r1866b1999],
7	likely	JJ	O	likely	rcmod	4	SENT_67	[p4l1906t1920r2138b2021],
8	to	TO	O	to	aux	9	SENT_67	[p4l12t2065r92b2127],
9	respond	VB	O	respond	xcomp	7	SENT_67	[p4l127t2048r466b2149],
10	to	TO	O	to	_	0	SENT_67	[p4l501t2065r581b2127],
11	various	JJ	O	various	amod	12	SENT_67	[p4l613t2049r917b2127],
12	drugs	NNS	O	drug	prep_to	9	SENT_67	[p4l954t2048r1193b2149],
13	is	VBZ	O	be	cop	14	SENT_67	[p4l1228t2049r1293b2127],
14	central	JJ	O	central	_	0	SENT_67	[p4l1330t2048r1620b2127],
15	to	TO	O	to	aux	16	SENT_67	[p4l1654t2065r1734b2127],
16	“	VB	O	“	xcomp	14	SENT_67	[p4l1774t2053r2132b2149],
17	person	NN	O	person	dobj	16	SENT_67	[p4l1774t2053r2132b2149],
18	—	JJ	O	—	amod	20	SENT_67	[p4l1774t2053r2132b2149],
19	alized	JJ	O	alized	amod	20	SENT_67	[p4l11t2176r263b2255],
20	medicine	NN	O	medicine	dep	17	SENT_67	[p4l301t2176r747b2255],
21	.	.	O	.	_	0	SENT_67	[p4l301t2176r747b2255],

1	”	NN	O	”	ccomp	7	SENT_68	[p4l301t2176r747b2255],
2	Increasingly	RB	O	increasingly	advmod	1	SENT_68	[p4l788t2176r1318b2277],
3	,	,	O	,	_	0	SENT_68	[p4l788t2176r1318b2277],
4	patients	NNS	O	patient	nsubjpass	7	SENT_68	[p4l1360t2177r1694b2277],
5	are	VBP	O	be	aux	7	SENT_68	[p4l1734t2203r1861b2255],
6	being	VBG	O	be	auxpass	7	SENT_68	[p4l1900t2176r2137b2277],
7	treated	VBN	O	treat	_	0	SENT_68	[p4l12t2304r310b2383],
8	by	IN	O	by	_	0	SENT_68	[p4l354t2304r451b2405],
9	focusing	VBG	O	focus	agent	7	SENT_68	[p4l490t2304r862b2405],
10	on	IN	O	on	_	0	SENT_68	[p4l903t2330r1009b2383],
11	specific	JJ	O	specific	amod	13	SENT_68	[p4l1054t2304r1384b2405],
12	oncogenic	JJ	O	oncogenic	amod	13	SENT_68	[p4l1427t2305r1867b2405],
13	pathways	NNS	O	pathway	prep_on	9	SENT_68	[p4l1908t2304r2132b2405, p4l7t2459r212b2533],
14	that	WDT	O	that	nsubjpass	16	SENT_68	[p4l253t2432r426b2511],
15	are	VBP	O	be	auxpass	16	SENT_68	[p4l459t2458r588b2511],
16	activated	VBN	O	activate	rcmod	13	SENT_68	[p4l626t2432r1004b2511],
17	in	IN	O	in	_	0	SENT_68	[p4l1042t2433r1125b2510],
18	their	PRP$	O	they	poss	20	SENT_68	[p4l1164t2432r1368b2511],
19	particular	JJ	O	particular	amod	20	SENT_68	[p4l1402t2432r1832b2533],
20	tumor	NN	O	tumor	prep_in	16	SENT_68	[p4l1868t2449r2136b2511],
21	rather	RB	O	rather	_	0	SENT_68	[p4l11t2560r270b2639],
22	than	IN	O	than	_	0	SENT_68	[p4l302t2560r499b2639],
23	on	IN	O	on	_	0	SENT_68	[p4l533t2586r639b2639],
24	the	DT	O	the	det	25	SENT_68	[p4l674t2560r806b2639],
25	tumor	NN	O	tumor	poss	27	SENT_68	[p4l841t2566r1171b2639],
26	’s	POS	O	’s	_	0	SENT_68	[p4l841t2566r1171b2639],
27	location	NN	O	location	prep_on	16	SENT_68	[p4l1206t2560r1554b2639],
28	or	CC	O	or	_	0	SENT_68	[p4l1589t2586r1678b2639],
29	histologic	JJ	O	histologic	amod	30	SENT_68	[p4l1708t2560r2134b2661],
30	features	NNS	O	feature	conj_or	27	SENT_68	[p4l11t2688r369b2767],
31	.	.	O	.	_	0	SENT_68	[p4l11t2688r369b2767],

1	Treating	VBG	O	treat	amod	2	SENT_69	[p4l411t2689r771b2789],
2	patients	NNS	O	patient	nsubj	11	SENT_69	[p4l805t2689r1139b2789],
3	with	IN	O	with	_	0	SENT_69	[p4l1176t2688r1368b2767],
4	drugs	NNS	O	drug	prep_with	2	SENT_69	[p4l1408t2688r1648b2789],
5	specific	JJ	O	specific	amod	4	SENT_69	[p4l1690t2688r2013b2789],
6	to	TO	O	to	_	0	SENT_69	[p4l2051t2705r2132b2767],
7	their	PRP$	O	they	poss	9	SENT_69	[p4l12t2816r215b2895],
8	particular	JJ	O	particular	amod	9	SENT_69	[p4l247t2816r676b2917],
9	tumor	NN	O	tumor	prep_to	5	SENT_69	[p4l709t2833r977b2895],
10	is	VBZ	O	be	cop	11	SENT_69	[p4l1009t2817r1074b2895],
11	likely	JJ	O	likely	_	0	SENT_69	[p4l1111t2816r1343b2917],
12	to	TO	O	to	aux	13	SENT_69	[p4l1374t2833r1456b2895],
13	yield	VB	O	yield	xcomp	11	SENT_69	[p4l1489t2816r1690b2917],
14	increased	VBN	O	increase	amod	16	SENT_69	[p4l1725t2816r2134b2895],
15	response	NN	O	response	nn	16	SENT_69	[p4l11t2970r384b3045],
16	rates	NNS	O	rate	dobj	13	SENT_69	[p4l416t2961r637b3040],
17	,	,	O	,	_	0	SENT_69	[p4l416t2961r637b3040],
18	prolonged	JJ	O	prolonged	amod	19	SENT_69	[p4l672t2944r1101b3045],
19	survival	NN	O	survival	conj_and	16	SENT_69	[p4l1134t2944r1479b3040],
20	,	,	O	,	_	0	SENT_69	[p4l1134t2944r1479b3040],
21	and	CC	O	and	_	0	SENT_69	[p4l1515t2944r1671b3023],
22	a	DT	O	a	det	23	SENT_69	[p4l1701t2971r1745b3023],
23	decrease	NN	O	decrease	conj_and	16	SENT_69	[p4l1775t2944r2133b3023],
24	in	IN	O	in	_	0	SENT_69	[p4l11t3073r94b3150],
25	the	DT	O	the	det	26	SENT_69	[p4l145t3072r277b3151],
26	number	NN	O	number	prep_in	23	SENT_69	[p4l328t3072r666b3151],
27	of	IN	O	of	_	0	SENT_69	[p4l715t3072r815b3151],
28	patients	NNS	O	patient	prep_of	26	SENT_69	[p4l846t3073r1187b3173],
29	who	WP	O	who	nsubjpass	31	SENT_69	[p4l1235t3072r1418b3151],
30	are	VBP	O	be	auxpass	31	SENT_69	[p4l1470t3099r1599b3151],
31	exposed	VBN	O	expose	rcmod	28	SENT_69	[p4l1650t3072r1999b3173],
32	to	TO	O	to	_	0	SENT_69	[p4l2050t3089r2132b3151],
33	toxic	JJ	O	toxic	amod	34	SENT_69	[p4l12t3201r217b3279],
34	drugs	NNS	O	drug	prep_to	31	SENT_69	[p4l261t3200r504b3301],
35	unnecessarily	RB	O	unnecessarily	advmod	31	SENT_69	[p4l550t3200r1155b3301],
36	.	.	O	.	_	0	SENT_69	[p4l550t3200r1155b3301],

1	Although	IN	O	although	mark	6	SENT_70	[p4l1200t3200r1607b3301],
2	these	DT	O	these	det	4	SENT_70	[p4l1651t3200r1875b3279],
3	additional	JJ	O	additional	amod	4	SENT_70	[p4l1917t3200r2132b3279, p4l12t3328r261b3407],
4	tests	NNS	O	test	nsubj	6	SENT_70	[p4l299t3345r492b3407],
5	may	MD	O	may	aux	6	SENT_70	[p4l533t3354r712b3429],
6	increase	VB	O	increase	advcl	16	SENT_70	[p4l745t3329r1096b3407],
7	the	DT	O	the	det	9	SENT_70	[p4l1135t3328r1268b3407],
8	initial	JJ	O	initial	amod	9	SENT_70	[p4l1306t3328r1562b3407],
9	cost	NN	O	cost	dobj	6	SENT_70	[p4l1600t3345r1775b3407],
10	of	IN	O	of	_	0	SENT_70	[p4l1809t3328r1908b3407],
11	care	NN	O	care	prep_of	9	SENT_70	[p4l1929t3354r2127b3424],
12	,	,	O	,	_	0	SENT_70	[p4l1929t3354r2127b3424],
13	they	PRP	O	they	nsubj	16	SENT_70	[p4l12t3456r197b3557],
14	may	MD	O	may	aux	16	SENT_70	[p4l239t3482r420b3557],
15	also	RB	O	also	advmod	16	SENT_70	[p4l462t3456r637b3535],
16	prove	VB	O	prove	_	0	SENT_70	[p4l683t3482r920b3557],
17	to	TO	O	to	aux	19	SENT_70	[p4l967t3473r1049b3535],
18	be	VB	O	be	auxpass	19	SENT_70	[p4l1098t3456r1195b3535],
19	cost	VBN	O	cost	xcomp	16	SENT_70	[p4l1243t3456r1821b3535],
20	—	RB	O	—	advmod	21	SENT_70	[p4l1243t3456r1821b3535],
21	effective	JJ	O	effective	acomp	19	SENT_70	[p4l1243t3456r1821b3535],
22	in	IN	O	in	_	0	SENT_70	[p4l1867t3457r1951b3534],
23	the	DT	O	the	det	25	SENT_70	[p4l1998t3456r2133b3535],
24	long	JJ	O	long	amod	25	SENT_70	[p4l10t3584r205b3685],
25	term	NN	O	term	prep_in	21	SENT_70	[p4l237t3601r442b3663],
26	by	IN	O	by	_	0	SENT_70	[p4l477t3584r575b3685],
27	reducing	VBG	O	reduce	agent	19	SENT_70	[p4l606t3584r991b3685],
28	the	DT	O	the	det	29	SENT_70	[p4l1023t3584r1158b3663],
29	costs	NNS	O	cost	dobj	27	SENT_70	[p4l1195t3601r1413b3663],
30	associated	VBN	O	associate	partmod	29	SENT_70	[p4l1449t3584r1903b3663],
31	with	IN	O	with	_	0	SENT_70	[p4l1934t3584r2133b3663],
32	ineffective	JJ	O	ineffective	amod	33	SENT_70	[p4l11t3713r456b3792],
33	treatments	NNS	O	treatment	prep_with	30	SENT_70	[p4l495t3730r982b3792],
34	.	.	O	.	_	0	SENT_70	[p4l495t3730r982b3792],

1	To	TO	O	to	aux	2	SENT_71	[p5l137t41r242b114],
2	tailor	VB	O	tailor	dep	14	SENT_71	[p5l278t35r510b114],
3	patients	NNS	O	patient	nsubj	5	SENT_71	[p5l540t36r905b136],
4	’	CD	NUMBER	’	num	5	SENT_71	[p5l540t36r905b136],
5	treatments	NNS	O	treatment	xcomp	2	SENT_71	[p5l944t52r1407b114],
6	to	TO	O	to	_	0	SENT_71	[p5l1444t52r1525b114],
7	their	PRP$	O	they	poss	8	SENT_71	[p5l1561t35r1765b114],
8	tumors	NNS	O	tumor	prep_to	5	SENT_71	[p5l1796t52r2128b131],
9	,	,	O	,	_	0	SENT_71	[p5l1796t52r2128b131],
10	however	RB	O	however	advmod	14	SENT_71	[p5l11t163r385b259],
11	,	,	O	,	_	0	SENT_71	[p5l11t163r385b259],
12	one	CD	NUMBER	one	nsubj	14	SENT_71	[p5l435t189r586b242],
13	must	MD	O	must	aux	14	SENT_71	[p5l630t180r845b242],
14	have	VB	O	have	_	0	SENT_71	[p5l883t163r1073b242],
15	a	DT	O	a	det	17	SENT_71	[p5l1116t190r1160b242],
16	sufficient	JJ	O	sufficient	amod	17	SENT_71	[p5l1203t163r1614b242],
17	quantity	NN	O	quantity	dobj	14	SENT_71	[p5l1653t164r2013b264],
18	of	IN	O	of	_	0	SENT_71	[p5l2052t163r2152b242],
19	tumor	NN	O	tumor	prep_of	17	SENT_71	[p5l12t308r279b370],
20	to	TO	O	to	_	0	SENT_71	[p5l317t308r398b370],
21	test	NN	O	test	prep_to	14	SENT_71	[p5l440t308r616b370],
22	.	.	O	.	_	0	SENT_71	[p5l440t308r616b370],

1	Obtaining	VBG	O	obtain	amod	3	SENT_72	[p5l661t291r1104b392],
2	such	JJ	O	such	amod	3	SENT_72	[p5l1142t291r1336b370],
3	quantities	NNS	O	quantity	nsubj	6	SENT_72	[p5l1377t292r1804b392],
4	can	MD	O	can	aux	6	SENT_72	[p5l1847t317r1996b370],
5	be	VB	O	be	cop	6	SENT_72	[p5l2037t291r2133b370],
6	problematic	JJ	O	problematic	_	0	SENT_72	[p5l10t419r548b520],
7	,	,	O	,	_	0	SENT_72	[p5l10t419r548b520],
8	particularly	RB	O	particularly	advmod	6	SENT_72	[p5l596t419r1099b520],
9	for	IN	O	for	_	0	SENT_72	[p5l1138t419r1262b498],
10	neoplasms	NNS	O	neoplasm	prep_for	6	SENT_72	[p5l1303t419r1760b520],
11	such	JJ	O	such	_	0	SENT_72	[p5l1809t419r2002b498],
12	as	IN	O	as	_	0	SENT_72	[p5l2046t446r2131b498],
13	lung	NN	O	lung	nn	14	SENT_72	[p5l10t547r203b648],
14	cancer	NN	O	cancer	prep_such_as	10	SENT_72	[p5l244t573r542b643],
15	,	,	O	,	_	0	SENT_72	[p5l244t573r542b643],
16	in	IN	O	in	_	0	SENT_72	[p5l591t548r674b625],
17	which	WDT	O	which	rel	21	SENT_72	[p5l713t547r976b626],
18	the	DT	O	the	det	19	SENT_72	[p5l1019t547r1151b626],
19	tumor	NN	O	tumor	nsubj	21	SENT_72	[p5l1196t564r1463b626],
20	is	VBZ	O	be	cop	21	SENT_72	[p5l1503t548r1569b626],
21	located	JJ	O	located	rcmod	14	SENT_72	[p5l1613t547r1922b626],
22	in	IN	O	in	_	0	SENT_72	[p5l1965t548r2048b625],
23	a	DT	O	a	det	25	SENT_72	[p5l2090t574r2134b626],
24	visceral	JJ	O	visceral	amod	25	SENT_72	[p5l7t675r310b754],
25	organ	NN	O	organ	prep_in	21	SENT_72	[p5l361t701r617b776],
26	.	.	O	.	_	0	SENT_72	[p5l361t701r617b776],

1	Biopsies	NNS	O	biopsy	nsubjpass	4	SENT_73	[p5l671t676r1001b776],
2	are	VBP	O	be	auxpass	4	SENT_73	[p5l1053t701r1176b754],
3	often	RB	O	often	advmod	4	SENT_73	[p5l1227t675r1436b754],
4	associated	VBN	O	associate	_	0	SENT_73	[p5l1486t675r1902b754],
5	with	IN	O	with	_	0	SENT_73	[p5l1947t675r2133b754],
6	complications	NNS	O	complication	prep_with	4	SENT_73	[p5l12t803r654b904],
7	,	,	O	,	_	0	SENT_73	[p5l12t803r654b904],
8	such	JJ	O	such	_	0	SENT_73	[p5l711t803r908b882],
9	as	IN	O	as	_	0	SENT_73	[p5l957t830r1044b882],
10	discomfort	NN	O	discomfort	prep_such_as	6	SENT_73	[p5l1097t803r1584b882],
11	and	CC	O	and	_	0	SENT_73	[p5l1628t803r1788b882],
12	risk	NN	O	risk	prep_such_as	6	SENT_73	[p5l1837t803r2005b883],
13	of	IN	O	of	_	0	SENT_73	[p5l2051t803r2152b882],
14	pneumothorax	NN	O	pneumothorax	prep_of	10	SENT_73	[p5l10t931r671b1032],
15	.	.	O	.	_	0	SENT_73	[p5l10t931r671b1032],

1	The	DT	O	the	det	2	SENT_74	[p5l724t931r884b1010],
2	assessment	NN	O	assessment	nsubj	17	SENT_74	[p5l936t948r1426b1010],
3	of	IN	O	of	_	0	SENT_74	[p5l1473t931r1573b1010],
4	more	JJR	O	more	dep	5	SENT_74	[p5l1605t957r1825b1010],
5	accessible	JJ	O	accessible	amod	6	SENT_74	[p5l1876t958r2132b1010, p5l13t1058r204b1136],
6	tissues	NNS	O	tissue	prep_of	2	SENT_74	[p5l240t1059r553b1153],
7	,	,	O	,	_	0	SENT_74	[p5l240t1059r553b1153],
8	such	JJ	O	such	_	0	SENT_74	[p5l595t1058r789b1137],
9	as	IN	O	as	_	0	SENT_74	[p5l823t1085r908b1136],
10	blood	NN	O	blood	nn	11	SENT_74	[p5l946t1058r1189b1136],
11	cells	NNS	O	cell	prep_such_as	2	SENT_74	[p5l1224t1058r1412b1136],
12	or	CC	O	or	_	0	SENT_74	[p5l1449t1084r1538b1136],
13	skin	NN	O	skin	prep_such_as	2	SENT_74	[p5l1571t1058r1774b1153],
14	,	,	O	,	_	0	SENT_74	[p5l1571t1058r1774b1153],
15	has	VBZ	O	have	aux	17	SENT_74	[p5l1815t1058r1959b1136],
16	not	RB	O	not	neg	17	SENT_74	[p5l1996t1075r2139b1136],
17	proved	VBN	O	prove	_	0	SENT_74	[p5l10t1186r293b1287],
18	to	TO	O	to	aux	20	SENT_74	[p5l332t1203r412b1265],
19	be	VB	O	be	cop	20	SENT_74	[p5l454t1186r549b1265],
20	helpful	JJ	O	helpful	xcomp	17	SENT_74	[p5l588t1186r886b1287],
21	as	IN	O	as	_	0	SENT_74	[p5l924t1213r1008b1265],
22	a	DT	O	a	det	23	SENT_74	[p5l1048t1213r1093b1265],
23	surrogate	NN	O	surrogate	prep_as	20	SENT_74	[p5l1132t1203r1529b1287],
24	for	IN	O	for	_	0	SENT_74	[p5l1569t1186r1689b1265],
25	tumor	NN	O	tumor	nn	26	SENT_74	[p5l1726t1203r1990b1265],
26	biopsy	NN	O	biopsy	prep_for	23	SENT_74	[p5l2026t1186r2132b1265, p5l12t1340r216b1415],
27	.	.	O	.	_	0	SENT_74	[p5l2026t1186r2132b1265, p5l12t1340r216b1415],

1	Thus	RB	O	thus	advmod	9	SENT_75	[p5l261t1314r496b1410],
2	,	,	O	,	_	0	SENT_75	[p5l261t1314r496b1410],
3	patients	NNS	O	patient	nsubj	9	SENT_75	[p5l542t1315r884b1415],
4	with	IN	O	with	_	0	SENT_75	[p5l924t1314r1119b1393],
5	suspected	VBN	O	suspect	amod	7	SENT_75	[p5l1162t1314r1582b1415],
6	lung	NN	O	lung	nn	7	SENT_75	[p5l1623t1314r1816b1415],
7	cancer	NN	O	cancer	prep_with	3	SENT_75	[p5l1855t1340r2136b1393],
8	often	RB	O	often	advmod	9	SENT_75	[p5l12t1442r234b1521],
9	undergo	VBP	O	undergo	_	0	SENT_75	[p5l270t1442r626b1543],
10	procedures	NNS	O	procedure	nsubj	16	SENT_75	[p5l662t1442r1137b1543],
11	such	JJ	O	such	_	0	SENT_75	[p5l1178t1442r1371b1521],
12	as	IN	O	as	_	0	SENT_75	[p5l1407t1469r1492b1521],
13	needle	NN	O	needle	nn	14	SENT_75	[p5l1530t1442r1808b1521],
14	aspira	NN	O	aspira	prep_such_as	10	SENT_75	[p5l1843t1443r2132b1543],
15	—	CD	NUMBER	—	num	16	SENT_75	[p5l1843t1443r2132b1543],
16	tion	NN	O	tion	xcomp	9	SENT_75	[p5l12t1571r181b1649],
17	that	WDT	O	that	nsubj	19	SENT_75	[p5l226t1570r399b1649],
18	frequently	RB	O	frequently	advmod	19	SENT_75	[p5l439t1570r878b1671],
19	yield	VBP	O	yield	rcmod	16	SENT_75	[p5l915t1570r1116b1671],
20	only	RB	O	only	advmod	22	SENT_75	[p5l1162t1570r1346b1671],
21	sparse	JJ	O	sparse	amod	22	SENT_75	[p5l1388t1596r1658b1671],
22	quantities	NNS	O	quantity	dobj	19	SENT_75	[p5l1704t1571r2131b1671],
23	of	IN	O	of	_	0	SENT_75	[p5l12t1698r112b1777],
24	cytologic	JJ	O	cytologic	amod	25	SENT_75	[p5l134t1698r522b1799],
25	material	NN	O	material	prep_of	22	SENT_75	[p5l560t1698r941b1777],
26	.	.	O	.	_	0	SENT_75	[p5l560t1698r941b1777],

1	Obtaining	VBG	O	obtain	_	0	SENT_76	[p5l987t1698r1430b1799],
2	adequate	JJ	O	adequate	amod	3	SENT_76	[p5l1466t1698r1848b1799],
3	material	NN	O	material	dobj	1	SENT_76	[p5l1888t1715r2132b1777, p5l11t1827r154b1906],
4	for	IN	O	for	_	0	SENT_76	[p5l198t1827r321b1906],
5	mechanistic	JJ	O	mechanistic	amod	6	SENT_76	[p5l362t1827r884b1906],
6	studies	NNS	O	study	prep_for	1	SENT_76	[p5l929t1827r1229b1906],
7	and	CC	O	and	_	0	SENT_76	[p5l1275t1827r1432b1906],
8	serial	JJ	O	serial	amod	9	SENT_76	[p5l1478t1827r1710b1906],
9	monitoring	NN	O	monitoring	prep_for	1	SENT_76	[p5l1753t1828r2132b1906, p5l11t1956r152b2056],

1	of	IN	O	of	_	0	SENT_77	[p5l203t1955r304b2034],
2	tumor	NN	O	tumor	prep_of	7	SENT_77	[p5l340t1972r612b2034],
3	genotypes	NNS	O	genotype	nsubj	7	SENT_77	[p5l663t1972r1108b2056],
4	has	VBZ	O	have	aux	7	SENT_77	[p5l1164t1955r1310b2034],
5	been	VBN	O	be	aux	7	SENT_77	[p5l1367t1955r1572b2034],
6	particularly	RB	O	particularly	advmod	7	SENT_77	[p5l1624t1955r2138b2056],
7	challenging	VBG	O	challenge	_	0	SENT_77	[p5l12t2083r510b2184],
8	for	IN	O	for	_	0	SENT_77	[p5l539t2083r661b2162],
9	patients	NNS	O	patient	prep_for	7	SENT_77	[p5l689t2084r1022b2184],
10	with	IN	O	with	_	0	SENT_77	[p5l1053t2083r1245b2163],
11	lung	NN	O	lung	nn	12	SENT_77	[p5l1276t2083r1466b2184],
12	cancer	NN	O	cancer	prep_with	9	SENT_77	[p5l1497t2109r1772b2162],
13	and	CC	O	and	_	0	SENT_77	[p5l1801t2083r1957b2162],
14	has	VBZ	O	have	aux	18	SENT_77	[p5l1989t2083r2131b2162],
15	been	VBN	O	be	cop	18	SENT_77	[p5l12t2211r216b2290],
16	a	DT	O	a	det	18	SENT_77	[p5l267t2238r311b2290],
17	major	JJ	O	major	amod	18	SENT_77	[p5l361t2212r616b2312],
18	barrier	NN	O	barrier	conj_and	7	SENT_77	[p5l665t2211r964b2290],
19	to	TO	O	to	_	0	SENT_77	[p5l1013t2228r1096b2290],
20	translating	VBG	O	translate	prepc_to	18	SENT_77	[p5l1149t2211r1635b2312],
21	laboratory	NN	O	laboratory	nn	22	SENT_77	[p5l1682t2211r2138b2312],
22	findings	NNS	O	finding	dobj	20	SENT_77	[p5l11t2339r375b2440],
23	into	IN	O	into	_	0	SENT_77	[p5l414t2340r583b2418],
24	therapy	NN	O	therapy	prep_into	20	SENT_77	[p5l623t2339r958b2440],
25	.	.	O	.	_	0	SENT_77	[p5l623t2339r958b2440],

1	In	IN	O	in	_	0	SENT_78	[p5l138t2475r228b2545],
2	this	DT	O	this	det	3	SENT_78	[p5l272t2467r432b2546],
3	issue	NN	O	issue	prep_in	11	SENT_78	[p5l478t2468r689b2546],
4	of	IN	O	of	_	0	SENT_78	[p5l734t2467r834b2546],
5	the	DT	O	the	det	6	SENT_78	[p5l860t2467r993b2546],
6	journal	NN	O	journal	prep_of	3	SENT_78	[p5l1022t2467r1332b2568],
7	,	,	O	,	_	0	SENT_78	[p5l1022t2467r1332b2568],
8	Maheswaran	NN	LOCATION	maheswaran	nsubj	11	SENT_78	[p5l1378t2467r1932b2546],
9	and	CC	O	and	_	0	SENT_78	[p5l1975t2467r2133b2546],
10	colleagues	NNS	O	colleague	conj_and	8	SENT_78	[p5l12t2595r449b2696],
11	describe	VBP	O	describe	_	0	SENT_78	[p5l483t2595r830b2674],
12	the	DT	O	the	det	13	SENT_78	[p5l861t2595r991b2674],
13	results	NNS	O	result	dobj	11	SENT_78	[p5l1022t2595r1298b2674],
14	of	IN	O	of	_	0	SENT_78	[p5l1332t2595r1430b2674],
15	a	DT	O	a	det	16	SENT_78	[p5l1441t2622r1486b2674],
16	study	NN	O	study	prep_of	13	SENT_78	[p5l1517t2595r1742b2696],
17	in	IN	O	in	_	0	SENT_78	[p5l1767t2596r1849b2673],
18	which	WDT	O	which	rel	20	SENT_78	[p5l1875t2595r2133b2674],
19	they	PRP	O	they	nsubj	20	SENT_78	[p5l12t2723r191b2824],
20	isolated	VBD	O	isolate	rcmod	16	SENT_78	[p5l221t2723r548b2802],
21	tumor	NN	O	tumor	nn	22	SENT_78	[p5l584t2723r1184b2802],
22	—	NN	O	—	nsubj	30	SENT_78	[p5l584t2723r1184b2802],
23	derived	VBN	O	derive	partmod	22	SENT_78	[p5l584t2723r1184b2802],
24	epithelial	JJ	O	epithelial	amod	25	SENT_78	[p5l1220t2723r1611b2824],
25	cells	NNS	O	cell	nsubj	26	SENT_78	[p5l1647t2723r1830b2802],
26	(	VBP	O	(	ccomp	23	SENT_78	[p5l1873t2724r2132b2815, p5l10t2851r256b2952],
27	circulating	VBG	O	circulate	xcomp	26	SENT_78	[p5l1873t2724r2132b2815, p5l10t2851r256b2952],
28	tumor	NN	O	tumor	nn	29	SENT_78	[p5l292t2868r555b2930],
29	cells	NNS	O	cell	dobj	27	SENT_78	[p5l591t2851r799b2943],
30	)	VBP	O	)	ccomp	20	SENT_78	[p5l591t2851r799b2943],
31	in	IN	O	in	_	0	SENT_78	[p5l842t2852r924b2929],
32	27	CD	NUMBER	27	num	33	SENT_78	[p5l962t2857r1060b2930],
33	patients	NNS	O	patient	prep_in	30	SENT_78	[p5l1097t2852r1431b2952],
34	with	IN	O	with	_	0	SENT_78	[p5l1467t2851r1658b2930],
35	metastatic	JJ	O	metastatic	amod	37	SENT_78	[p5l1697t2852r2134b2930],
36	non	JJ	O	non	amod	37	SENT_78	[p5l11t2979r639b3058],
37	—	NN	O	—	prep_with	33	SENT_78	[p5l11t2979r639b3058],
38	small	JJ	O	small	amod	42	SENT_78	[p5l11t2979r639b3058],
39	—	NN	O	—	nn	42	SENT_78	[p5l11t2979r639b3058],
40	cell	NN	O	cell	nn	42	SENT_78	[p5l11t2979r639b3058],
41	lung	NN	O	lung	nn	42	SENT_78	[p5l671t2979r861b3080],
42	cancer	NN	O	cancer	dobj	30	SENT_78	[p5l892t2983r1225b3058],
43	.6	CD	NUMBER	.6	nsubj	77	SENT_78	[p5l892t2983r1225b3058],
44	Using	VBG	O	use	partmod	43	SENT_78	[p5l1259t2980r1506b3080],
45	a	DT	O	a	det	47	SENT_78	[p5l1536t3006r1580b3058],
46	microfluidic	JJ	O	microfluidic	amod	47	SENT_78	[p5l1612t2979r2134b3058],
47	device	NN	O	device	dobj	44	SENT_78	[p5l12t3107r269b3186],
48	mediated	VBN	O	mediate	partmod	47	SENT_78	[p5l303t3107r694b3186],
49	by	IN	O	by	_	0	SENT_78	[p5l729t3107r825b3208],
50	the	DT	O	the	det	51	SENT_78	[p5l855t3107r986b3186],
51	interaction	NN	O	interaction	agent	48	SENT_78	[p5l1019t3108r1476b3186],
52	between	IN	O	between	_	0	SENT_78	[p5l1511t3107r1862b3187],
53	circulating	VBG	O	circulate	prepc_between	51	SENT_78	[p5l1898t3108r2132b3186, p5l10t3235r261b3336],
54	tumor	NN	O	tumor	nn	55	SENT_78	[p5l310t3252r578b3314],
55	cells	NNS	O	cell	dobj	53	SENT_78	[p5l628t3235r815b3314],
56	and	CC	O	and	_	0	SENT_78	[p5l869t3235r1026b3314],
57	microposts	NNS	O	micropost	dobj	53	SENT_78	[p5l1079t3236r1558b3336],
58	coated	VBN	O	coat	partmod	55	SENT_78	[p5l1613t3235r1890b3314],
59	with	IN	O	with	_	0	SENT_78	[p5l1938t3235r2133b3315],
60	antibody	NN	O	antibody	prep_with	58	SENT_78	[p5l11t3363r383b3464],
61	against	IN	O	against	_	0	SENT_78	[p5l409t3364r718b3464],
62	epithelial	JJ	O	epithelial	amod	69	SENT_78	[p5l746t3363r1315b3464],
63	—	NN	O	—	nn	69	SENT_78	[p5l746t3363r1315b3464],
64	cell	NN	O	cell	nn	69	SENT_78	[p5l746t3363r1315b3464],
65	adhesion	NN	O	adhesion	nn	69	SENT_78	[p5l1346t3363r1723b3442],
66	molecule	NN	O	molecule	nn	69	SENT_78	[p5l1755t3363r2133b3442],
67	(	CD	NUMBER	(	num	69	SENT_78	[p5l16t3497r397b3592],
68	EpCAM	NN	O	epcam	nn	69	SENT_78	[p5l16t3497r397b3592],
69	)	NN	O	)	prep_against	58	SENT_78	[p5l16t3497r397b3592],
70	under	IN	O	under	_	0	SENT_78	[p5l437t3491r684b3570],
71	precisely	RB	O	precisely	advmod	76	SENT_78	[p5l714t3491r1083b3592],
72	controlled	VBN	O	control	amod	76	SENT_78	[p5l1114t3491r1541b3570],
73	laminar	NN	O	laminar	nn	76	SENT_78	[p5l1575t3491r2137b3570],
74	—	NN	O	—	nn	76	SENT_78	[p5l1575t3491r2137b3570],
75	flow	NN	O	flow	nn	76	SENT_78	[p5l1575t3491r2137b3570],
76	conditions	NNS	O	condition	prep_under	69	SENT_78	[p5l12t3619r527b3715],
77	,7	VBP	O	,7	rcmod	42	SENT_78	[p5l12t3619r527b3715],
78	they	PRP	O	they	nsubj	80	SENT_78	[p5l567t3619r750b3720],
79	were	VBD	O	be	cop	80	SENT_78	[p5l780t3645r981b3698],
80	able	JJ	O	able	ccomp	77	SENT_78	[p5l1021t3619r1191b3698],
81	to	TO	O	to	aux	82	SENT_78	[p5l1231t3636r1312b3698],
82	isolate	VB	O	isolate	xcomp	80	SENT_78	[p5l1352t3619r1630b3698],
83	circulating	VBG	O	circulate	xcomp	82	SENT_78	[p5l1670t3619r2137b3720],
84	tumor	NN	O	tumor	nn	85	SENT_78	[p6l12t37r279b99],
85	cells	NNS	O	cell	dobj	83	SENT_78	[p6l317t20r504b99],
86	from	IN	O	from	_	0	SENT_78	[p6l546t20r756b99],
87	all	DT	O	all	det	89	SENT_78	[p6l795t20r900b99],
88	27	CD	NUMBER	27	num	89	SENT_78	[p6l939t26r1038b99],
89	patients	NNS	O	patient	prep_from	83	SENT_78	[p6l1077t21r1443b121],
90	.	.	O	.	_	0	SENT_78	[p6l1077t21r1443b121],

1	Such	JJ	O	such	amod	2	SENT_79	[p6l1491t20r1692b99],
2	cells	NNS	O	cell	nsubj	3	SENT_79	[p6l1733t20r1920b99],
3	represent	VBP	O	represent	conj_and	3	SENT_79	[p6l1962t46r2132b121, p6l11t165r274b227],
4	a	DT	O	a	det	6	SENT_79	[p6l317t175r361b227],
5	potential	JJ	O	potential	amod	6	SENT_79	[p6l408t148r795b249],
6	alternative	NN	O	alternative	dobj	3	SENT_79	[p6l843t148r1293b228],
7	to	TO	O	to	_	0	SENT_79	[p6l1343t165r1425b227],
8	invasive	JJ	O	invasive	amod	9	SENT_79	[p6l1475t149r1809b227],
9	biopsy	NN	O	biopsy	prep_to	3	SENT_79	[p6l1859t148r2138b249],
10	as	IN	O	as	_	0	SENT_79	[p6l10t303r96b355],
11	a	DT	O	a	det	12	SENT_79	[p6l137t303r181b355],
12	source	NN	O	source	prep_as	9	SENT_79	[p6l222t302r499b355],
13	of	IN	O	of	_	0	SENT_79	[p6l541t276r640b355],
14	cancer	NN	O	cancer	nn	15	SENT_79	[p6l663t302r944b355],
15	cells	NNS	O	cell	prep_of	12	SENT_79	[p6l982t276r1168b355],
16	for	IN	O	for	_	0	SENT_79	[p6l1210t276r1334b355],
17	genotypic	JJ	O	genotypic	amod	18	SENT_79	[p6l1370t277r1790b377],
18	studies	NNS	O	study	prep_for	15	SENT_79	[p6l1831t276r2130b355],
19	and	CC	O	and	_	0	SENT_79	[p6l10t405r168b484],
20	molecular	JJ	O	molecular	amod	21	SENT_79	[p6l203t405r637b484],
21	characterization	NN	O	characterization	prep_for	15	SENT_79	[p6l670t405r1370b484],
22	and	CC	O	and	_	0	SENT_79	[p6l1405t405r1562b484],
23	for	IN	O	for	_	0	SENT_79	[p6l1597t405r1721b484],
24	monitoring	NN	O	monitoring	prep_for	3	SENT_79	[p6l1753t406r2132b484, p6l10t534r150b634],

1	changes	NNS	O	change	_	0	SENT_80	[p6l194t533r541b634],
2	during	IN	O	during	_	0	SENT_80	[p6l590t533r879b634],
3	therapy	NN	O	therapy	prep_during	1	SENT_80	[p6l922t533r1253b634],
4	.	.	O	.	_	0	SENT_80	[p6l922t533r1253b634],

1	However	RB	O	however	advmod	38	SENT_81	[p6l1302t541r1689b629],
2	,	,	O	,	_	0	SENT_81	[p6l1302t541r1689b629],
3	since	IN	O	since	mark	9	SENT_81	[p6l1741t534r1951b612],
4	cir	NN	O	cir	nn	5	SENT_81	[p6l1996t534r2132b612],
5	—	NN	O	—	nsubj	9	SENT_81	[p6l1996t534r2132b612],
6	culating	VBG	O	culate	partmod	5	SENT_81	[p6l12t661r358b762],
7	tumor	NN	O	tumor	nn	8	SENT_81	[p6l388t678r652b740],
8	cells	NNS	O	cell	dobj	6	SENT_81	[p6l683t661r865b740],
9	make	VBP	O	make	advcl	38	SENT_81	[p6l901t661r1130b741],
10	up	RP	O	up	prt	9	SENT_81	[p6l1163t687r1267b762],
11	as	IN	O	as	_	0	SENT_81	[p6l1303t688r1388b740],
12	few	JJ	O	few	advmod	13	SENT_81	[p6l1426t661r1580b740],
13	as	IN	O	as	quantmod	14	SENT_81	[p6l1611t688r1696b740],
14	1	CD	NUMBER	1	num	15	SENT_81	[p6l1737t667r1781b739],
15	cell	NN	O	cell	prep_as	9	SENT_81	[p6l1818t661r1963b740],
16	per	IN	O	per	_	0	SENT_81	[p6l1996t687r2137b762],
17	1x109	CD	NUMBER	1x109	num	19	SENT_81	[p6l14t795r250b868],
18	hematologic	JJ	O	hematologic	amod	19	SENT_81	[p6l291t789r824b890],
19	cells	NNS	O	cell	prep_per	15	SENT_81	[p6l863t789r1051b868],
20	in	IN	O	in	_	0	SENT_81	[p6l1092t790r1175b867],
21	the	DT	O	the	det	22	SENT_81	[p6l1214t789r1347b868],
22	blood	NN	O	blood	prep_in	19	SENT_81	[p6l1388t789r1630b868],
23	of	IN	O	of	_	0	SENT_81	[p6l1671t789r1770b868],
24	patients	NNS	O	patient	prep_of	22	SENT_81	[p6l1790t790r2131b890],
25	with	IN	O	with	_	0	SENT_81	[p6l7t916r202b995],
26	metastatic	JJ	O	metastatic	amod	27	SENT_81	[p6l263t917r710b994],
27	cancer	NN	O	cancer	prep_with	24	SENT_81	[p6l772t942r1070b1011],
28	,	,	O	,	_	0	SENT_81	[p6l772t942r1070b1011],
29	the	DT	O	the	det	30	SENT_81	[p6l1138t916r1270b994],
30	identification	NN	O	identification	nsubj	38	SENT_81	[p6l1332t916r1915b994],
31	and	CC	O	and	_	0	SENT_81	[p6l1976t916r2134b994],
32	isolation	NN	O	isolation	conj_and	30	SENT_81	[p6l11t1045r392b1124],
33	of	IN	O	of	_	0	SENT_81	[p6l433t1045r535b1124],
34	these	DT	O	these	det	35	SENT_81	[p6l556t1045r784b1124],
35	cells	NNS	O	cell	prep_of	30	SENT_81	[p6l825t1045r1017b1124],
36	have	VBP	O	have	aux	38	SENT_81	[p6l1059t1045r1252b1124],
37	been	VBN	O	be	cop	38	SENT_81	[p6l1293t1045r1497b1124],
38	difficult	JJ	O	difficult	_	0	SENT_81	[p6l1538t1045r1967b1124],
39	.8	CD	NUMBER	.8	tmod	38	SENT_81	[p6l1538t1045r1967b1124],
40	Although	IN	O	although	prep	38	SENT_81	[p6l2004t1045r2132b1123, p6l12t1173r320b1274],

1	quantification	NN	O	quantification	nsubjpass	19	SENT_82	[p6l360t1173r975b1274],
2	of	IN	O	of	_	0	SENT_82	[p6l1015t1173r1115b1252],
3	circulating	VBG	O	circulate	prepc_of	1	SENT_82	[p6l1137t1173r1603b1274],
4	tumor	NN	O	tumor	nn	5	SENT_82	[p6l1640t1190r1907b1252],
5	cells	NNS	O	cell	dobj	3	SENT_82	[p6l1944t1173r2131b1252],
6	with	IN	O	with	_	0	SENT_82	[p6l7t1301r202b1381],
7	the	DT	O	the	det	8	SENT_82	[p6l244t1301r376b1380],
8	use	NN	O	use	prep_with	3	SENT_82	[p6l418t1328r558b1380],
9	of	IN	O	of	_	0	SENT_82	[p6l601t1301r701b1380],
10	magnetic	JJ	O	magnetic	amod	12	SENT_82	[p6l724t1302r1124b1402],
11	bead	NN	O	bead	nn	12	SENT_82	[p6l1165t1301r1895b1402],
12	—	NN	O	—	prep_of	8	SENT_82	[p6l1165t1301r1895b1402],
13	conjugated	VBN	O	conjugate	partmod	12	SENT_82	[p6l1165t1301r1895b1402],
14	antibodies	NNS	O	antibody	dobj	13	SENT_82	[p6l1935t1302r2132b1380, p6l12t1429r286b1508],
15	against	IN	O	against	_	0	SENT_82	[p6l326t1430r635b1530],
16	EpCAM	NNP	O	EpCAM	prep_against	14	SENT_82	[p6l667t1435r991b1530],
17	has	VBZ	O	have	aux	19	SENT_82	[p6l1031t1429r1173b1508],
18	been	VBN	O	be	auxpass	19	SENT_82	[p6l1214t1429r1412b1508],
19	approved	VBN	O	approve	_	0	SENT_82	[p6l1450t1429r1832b1530],
20	by	IN	O	by	_	0	SENT_82	[p6l1872t1429r1968b1530],
21	the	DT	O	the	det	25	SENT_82	[p6l2002t1429r2133b1508],
22	Food	NNP	ORGANIZATION	Food	nn	25	SENT_82	[p6l9t1557r227b1636],
23	and	CC	ORGANIZATION	and	_	0	SENT_82	[p6l277t1557r437b1636],
24	Drug	NNP	ORGANIZATION	Drug	nn	25	SENT_82	[p6l485t1564r710b1658],
25	Administration	NNP	ORGANIZATION	Administration	agent	19	SENT_82	[p6l753t1557r1433b1636],
26	as	IN	O	as	_	0	SENT_82	[p6l1483t1584r1569b1636],
27	a	DT	O	a	det	28	SENT_82	[p6l1621t1584r1666b1636],
28	means	NN	O	means	prep_as	19	SENT_82	[p6l1714t1583r1997b1636],
29	of	IN	O	of	_	0	SENT_82	[p6l2051t1557r2152b1636],
30	monitoring	NN	O	monitoring	nn	31	SENT_82	[p6l11t1686r504b1786],
31	patients	NNS	O	patient	prep_of	28	SENT_82	[p6l547t1686r888b1786],
32	with	IN	O	with	_	0	SENT_82	[p6l933t1685r1129b1764],
33	metastatic	JJ	O	metastatic	amod	34	SENT_82	[p6l1177t1686r1623b1764],
34	breast	NN	O	breast	prep_with	19	SENT_82	[p6l1671t1685r1934b1764],
35	and	CC	O	and	_	0	SENT_82	[p6l1975t1685r2133b1764],
36	prostate	NN	O	prostate	nn	37	SENT_82	[p6l10t1830r367b1914],
37	cancer	NN	O	cancer	prep_with	19	SENT_82	[p6l418t1839r723b1909],
38	,	,	O	,	_	0	SENT_82	[p6l418t1839r723b1909],
39	its	PRP$	O	its	poss	40	SENT_82	[p6l779t1814r880b1892],
40	use	NN	O	use	nsubj	46	SENT_82	[p6l933t1840r1075b1892],
41	in	IN	O	in	_	0	SENT_82	[p6l1126t1814r1210b1891],
42	affecting	VBG	O	affect	prepc_in	40	SENT_82	[p6l1261t1813r1658b1914],
43	treatment	NN	O	treatment	nn	44	SENT_82	[p6l1706t1830r2138b1892],
44	decisions	NNS	O	decision	dobj	42	SENT_82	[p6l12t1940r406b2018],
45	is	VBZ	O	be	cop	46	SENT_82	[p6l454t1941r520b2018],
46	debatable	JJ	O	debatable	ccomp	19	SENT_82	[p6l569t1940r1142b2018],
47	.9	CD	NUMBER	.9	number	48	SENT_82	[p6l569t1940r1142b2018],
48	'11	CD	NUMBER	'11	dep	46	SENT_82	[p6l569t1940r1142b2018],
49	Furthermore	RB	O	furthermore	advmod	46	SENT_82	[p6l1188t1940r1760b2035],
50	,	,	O	,	_	0	SENT_82	[p6l1188t1940r1760b2035],
51	the	DT	O	the	det	52	SENT_82	[p6l1813t1940r1946b2018],
52	use	NN	O	use	nsubjpass	61	SENT_82	[p6l1993t1967r2133b2019],
53	of	IN	O	of	_	0	SENT_82	[p6l12t2069r113b2148],
54	such	JJ	O	such	amod	55	SENT_82	[p6l156t2069r353b2148],
55	cells	NNS	O	cell	prep_of	52	SENT_82	[p6l414t2069r606b2148],
56	for	IN	O	for	_	0	SENT_82	[p6l668t2069r793b2148],
57	molecular	JJ	O	molecular	amod	58	SENT_82	[p6l850t2069r1292b2148],
58	studies	NNS	O	study	prep_for	55	SENT_82	[p6l1351t2069r1657b2148],
59	has	VBZ	O	have	aux	61	SENT_82	[p6l1720t2069r1866b2148],
60	been	VBN	O	be	auxpass	61	SENT_82	[p6l1929t2069r2133b2148],
61	limited	VBN	O	limit	ccomp	19	SENT_82	[p6l10t2197r325b2276],
62	by	IN	O	by	_	0	SENT_82	[p6l371t2197r469b2298],
63	difficulties	NNS	O	difficulty	agent	61	SENT_82	[p6l510t2197r992b2276],
64	in	IN	O	in	_	0	SENT_82	[p6l1039t2198r1123b2275],
65	isolating	VBG	O	isolate	prepc_in	61	SENT_82	[p6l1168t2197r1554b2298],
66	an	DT	O	a	det	68	SENT_82	[p6l1595t2223r1699b2276],
67	adequate	JJ	O	adequate	amod	68	SENT_82	[p6l1744t2197r2133b2298],
68	number	NN	O	number	dobj	65	SENT_82	[p6l11t2325r344b2404],
69	of	IN	O	of	_	0	SENT_82	[p6l374t2325r473b2404],
70	cells	NNS	O	cell	prep_of	68	SENT_82	[p6l489t2325r672b2404],
71	of	IN	O	of	_	0	SENT_82	[p6l708t2325r807b2404],
72	sufficient	JJ	O	sufficient	amod	73	SENT_82	[p6l823t2325r1225b2404],
73	purity	NN	O	purity	prep_of	70	SENT_82	[p6l1253t2326r1507b2426],
74	in	IN	O	in	_	0	SENT_82	[p6l1535t2326r1617b2403],
75	a	DT	O	a	det	77	SENT_82	[p6l1650t2352r1694b2404],
76	reproducible	JJ	O	reproducible	amod	77	SENT_82	[p6l1726t2325r2132b2426, p6l11t2454r161b2533],
77	manner	NN	O	manner	prep_in	65	SENT_82	[p6l199t2480r554b2533],
78	.	.	O	.	_	0	SENT_82	[p6l199t2480r554b2533],

1	In	IN	O	in	_	0	SENT_83	[p6l138t2590r225b2660],
2	the	DT	O	the	det	5	SENT_83	[p6l259t2582r387b2661],
3	microﬂuidic	JJ	O	microﬂuidic	amod	5	SENT_83	[p6l421t2582r931b2661],
4	device	NN	O	device	nn	5	SENT_83	[p6l964t2582r1216b2661],
5	(	NN	O	(	prep_in	6	SENT_83	[p6l1254t2582r1518b2674],
6	called	VBD	O	call	_	0	SENT_83	[p6l1254t2582r1518b2674],
7	the	DT	O	the	det	11	SENT_83	[p6l1552t2582r1680b2661],
8	CTC	NNP	O	CTC	nn	11	SENT_83	[p6l1713t2582r2128b2683],
9	—	CD	NUMBER	—	num	11	SENT_83	[p6l1713t2582r2128b2683],
10	chip	NN	O	chip	nn	11	SENT_83	[p6l1713t2582r2128b2683],
11	)	NN	O	)	dobj	6	SENT_83	[p6l1713t2582r2128b2683],
12	used	VBN	O	use	partmod	11	SENT_83	[p6l11t2710r211b2789],
13	by	IN	O	by	_	0	SENT_83	[p6l268t2710r366b2811],
14	Maheswaran	NNP	O	Maheswaran	agent	12	SENT_83	[p6l415t2710r978b2789],
15	et	FW	O	et	nn	16	SENT_83	[p6l1035t2727r1114b2789],
16	al.	FW	O	al.	nsubj	6	SENT_83	[p6l1165t2710r1291b2806],
17	,	,	O	,	_	0	SENT_83	[p6l1165t2710r1291b2806],
18	blood	NN	O	blood	appos	16	SENT_83	[p6l1353t2710r1600b2789],
19	flows	VBZ	O	flow	rcmod	18	SENT_83	[p6l1657t2710r1897b2789],
20	past	JJ	DATE	past	amod	21	SENT_83	[p6l1954t2727r2138b2811],
21	EpCAM	NN	O	epcam	dobj	19	SENT_83	[p6l9t2838r644b2939],
22	—	CD	NUMBER	—	num	24	SENT_83	[p6l9t2838r644b2939],
23	coated	JJ	O	coated	amod	24	SENT_83	[p6l9t2838r644b2939],
24	microposts	NNS	O	micropost	npadvmod	19	SENT_83	[p6l685t2839r1155b2939],
25	under	IN	O	under	_	0	SENT_83	[p6l1198t2838r1444b2917],
26	conditions	NNS	O	condition	prep_under	19	SENT_83	[p6l1484t2838r1925b2917],
27	that	WDT	O	that	nsubj	28	SENT_83	[p6l1969t2838r2138b2917],
28	optimize	VBP	O	optimize	rcmod	26	SENT_83	[p6l12t2967r394b3067],
29	the	DT	O	the	det	30	SENT_83	[p6l438t2966r571b3045],
30	capture	NN	O	capture	dobj	28	SENT_83	[p6l614t2983r933b3067],
31	of	IN	O	of	_	0	SENT_83	[p6l977t2966r1077b3045],
32	circulating	VBG	O	circulate	prepc_of	30	SENT_83	[p6l1102t2966r1568b3067],
33	tumor	NN	O	tumor	nn	34	SENT_83	[p6l1608t2983r1876b3045],
34	cells	NNS	O	cell	dobj	32	SENT_83	[p6l1916t2966r2128b3045],
35	.	.	O	.	_	0	SENT_83	[p6l1916t2966r2128b3045],

1	The	DT	O	the	det	2	SENT_84	[p6l8t3094r168b3173],
2	investigators	NNS	O	investigator	nsubj	3	SENT_84	[p6l208t3095r756b3195],
3	used	VBN	O	use	_	0	SENT_84	[p6l799t3094r995b3173],
4	this	DT	O	this	det	5	SENT_84	[p6l1036t3094r1195b3173],
5	device	NN	O	device	dobj	3	SENT_84	[p6l1239t3094r1501b3173],
6	to	TO	O	to	aux	7	SENT_84	[p6l1543t3111r1624b3173],
7	isolate	VB	O	isolate	infmod	5	SENT_84	[p6l1665t3094r1942b3173],
8	viable	JJ	O	viable	acomp	7	SENT_84	[p6l1979t3095r2132b3173, p6l12t3222r134b3301],
9	circulating	VBG	O	circulate	xcomp	3	SENT_84	[p6l174t3222r642b3323],
10	tumor	NN	O	tumor	nn	11	SENT_84	[p6l679t3239r946b3301],
11	cells	NNS	O	cell	dobj	9	SENT_84	[p6l984t3222r1171b3301],
12	from	IN	O	from	prep	9	SENT_84	[p6l1213t3222r1423b3301],
13	virtually	RB	O	virtually	advmod	12	SENT_84	[p6l1458t3222r1822b3323],
14	all	PDT	O	all	predet	16	SENT_84	[p6l1856t3222r1961b3301],
15	the	DT	O	the	det	16	SENT_84	[p6l2001t3222r2134b3301],
16	patients	NNS	O	patient	pobj	12	SENT_84	[p6l10t3351r358b3451],
17	with	IN	O	with	dep	12	SENT_84	[p6l414t3350r612b3430],
18	metastatic	JJ	O	metastatic	amod	19	SENT_84	[p6l671t3351r1128b3429],
19	cancer	NN	O	cancer	pobj	17	SENT_84	[p6l1186t3376r1472b3429],
20	but	CC	O	but	_	0	SENT_84	[p6l1527t3350r1670b3429],
21	not	RB	O	not	prep	9	SENT_84	[p6l1722t3367r1867b3429],
22	from	IN	O	from	dep	12	SENT_84	[p6l1920t3350r2134b3429],
23	healthy	JJ	O	healthy	amod	25	SENT_84	[p6l11t3478r322b3579],
24	control	JJ	O	control	amod	25	SENT_84	[p6l350t3478r649b3557],
25	subjects	NNS	O	subject	pobj	22	SENT_84	[p6l683t3478r1076b3579],
26	?	.	O	?	_	0	SENT_84	[p6l683t3478r1076b3579],

1	In	IN	O	in	_	0	SENT_85	[p6l1107t3486r1194b3556],
2	their	PRP$	O	they	poss	3	SENT_85	[p6l1227t3478r1426b3557],
3	study	NN	O	study	prep_in	7	SENT_85	[p6l1457t3478r1694b3579],
4	,	,	O	,	_	0	SENT_85	[p6l1457t3478r1694b3579],
5	they	PRP	O	they	nsubj	7	SENT_85	[p6l1732t3478r1911b3579],
6	were	VBD	O	be	cop	7	SENT_85	[p6l1934t3504r2133b3557],
7	able	JJ	O	able	_	0	SENT_85	[p6l11t3606r184b3685],
8	to	TO	O	to	aux	9	SENT_85	[p6l246t3623r328b3685],
9	identify	VB	O	identify	xcomp	7	SENT_85	[p6l390t3606r731b3707],
10	EGFR	NN	ORGANIZATION	egfr	dobj	9	SENT_85	[p6l786t3613r1000b3686],
11	activating	VBG	O	activate	xcomp	9	SENT_85	[p6l1054t3607r1486b3707],
12	mutations	NNS	O	mutation	dobj	11	SENT_85	[p6l1544t3607r1987b3685],
13	in	IN	O	in	prep	11	SENT_85	[p6l2049t3607r2134b3684],

1	92	CD	PERCENT	92	num	2	SENT_86	[p7l11t25r196b99],
2	%	NN	PERCENT	%	_	0	SENT_86	[p7l11t25r196b99],
3	of	IN	O	of	_	0	SENT_86	[p7l235t20r335b99],
4	patients	NNS	O	patient	prep_of	2	SENT_86	[p7l355t21r696b121],
5	with	IN	O	with	_	0	SENT_86	[p7l734t20r929b99],
6	advanced	JJ	O	advanced	amod	8	SENT_86	[p7l968t20r1364b99],
7	lung	NN	O	lung	nn	8	SENT_86	[p7l1402t20r1595b121],
8	cancer	NN	O	cancer	prep_with	4	SENT_86	[p7l1632t46r1931b116],
9	,	,	O	,	_	0	SENT_86	[p7l1632t46r1931b116],
10	and	CC	O	and	_	0	SENT_86	[p7l1975t20r2133b99],
11	T79OM	NN	O	t79om	conj_and	2	SENT_86	[p7l8t154r335b244],
12	,	,	O	,	_	0	SENT_86	[p7l8t154r335b244],
13	a	DT	O	a	det	14	SENT_86	[p7l375t175r419b227],
14	mutation	NN	O	mutation	appos	2	SENT_86	[p7l453t149r845b227],
15	that	WDT	O	that	nsubj	16	SENT_86	[p7l881t148r1053b227],
16	confers	VBZ	O	confer	rcmod	14	SENT_86	[p7l1084t148r1398b227],
17	drug	NN	O	drug	nn	18	SENT_86	[p7l1436t148r1639b249],
18	resistance	NN	O	resistance	dobj	16	SENT_86	[p7l1671t149r2128b244],
19	,	,	O	,	_	0	SENT_86	[p7l1671t149r2128b244],
20	in	IN	O	in	_	0	SENT_86	[p7l11t277r95b354],
21	55	CD	PERCENT	55	num	22	SENT_86	[p7l154t281r337b355],
22	%	NN	PERCENT	%	prep_in	2	SENT_86	[p7l154t281r337b355],
23	of	IN	O	of	_	0	SENT_86	[p7l394t276r495b355],
24	patients	NNS	O	patient	prep_of	22	SENT_86	[p7l533t277r907b377],
25	.	.	O	.	_	0	SENT_86	[p7l533t277r907b377],

1	In	IN	O	in	_	0	SENT_87	[p7l969t284r1059b354],
2	12	CD	NUMBER	12	num	3	SENT_87	[p7l1120t282r1218b354],
3	patients	NNS	O	patient	prep_in	27	SENT_87	[p7l1276t277r1625b377],
4	for	IN	O	for	_	0	SENT_87	[p7l1684t276r1809b355],
5	whom	WP	O	whom	dobj	18	SENT_87	[p7l1859t276r2134b355],
6	primary	JJ	O	primary	amod	8	SENT_87	[p7l10t405r353b505],
7	tumor	NN	O	tumor	nn	8	SENT_87	[p7l394t421r657b483],
8	samples	NNS	O	sample	nsubj	18	SENT_87	[p7l701t404r1062b505],
9	,	,	O	,	_	0	SENT_87	[p7l701t404r1062b505],
10	circulating	VBG	O	circulate	partmod	8	SENT_87	[p7l1113t404r1569b505],
11	tumor	NN	O	tumor	nn	12	SENT_87	[p7l1610t421r1874b483],
12	cells	NNS	O	cell	dobj	10	SENT_87	[p7l1916t404r2128b500],
13	,	,	O	,	_	0	SENT_87	[p7l1916t404r2128b500],
14	and	CC	O	and	_	0	SENT_87	[p7l11t532r168b611],
15	plasma	NN	O	plasma	nsubj	18	SENT_87	[p7l203t532r513b633],
16	were	VBD	O	be	cop	18	SENT_87	[p7l543t558r745b612],
17	all	DT	O	all	dep	18	SENT_87	[p7l781t532r886b611],
18	available	JJ	O	available	prepc_for	3	SENT_87	[p7l921t532r1292b611],
19	for	IN	O	for	_	0	SENT_87	[p7l1329t532r1452b611],
20	analysis	NN	O	analysis	prep_for	18	SENT_87	[p7l1484t532r1849b633],
21	,	,	O	,	_	0	SENT_87	[p7l1484t532r1849b633],
22	genotyping	NN	O	genotyping	nsubj	27	SENT_87	[p7l1890t558r2132b633, p7l12t661r289b761],
23	of	IN	O	of	_	0	SENT_87	[p7l328t660r428b739],
24	circulating	VBG	O	circulate	prepc_of	22	SENT_87	[p7l453t660r919b761],
25	tumor	NN	O	tumor	nn	26	SENT_87	[p7l959t677r1227b739],
26	cells	NNS	O	cell	dobj	24	SENT_87	[p7l1266t660r1453b739],
27	had	VBD	O	have	_	0	SENT_87	[p7l1498t660r1654b739],
28	a	DT	O	a	det	29	SENT_87	[p7l1695t687r1739b739],
29	sensitivity	NN	O	sensitivity	dobj	27	SENT_87	[p7l1782t661r2132b739, p7l11t789r118b889],
30	of	IN	O	of	_	0	SENT_87	[p7l151t788r251b867],
31	92	CD	PERCENT	92	num	32	SENT_87	[p7l269t793r477b867],
32	%	NN	PERCENT	%	prep_of	29	SENT_87	[p7l269t793r477b867],
33	.	.	O	.	_	0	SENT_87	[p7l269t793r477b867],

1	Perhaps	RB	O	perhaps	advmod	3	SENT_88	[p7l518t788r855b889],
2	more	RBR	O	more	advmod	3	SENT_88	[p7l893t814r1113b867],
3	important	JJ	O	important	ccomp	8	SENT_88	[p7l1149t789r1610b889],
4	,	,	O	,	_	0	SENT_88	[p7l1149t789r1610b889],
5	the	DT	O	the	det	6	SENT_88	[p7l1653t788r1786b867],
6	investigators	NNS	O	investigator	nsubj	8	SENT_88	[p7l1822t789r2132b867, p7l11t933r282b1017],
7	also	RB	O	also	advmod	8	SENT_88	[p7l342t916r517b995],
8	showed	VBD	O	show	_	0	SENT_88	[p7l579t916r907b996],
9	that	IN	O	that	complm	16	SENT_88	[p7l968t916r1143b995],
10	serial	NN	O	serial	nn	11	SENT_88	[p7l1199t916r1435b995],
11	genotyping	NN	O	genotyping	nsubj	16	SENT_88	[p7l1494t917r1994b1017],
12	of	IN	O	of	_	0	SENT_88	[p7l2050t916r2152b995],
13	circulating	VBG	O	circulate	prepc_of	11	SENT_88	[p7l12t1044r474b1145],
14	tumor	NN	O	tumor	nn	15	SENT_88	[p7l509t1061r774b1123],
15	cells	NNS	O	cell	dobj	13	SENT_88	[p7l810t1044r995b1123],
16	seemed	VBD	O	seem	ccomp	8	SENT_88	[p7l1036t1044r1354b1123],
17	to	TO	O	to	aux	18	SENT_88	[p7l1392t1061r1472b1123],
18	have	VB	O	have	xcomp	16	SENT_88	[p7l1512t1044r1700b1123],
19	functional	JJ	O	functional	amod	20	SENT_88	[p7l1738t1044r2132b1123, p7l11t1172r85b1251],
20	significance	NN	O	significance	dobj	18	SENT_88	[p7l132t1172r678b1273],
21	,	,	O	,	_	0	SENT_88	[p7l132t1172r678b1273],
22	since	IN	O	since	mark	31	SENT_88	[p7l731t1173r946b1251],
23	a	DT	O	a	det	24	SENT_88	[p7l991t1199r1035b1251],
24	decrease	NN	O	decrease	nsubjpass	31	SENT_88	[p7l1080t1172r1445b1251],
25	in	IN	O	in	_	0	SENT_88	[p7l1491t1173r1574b1250],
26	the	DT	O	the	det	27	SENT_88	[p7l1620t1172r1752b1251],
27	number	NN	O	number	prep_in	24	SENT_88	[p7l1799t1172r2136b1251],
28	of	IN	O	of	_	0	SENT_88	[p7l12t1300r113b1379],
29	cells	NNS	O	cell	prep_of	27	SENT_88	[p7l142t1300r333b1379],
30	was	VBD	O	be	auxpass	31	SENT_88	[p7l378t1327r542b1379],
31	correlated	VBN	O	correlate	parataxis	18	SENT_88	[p7l592t1300r1033b1379],
32	with	IN	O	with	_	0	SENT_88	[p7l1075t1300r1274b1380],
33	a	DT	O	a	det	35	SENT_88	[p7l1320t1327r1364b1379],
34	radiographic	JJ	O	radiographic	amod	35	SENT_88	[p7l1409t1300r1971b1401],
35	response	NN	O	response	prep_with	31	SENT_88	[p7l2017t1326r2132b1379, p7l13t1454r301b1529],
36	to	TO	O	to	_	0	SENT_88	[p7l349t1445r429b1507],
37	gefitinib	NN	O	gefitinib	prep_to	31	SENT_88	[p7l476t1428r839b1529],
38	in	IN	O	in	_	0	SENT_88	[p7l886t1429r968b1506],
39	four	CD	NUMBER	four	num	40	SENT_88	[p7l1015t1428r1192b1507],
40	patients	NNS	O	patient	prep_in	37	SENT_88	[p7l1234t1429r1591b1529],
41	,	,	O	,	_	0	SENT_88	[p7l1234t1429r1591b1529],
42	whereas	IN	O	whereas	mark	51	SENT_88	[p7l1639t1428r1983b1507],
43	an	DT	O	a	det	44	SENT_88	[p7l2032t1454r2133b1507],
44	increase	NN	O	increase	nsubjpass	51	SENT_88	[p7l11t1558r362b1636],
45	in	IN	O	in	_	0	SENT_88	[p7l413t1558r496b1635],
46	the	DT	O	the	det	47	SENT_88	[p7l547t1557r680b1636],
47	number	NN	O	number	prep_in	44	SENT_88	[p7l732t1557r1069b1636],
48	of	IN	O	of	_	0	SENT_88	[p7l1118t1557r1218b1636],
49	cells	NNS	O	cell	prep_of	47	SENT_88	[p7l1251t1557r1438b1636],
50	was	VBD	O	be	auxpass	51	SENT_88	[p7l1487t1584r1649b1636],
51	correlated	VBN	O	correlate	advcl	18	SENT_88	[p7l1703t1557r2134b1636],
52	with	IN	O	with	_	0	SENT_88	[p7l7t1685r198b1765],
53	the	DT	O	the	det	54	SENT_88	[p7l235t1685r366b1764],
54	emergence	NN	O	emergence	prep_with	51	SENT_88	[p7l402t1711r855b1786],
55	of	IN	O	of	_	0	SENT_88	[p7l891t1685r990b1764],
56	additional	JJ	O	additional	amod	58	SENT_88	[p7l1007t1685r1434b1764],
57	EGFR	NN	ORGANIZATION	egfr	nn	58	SENT_88	[p7l1467t1692r1676b1765],
58	mutations	NNS	O	mutation	prep_of	54	SENT_88	[p7l1706t1686r2131b1764],
59	and	CC	O	and	_	0	SENT_88	[p7l11t1813r168b1892],
60	clinical	JJ	O	clinical	amod	61	SENT_88	[p7l207t1813r520b1892],
61	progression	NN	O	progression	prep_of	54	SENT_88	[p7l556t1814r1090b1914],
62	.	.	O	.	_	0	SENT_88	[p7l556t1814r1090b1914],

1	The	DT	O	the	det	2	SENT_89	[p7l137t1941r299b2020],
2	ability	NN	O	ability	nsubj	12	SENT_89	[p7l362t1941r638b2042],
3	to	TO	O	to	aux	4	SENT_89	[p7l696t1958r779b2020],
4	detect	VB	O	detect	infmod	2	SENT_89	[p7l843t1941r1107b2020],
5	genetic	JJ	O	genetic	amod	6	SENT_89	[p7l1164t1942r1479b2042],
6	markers	NNS	O	marker	dobj	4	SENT_89	[p7l1541t1941r1898b2021],
7	that	WDT	O	that	nsubj	8	SENT_89	[p7l1963t1941r2139b2020],
8	guide	VBP	O	guide	rcmod	6	SENT_89	[p7l11t2069r249b2170],
9	treatment	NN	O	treatment	dobj	8	SENT_89	[p7l293t2086r718b2148],
10	is	VBZ	O	be	cop	12	SENT_89	[p7l755t2070r821b2148],
11	obviously	RB	O	obviously	advmod	12	SENT_89	[p7l867t2069r1272b2170],
12	essential	JJ	O	essential	_	0	SENT_89	[p7l1312t2069r1688b2148],
13	in	IN	O	in	_	0	SENT_89	[p7l1730t2070r1813b2147],
14	identifying	VBG	O	identify	prepc_in	12	SENT_89	[p7l1857t2069r2132b2148, p7l11t2197r230b2298],
15	the	DT	O	the	det	17	SENT_89	[p7l266t2197r397b2276],
16	appropriate	JJ	O	appropriate	amod	17	SENT_89	[p7l435t2198r918b2298],
17	therapy	NN	O	therapy	dobj	14	SENT_89	[p7l957t2197r1284b2298],
18	.	.	O	.	_	0	SENT_89	[p7l957t2197r1284b2298],

1	Equally	RB	O	equally	advmod	2	SENT_90	[p7l1327t2197r1643b2298],
2	important	JJ	O	important	advmod	8	SENT_90	[p7l1676t2198r2128b2298],
3	,	,	O	,	_	0	SENT_90	[p7l1676t2198r2128b2298],
4	however	RB	O	however	advmod	8	SENT_90	[p7l11t2324r386b2419],
5	,	,	O	,	_	0	SENT_90	[p7l11t2324r386b2419],
6	is	VBZ	O	be	cop	8	SENT_90	[p7l437t2325r503b2402],
7	the	DT	O	the	det	8	SENT_90	[p7l552t2324r684b2402],
8	need	NN	O	need	_	0	SENT_90	[p7l731t2324r932b2402],
9	to	TO	O	to	aux	10	SENT_90	[p7l979t2341r1061b2402],
10	monitor	VB	O	monitor	infmod	8	SENT_90	[p7l1108t2325r1458b2402],
11	tumor	NN	O	tumor	nn	12	SENT_90	[p7l1503t2341r1770b2403],
12	cells	NNS	O	cell	dobj	10	SENT_90	[p7l1814t2324r2001b2402],
13	to	TO	O	to	aux	14	SENT_90	[p7l2050t2341r2132b2402],
14	determine	VB	O	determine	xcomp	10	SENT_90	[p7l12t2452r450b2531],
15	whether	IN	O	whether	complm	19	SENT_90	[p7l503t2452r858b2531],
16	the	DT	O	the	det	17	SENT_90	[p7l914t2452r1046b2531],
17	therapy	NN	O	therapy	nsubj	19	SENT_90	[p7l1104t2452r1426b2553],
18	is	VBZ	O	be	cop	19	SENT_90	[p7l1479t2453r1545b2531],
19	“	JJ	O	“	ccomp	14	SENT_90	[p7l1608t2452r1946b2553],
20	hitting	VBG	O	hit	xcomp	19	SENT_90	[p7l1608t2452r1946b2553],
21	the	DT	O	the	det	22	SENT_90	[p7l2001t2452r2133b2531],
22	target	NN	O	target	dobj	20	SENT_90	[p7l12t2586r328b2681],
23	.	.	O	.	_	0	SENT_90	[p7l12t2586r328b2681],

1	”	NN	O	”	_	0	SENT_91	[p7l12t2586r328b2681],
2	When	WRB	O	when	advmod	9	SENT_91	[p7l381t2580r634b2659],
3	drugs	NNS	O	drug	nsubj	9	SENT_91	[p7l687t2580r930b2681],
4	that	WDT	O	that	nsubj	5	SENT_91	[p7l984t2580r1156b2659],
5	perturb	VBP	O	perturb	rcmod	3	SENT_91	[p7l1201t2580r1525b2681],
6	pathways	NNS	O	pathway	dobj	5	SENT_91	[p7l1577t2580r1975b2681],
7	do	VBP	O	do	aux	9	SENT_91	[p7l2029t2580r2132b2659],
8	not	RB	O	not	neg	9	SENT_91	[p7l11t2724r154b2785],
9	work	VB	O	work	advcl	14	SENT_91	[p7l183t2707r423b2802],
10	,	,	O	,	_	0	SENT_91	[p7l183t2707r423b2802],
11	it	PRP	O	it	nsubj	14	SENT_91	[p7l467t2708r526b2785],
12	is	VBZ	O	be	cop	14	SENT_91	[p7l559t2708r625b2785],
13	often	RB	O	often	advmod	14	SENT_91	[p7l666t2707r888b2785],
14	unclear	JJ	O	unclear	rcmod	1	SENT_91	[p7l928t2707r1248b2786],
15	whether	IN	O	whether	complm	21	SENT_91	[p7l1279t2707r1634b2786],
16	the	DT	O	the	det	17	SENT_91	[p7l1671t2707r1804b2785],
17	lack	NN	O	lack	nsubj	21	SENT_91	[p7l1841t2707r2017b2786],
18	of	IN	O	of	_	0	SENT_91	[p7l2052t2707r2152b2785],
19	activity	NN	O	activity	prep_of	17	SENT_91	[p7l11t2836r305b2936],
20	is	VBZ	O	be	cop	21	SENT_91	[p7l334t2836r398b2914],
21	due	JJ	O	due	ccomp	14	SENT_91	[p7l434t2835r579b2914],
22	to	TO	O	to	_	0	SENT_91	[p7l613t2852r693b2914],
23	an	DT	O	a	det	25	SENT_91	[p7l728t2861r829b2914],
24	ineffective	JJ	O	ineffective	amod	25	SENT_91	[p7l861t2835r1286b2914],
25	drug	NN	O	drug	prep_to	21	SENT_91	[p7l1321t2835r1519b2936],
26	or	CC	O	or	_	0	SENT_91	[p7l1550t2861r1636b2914],
27	a	DT	O	a	det	28	SENT_91	[p7l1667t2862r1711b2914],
28	drug	NN	O	drug	prep_to	21	SENT_91	[p7l1744t2835r1942b2936],
29	that	WDT	O	that	rcmod	28	SENT_91	[p7l1972t2835r2138b2914],

1	N	NN	O	n	nn	3	SENT_92	[p7l542t3021r555b3036],
2	ENGLJ	NN	O	englj	nn	3	SENT_92	[p7l570t3021r648b3043],
3	MED359	NN	O	med359	_	0	SENT_92	[p7l663t3021r790b3043],
4	;	:	O	;	_	0	SENT_92	[p7l663t3021r790b3043],
5	4	CD	NUMBER	4	num	7	SENT_92	[p7l663t3021r790b3043],
6	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	7	SENT_92	[p7l822t3021r1024b3043],
7	ULY24	NN	O	uly24	dep	3	SENT_92	[p7l1069t3021r1158b3043],
8	,	,	O	,	_	0	SENT_92	[p7l1069t3021r1158b3043],
9	2008	CD	DATE	2008	num	10	SENT_92	[p7l1169t3015r1233b3037],
10	419	CD	NUMBER	419	appos	7	SENT_92	[p7l1958t3011r2016b3034],

1	The	DT	O	the	det	6	SENT_93	[p7l702t3054r753b3078],
2	New	NNP	O	New	nn	6	SENT_93	[p7l762t3055r824b3078],
3	England	NNP	O	England	nn	6	SENT_93	[p7l833t3054r944b3085],
4	J	NNP	O	J	nn	6	SENT_93	[p7l952t3055r965b3078],
5	ouma	NN	O	ouma	nn	6	SENT_93	[p7l966t3062r1041b3078],
6	o	NN	O	o	_	0	SENT_93	[p7l1059t3062r1075b3078],
7	Medicine	NN	O	medicine	dep	6	SENT_93	[p7l1095t3054r1220b3078],

1	Downloaded	VBN	O	download	_	0	SENT_94	[p7l144t3095r314b3118],
2	from	IN	O	from	_	0	SENT_94	[p7l323t3095r387b3118],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_94	[p7l396t3095r514b3125],
4	at	IN	O	at	_	0	SENT_94	[p7l524t3099r547b3118],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_94	[p7l556t3095r738b3118],
6	on	IN	O	on	_	0	SENT_94	[p7l748t3102r780b3118],
7	January	NNP	DATE	January	prep_on	1	SENT_94	[p7l789t3095r892b3125],
8	5	CD	DATE	5	num	7	SENT_94	[p7l902t3095r924b3123],
9	,	,	DATE	,	_	0	SENT_94	[p7l902t3095r924b3123],
10	2014	CD	DATE	2014	num	7	SENT_94	[p7l935t3095r1007b3118],
11	.	.	O	.	_	0	SENT_94	[p7l935t3095r1007b3118],

1	For	IN	O	for	_	0	SENT_95	[p7l1018t3095r1064b3118],
2	personal	JJ	O	personal	amod	3	SENT_95	[p7l1072t3095r1185b3125],
3	use	NN	O	use	pobj	1	SENT_95	[p7l1194t3102r1237b3118],
4	only	RB	O	only	advmod	3	SENT_95	[p7l1247t3095r1312b3125],
5	.	.	O	.	_	0	SENT_95	[p7l1247t3095r1312b3125],

1	No	DT	O	no	det	3	SENT_96	[p7l1322t3095r1362b3118],
2	other	JJ	O	other	amod	3	SENT_96	[p7l1372t3095r1440b3118],
3	uses	NNS	O	use	_	0	SENT_96	[p7l1448t3102r1504b3118],
4	without	IN	O	without	_	0	SENT_96	[p7l1514t3095r1616b3118],
5	permission	NN	O	permission	prep_without	3	SENT_96	[p7l1624t3095r1776b3125],
6	.	.	O	.	_	0	SENT_96	[p7l1624t3095r1776b3125],

1	Copyright	NN	O	copyright	_	0	SENT_97	[p7l494t3136r629b3167],
2	©	CD	NUMBER	©	num	6	SENT_97	[p7l638t3136r661b3160],
3	2008	CD	DATE	2008	num	6	SENT_97	[p7l671t3136r736b3160],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_97	[p7l746t3136r937b3160],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_97	[p7l947t3136r1055b3160],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_97	[p7l1065t3136r1170b3167],
7	.	.	O	.	_	0	SENT_97	[p7l1065t3136r1170b3167],

1	All	DT	O	all	det	2	SENT_98	[p7l1181t3136r1223b3160],
2	rights	NNS	O	rights	nsubj	3	SENT_98	[p7l1232t3136r1306b3167],
3	reserved	VBN	O	reserve	_	0	SENT_98	[p7l1316t3136r1435b3160],
4	.	.	O	.	_	0	SENT_98	[p7l1316t3136r1435b3160],

1	The	DT	O	the	det	4	SENT_99	[p7l673t3242r718b3263],
2	NEW	NNP	O	NEW	nn	4	SENT_99	[p7l737t3244r822b3263],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_99	[p7l841t3244r1029b3263],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_99	[p7l1048t3244r1227b3270],
5	of	IN	O	of	_	0	SENT_99	[p7l1247t3242r1275b3269],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_99	[p7l1287t3244r1486b3263],

1	does	VBZ	O	do	aux	3	SENT_100	[p7l12t3464r206b3543],
2	not	RB	O	not	neg	3	SENT_100	[p7l254t3481r397b3543],
3	reach	VB	O	reach	_	0	SENT_100	[p7l438t3464r669b3543],
4	its	PRP$	O	its	poss	5	SENT_100	[p7l714t3465r812b3543],
5	target	NN	O	target	dobj	3	SENT_100	[p7l861t3481r1117b3565],
6	or	CC	O	or	_	0	SENT_100	[p7l1159t3490r1247b3543],
7	to	TO	O	to	conj_or	3	SENT_100	[p7l1291t3481r1372b3543],
8	a	DT	O	a	det	10	SENT_100	[p7l1419t3491r1463b3543],
9	targeted	VBN	O	target	amod	10	SENT_100	[p7l1509t3464r1864b3565],
10	pathway	NN	O	pathway	pobj	7	SENT_100	[p7l1908t3464r2133b3565, p7l7t3619r175b3693],
11	that	WDT	O	that	nsubj	16	SENT_100	[p7l209t3592r381b3671],
12	is	VBZ	O	be	cop	16	SENT_100	[p7l414t3593r480b3671],
13	not	RB	O	not	neg	16	SENT_100	[p7l521t3609r664b3671],
14	a	DT	O	a	det	16	SENT_100	[p7l696t3619r741b3671],
15	major	JJ	O	major	amod	16	SENT_100	[p7l777t3593r1027b3693],
16	factor	NN	O	factor	rcmod	10	SENT_100	[p7l1062t3592r1313b3671],
17	in	IN	O	in	_	0	SENT_100	[p7l1347t3593r1431b3670],
18	carcinogenesis	NN	O	carcinogenesis	prep_in	16	SENT_100	[p7l1470t3593r2128b3693],
19	.	.	O	.	_	0	SENT_100	[p7l1470t3593r2128b3693],

1	For	IN	O	for	_	0	SENT_101	[p8l11t28r153b99],
2	decades	NNS	DURATION	decade	prep_for	10	SENT_101	[p8l196t20r554b116],
3	,	,	O	,	_	0	SENT_101	[p8l196t20r554b116],
4	lung	NN	O	lung	nn	7	SENT_101	[p8l604t20r1115b121],
5	—	NN	O	—	nn	7	SENT_101	[p8l604t20r1115b121],
6	cancer	NN	O	cancer	nn	7	SENT_101	[p8l604t20r1115b121],
7	oncologists	NNS	O	oncologist	nsubjpass	10	SENT_101	[p8l1159t20r1649b121],
8	have	VBP	O	have	aux	10	SENT_101	[p8l1697t20r1886b99],
9	been	VBN	O	be	auxpass	10	SENT_101	[p8l1933t20r2134b99],
10	frustrated	VBN	O	frustrate	_	0	SENT_101	[p8l12t148r439b227],
11	by	IN	O	by	_	0	SENT_101	[p8l478t148r575b249],
12	difficulties	NNS	O	difficulty	agent	10	SENT_101	[p8l608t148r1078b227],
13	associated	VBN	O	associate	dep	12	SENT_101	[p8l1117t148r1562b227],
14	with	IN	O	with	_	0	SENT_101	[p8l1595t148r1790b227],
15	serially	RB	O	serially	advmod	16	SENT_101	[p8l1829t148r2138b249],
16	obtaining	VBG	O	obtain	prepc_with	13	SENT_101	[p8l12t276r435b377],
17	tumor	NN	O	tumor	nn	18	SENT_101	[p8l469t293r737b355],
18	tissue	NN	O	tissue	dobj	16	SENT_101	[p8l771t277r1017b355],
19	with	IN	O	with	_	0	SENT_101	[p8l1049t276r1244b355],
20	which	WDT	O	which	nsubj	22	SENT_101	[p8l1276t276r1539b355],
21	to	TO	O	to	aux	22	SENT_101	[p8l1577t293r1658b355],
22	determine	VB	O	determine	prepc_with	16	SENT_101	[p8l1697t276r2134b355],
23	whether	IN	O	whether	complm	32	SENT_101	[p8l7t404r363b483],
24	molecular	JJ	O	molecular	amod	25	SENT_101	[p8l406t404r839b483],
25	pathways	NNS	O	pathway	nsubjpass	32	SENT_101	[p8l881t404r1280b505],
26	in	IN	O	in	_	0	SENT_101	[p8l1328t405r1412b482],
27	tumor	NN	O	tumor	nn	28	SENT_101	[p8l1458t421r1726b483],
28	cells	NNS	O	cell	prep_in	25	SENT_101	[p8l1770t404r1957b483],
29	are	VBP	O	be	aux	32	SENT_101	[p8l2005t430r2134b483],
30	indeed	RB	O	indeed	advmod	32	SENT_101	[p8l11t532r298b611],
31	being	VBG	O	be	auxpass	32	SENT_101	[p8l344t532r585b633],
32	inhibited	VBD	O	inhibit	ccomp	22	SENT_101	[p8l626t532r1016b611],
33	or	CC	O	or	_	0	SENT_101	[p8l1061t558r1150b611],
34	otherwise	RB	O	otherwise	advmod	35	SENT_101	[p8l1192t532r1616b611],
35	affected	VBN	O	affect	conj_or	13	SENT_101	[p8l1661t532r2006b611],
36	in	IN	O	in	_	0	SENT_101	[p8l2051t533r2134b610],
37	the	DT	O	the	det	38	SENT_101	[p8l12t660r145b739],
38	manner	NN	O	manner	prep_in	35	SENT_101	[p8l183t686r520b739],
39	predicted	VBD	O	predict	partmod	38	SENT_101	[p8l554t660r980b761],
40	.	.	O	.	_	0	SENT_101	[p8l554t660r980b761],

1	Whether	IN	O	whether	complm	10	SENT_102	[p8l137t788r519b867],
2	the	DT	O	the	det	3	SENT_102	[p8l591t788r726b867],
3	technique	NN	O	technique	nsubj	10	SENT_102	[p8l801t788r1231b889],
4	described	VBN	O	describe	partmod	3	SENT_102	[p8l1306t788r1726b867],
5	by	IN	O	by	_	0	SENT_102	[p8l1801t788r1899b889],
6	Maheswaran	NNP	O	Maheswaran	agent	4	SENT_102	[p8l1966t796r2133b867, p8l12t916r433b995],
7	et	FW	O	et	nn	8	SENT_102	[p8l473t933r550b995],
8	al.	FW	O	al.	dobj	4	SENT_102	[p8l582t916r679b995],
9	will	MD	O	will	aux	10	SENT_102	[p8l718t916r882b996],
10	allow	VB	O	allow	csubj	28	SENT_102	[p8l919t916r1154b995],
11	the	DT	O	the	det	12	SENT_102	[p8l1188t916r1321b995],
12	isolation	NN	O	isolation	dobj	10	SENT_102	[p8l1358t916r1731b995],
13	of	IN	O	of	_	0	SENT_102	[p8l1770t916r1870b995],
14	viable	JJ	O	viable	amod	15	SENT_102	[p8l1884t916r2134b995],
15	cells	NNS	O	cell	prep_of	12	SENT_102	[p8l12t1044r199b1123],
16	of	IN	O	of	_	0	SENT_102	[p8l240t1044r340b1123],
17	sufficient	JJ	O	sufficient	amod	18	SENT_102	[p8l361t1044r772b1123],
18	quantity	NN	O	quantity	prep_of	15	SENT_102	[p8l806t1045r1165b1145],
19	and	CC	O	and	_	0	SENT_102	[p8l1198t1044r1356b1123],
20	purity	NN	O	purity	conj_and	18	SENT_102	[p8l1392t1045r1652b1145],
21	to	TO	O	to	aux	22	SENT_102	[p8l1686t1061r1767b1123],
22	identify	VB	O	identify	xcomp	10	SENT_102	[p8l1805t1044r2138b1145],
23	treatment	NN	O	treatment	nn	24	SENT_102	[p8l12t1190r436b1252],
24	effects	NNS	O	effect	dobj	22	SENT_102	[p8l476t1173r758b1252],
25	on	IN	O	on	_	0	SENT_102	[p8l805t1199r911b1252],
26	cancer	NN	O	cancer	nn	27	SENT_102	[p8l957t1199r1238b1252],
27	cells	NNS	O	cell	prep_on	22	SENT_102	[p8l1280t1173r1467b1252],
28	remains	VBZ	O	remain	_	0	SENT_102	[p8l1514t1174r1862b1252],
29	to	TO	O	to	aux	31	SENT_102	[p8l1909t1190r1991b1252],
30	be	VB	O	be	auxpass	31	SENT_102	[p8l2037t1173r2133b1252],
31	seen	VBN	O	see	xcomp	28	SENT_102	[p8l13t1327r224b1380],
32	.	.	O	.	_	0	SENT_102	[p8l13t1327r224b1380],

1	One	CD	NUMBER	one	nsubj	3	SENT_103	[p8l274t1307r446b1380],
2	also	RB	O	also	advmod	3	SENT_103	[p8l490t1301r661b1380],
3	wonders	VBZ	O	wonder	_	0	SENT_103	[p8l702t1301r1066b1380],
4	whether	IN	O	whether	complm	8	SENT_103	[p8l1109t1301r1464b1380],
5	this	DT	O	this	det	6	SENT_103	[p8l1506t1301r1665b1380],
6	technique	NN	O	technique	nsubj	8	SENT_103	[p8l1712t1301r2133b1402],
7	will	MD	O	will	aux	8	SENT_103	[p8l7t1429r166b1508],
8	allow	VB	O	allow	ccomp	3	SENT_103	[p8l197t1429r424b1508],
9	consistent	JJ	O	consistent	amod	10	SENT_103	[p8l454t1430r874b1508],
10	detection	NN	O	detection	dobj	8	SENT_103	[p8l902t1429r1281b1508],
11	and	CC	O	and	_	0	SENT_103	[p8l1313t1429r1467b1508],
12	isolation	NN	O	isolation	conj_and	10	SENT_103	[p8l1499t1429r1854b1508],
13	of	IN	O	of	_	0	SENT_103	[p8l1889t1429r1986b1508],
14	puriﬁed	JJ	O	puriﬁed	acomp	17	SENT_103	[p8l1999t1455r2133b1530, p8l12t1557r257b1653],
15	,	,	O	,	_	0	SENT_103	[p8l1999t1455r2133b1530, p8l12t1557r257b1653],
16	viable	JJ	O	viable	dep	14	SENT_103	[p8l302t1557r551b1636],
17	circulating	VBG	O	circulate	prepc_of	10	SENT_103	[p8l598t1557r1065b1658],
18	tumor	NN	O	tumor	nn	19	SENT_103	[p8l1107t1574r1375b1636],
19	cells	NNS	O	cell	dobj	17	SENT_103	[p8l1418t1557r1605b1636],
20	from	IN	O	from	_	0	SENT_103	[p8l1653t1557r1863b1636],
21	other	JJ	O	other	amod	23	SENT_103	[p8l1909t1557r2137b1636],
22	tumor	NN	O	tumor	nn	23	SENT_103	[p8l12t1702r280b1764],
23	types	NNS	O	type	prep_from	17	SENT_103	[p8l317t1702r541b1786],
24	and	CC	O	and	_	0	SENT_103	[p8l582t1685r740b1764],
25	for	IN	O	for	_	0	SENT_103	[p8l779t1685r902b1764],
26	molecular	JJ	O	molecular	amod	27	SENT_103	[p8l938t1685r1372b1764],
27	analysis	NN	O	analysis	prep_for	17	SENT_103	[p8l1408t1685r1747b1786],
28	of	IN	O	of	_	0	SENT_103	[p8l1789t1685r1889b1764],
29	pathways	NNS	O	pathway	prep_of	27	SENT_103	[p8l1909t1685r2133b1786, p8l7t1840r213b1914],
30	other	JJ	O	other	dep	29	SENT_103	[p8l271t1813r498b1892],
31	than	IN	O	than	_	0	SENT_103	[p8l550t1813r747b1892],
32	that	DT	O	that	prep_than	29	SENT_103	[p8l802t1813r974b1892],
33	of	IN	O	of	_	0	SENT_103	[p8l1025t1813r1124b1892],
34	EGFR	NN	ORGANIZATION	egfr	prep_of	32	SENT_103	[p8l1160t1819r1430b1897],
35	.	.	O	.	_	0	SENT_103	[p8l1160t1819r1430b1897],

1	Moreover	RB	O	moreover	advmod	5	SENT_104	[p8l1488t1821r1912b1909],
2	,	,	O	,	_	0	SENT_104	[p8l1488t1821r1912b1909],
3	this	DT	O	this	det	4	SENT_104	[p8l1973t1813r2133b1892],
4	study	NN	O	study	nsubj	5	SENT_104	[p8l13t1941r239b2042],
5	represents	VBZ	O	represent	_	0	SENT_104	[p8l266t1958r698b2042],
6	a	DT	O	a	det	7	SENT_104	[p8l732t1968r776b2020],
7	proof	NN	O	proof	dobj	5	SENT_104	[p8l805t1941r1051b2042],
8	of	IN	O	of	_	0	SENT_104	[p8l1066t1941r1164b2020],
9	principle	NN	O	principle	prep_of	7	SENT_104	[p8l1177t1941r1569b2042],
10	,	,	O	,	_	0	SENT_104	[p8l1177t1941r1569b2042],
11	and	CC	O	and	_	0	SENT_104	[p8l1605t1941r1761b2020],
12	the	DT	O	the	det	13	SENT_104	[p8l1793t1941r1924b2020],
13	ease	NN	O	ease	nsubj	23	SENT_104	[p8l1957t1968r2134b2020],
14	with	IN	O	with	_	0	SENT_104	[p8l7t2069r203b2148],
15	which	WDT	O	which	rel	20	SENT_104	[p8l237t2069r500b2148],
16	this	DT	O	this	det	17	SENT_104	[p8l539t2069r698b2148],
17	approach	NN	O	approach	nsubjpass	20	SENT_104	[p8l738t2069r1133b2170],
18	can	MD	O	can	aux	20	SENT_104	[p8l1173t2095r1322b2148],
19	be	VB	O	be	auxpass	20	SENT_104	[p8l1361t2069r1457b2148],
20	used	VBN	O	use	rcmod	13	SENT_104	[p8l1497t2069r1693b2148],
21	by	IN	O	by	_	0	SENT_104	[p8l1733t2069r1830b2170],
22	others	NNS	O	other	agent	20	SENT_104	[p8l1864t2069r2132b2148],
23	remains	VBZ	O	remain	conj_and	5	SENT_104	[p8l12t2198r353b2276],
24	to	TO	O	to	aux	26	SENT_104	[p8l392t2214r473b2276],
25	be	VB	O	be	auxpass	26	SENT_104	[p8l511t2197r607b2276],
26	determined	VBN	O	determine	xcomp	23	SENT_104	[p8l644t2197r1151b2276],
27	.	.	O	.	_	0	SENT_104	[p8l644t2197r1151b2276],

1	That	DT	O	that	nsubj	2	SENT_105	[p8l1190t2197r1387b2276],
2	said	VBD	O	say	ccomp	17	SENT_105	[p8l1420t2197r1609b2293],
3	,	,	O	,	_	0	SENT_105	[p8l1420t2197r1609b2293],
4	the	DT	O	the	det	5	SENT_105	[p8l1653t2197r1783b2276],
5	capture	NN	O	capture	nsubj	17	SENT_105	[p8l1821t2214r2134b2298],
6	and	CC	O	and	_	0	SENT_105	[p8l11t2325r169b2404],
7	analysis	NN	O	analysis	nsubj	17	SENT_105	[p8l208t2325r548b2426],
8	of	IN	O	of	_	0	SENT_105	[p8l591t2325r691b2404],
9	circulating	VBG	O	circulate	prepc_of	5	SENT_105	[p8l714t2325r1181b2426],
10	tumor	NN	O	tumor	nn	11	SENT_105	[p8l1218t2342r1485b2404],
11	cells	NNS	O	cell	dobj	9	SENT_105	[p8l1524t2325r1710b2404],
12	from	IN	O	from	_	0	SENT_105	[p8l1752t2325r1963b2404],
13	patients	NNS	O	patient	prep_from	9	SENT_105	[p8l2002t2351r2133b2426, p8l12t2454r238b2532],
14	with	IN	O	with	_	0	SENT_105	[p8l273t2453r461b2532],
15	lung	NN	O	lung	nn	16	SENT_105	[p8l498t2453r685b2554],
16	cancer	NN	O	cancer	prep_with	13	SENT_105	[p8l720t2479r990b2532],
17	represents	VBZ	O	represent	_	0	SENT_105	[p8l1025t2470r1447b2554],
18	a	DT	O	a	det	21	SENT_105	[p8l1486t2480r1530b2532],
19	new	JJ	O	new	amod	21	SENT_105	[p8l1566t2479r1739b2532],
20	diagnostic	JJ	O	diagnostic	amod	21	SENT_105	[p8l1774t2453r2133b2554, p8l12t2582r113b2660],
21	approach	NN	O	approach	dobj	17	SENT_105	[p8l146t2581r534b2682],
22	that	WDT	O	that	nsubj	24	SENT_105	[p8l569t2581r738b2660],
23	may	MD	O	may	aux	24	SENT_105	[p8l768t2607r944b2682],
24	bring	VB	O	bring	rcmod	21	SENT_105	[p8l975t2581r1203b2682],
25	us	PRP	O	we	nsubj	26	SENT_105	[p8l1234t2608r1325b2660],
26	closer	JJR	O	closer	xcomp	24	SENT_105	[p8l1362t2581r1610b2660],
27	to	TO	O	to	_	0	SENT_105	[p8l1641t2598r1722b2660],
28	an	DT	O	a	det	29	SENT_105	[p8l1757t2607r1859b2660],
29	era	NN	O	era	prep_to	26	SENT_105	[p8l1894t2607r2020b2660],
30	of	IN	O	of	_	0	SENT_105	[p8l2054t2581r2152b2660],
31	individualized	JJ	O	individualized	amod	32	SENT_105	[p8l11t2710r626b2789],
32	medicine	NN	O	medicine	prep_of	29	SENT_105	[p8l664t2710r1079b2789],
33	.	.	O	.	_	0	SENT_105	[p8l664t2710r1079b2789],

1	Dr.	NNP	O	Dr.	nn	2	SENT_106	[p8l96t2858r194b2912],
2	Schiller	NNP	PERSON	Schiller	nsubj	3	SENT_106	[p8l229t2853r472b2912],
3	reports	VBZ	O	report	_	0	SENT_106	[p8l498t2866r727b2928],
4	receiving	VBG	O	receive	xcomp	3	SENT_106	[p8l756t2854r1049b2928],
5	consulting	NN	O	consulting	nn	6	SENT_106	[p8l1076t2853r1421b2928],
6	fees	NNS	O	fee	dobj	4	SENT_106	[p8l1446t2852r1570b2911],
7	from	IN	O	from	_	0	SENT_106	[p8l1600t2852r1758b2912],
8	Genentech	NNP	ORGANIZATION	Genentech	prep_from	4	SENT_106	[p8l1786t2853r2135b2912],
9	and	CC	O	and	_	0	SENT_106	[p8l11t2940r129b2999],
10	Bristol	NNP	LOCATION	Bristol	conj_and	8	SENT_106	[p8l153t2940r579b3015],
11	.	.	O	.	_	0	SENT_106	[p8l153t2940r579b3015],

1	—	NN	O	—	_	0	SENT_107	[p8l153t2940r579b3015],
2	.	.	O	.	_	0	SENT_107	[p8l153t2940r579b3015],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_108	[p8l153t2940r579b3015],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_108	[p8l607t2940r827b3015],
3	and	CC	O	and	_	0	SENT_108	[p8l852t2940r971b2999],
4	grant	NN	O	grant	nn	5	SENT_108	[p8l995t2953r1171b3015],
5	support	NN	O	support	conj_and	2	SENT_108	[p8l1193t2953r1443b3015],
6	from	IN	O	from	rcmod	2	SENT_108	[p8l1463t2939r1622b2999],
7	Genentech	NNP	ORGANIZATION	Genentech	pobj	6	SENT_108	[p8l1646t2940r1992b2999],
8	and	CC	O	and	_	0	SENT_108	[p8l2016t2940r2135b2999],
9	doing	VBG	O	do	rcmod	2	SENT_108	[p8l12t3027r197b3102],
10	uncompensated	JJ	O	uncompensated	amod	12	SENT_108	[p8l236t3027r749b3102],
11	consulting	NN	O	consulting	nn	12	SENT_108	[p8l791t3027r1136b3102],
12	work	NN	O	work	dobj	9	SENT_108	[p8l1171t3027r1338b3087],
13	for	IN	O	for	_	0	SENT_108	[p8l1375t3026r1468b3086],
14	Imclone	NNP	ORGANIZATION	Imclone	prep_for	12	SENT_108	[p8l1507t3027r1786b3086],
15	.	.	O	.	_	0	SENT_108	[p8l1507t3027r1786b3086],

1	No	DT	O	no	det	4	SENT_109	[p8l1829t3032r1923b3086],
2	other	JJ	O	other	amod	4	SENT_109	[p8l1966t3027r2137b3086],
3	potential	JJ	O	potential	amod	4	SENT_109	[p8l10t3114r301b3189],
4	conflict	NN	O	conflict	nsubjpass	12	SENT_109	[p8l325t3113r577b3173],
5	of	IN	O	of	_	0	SENT_109	[p8l598t3113r673b3173],
6	interest	NN	O	interest	prep_of	4	SENT_109	[p8l682t3115r927b3173],
7	relevant	JJ	O	relevant	amod	6	SENT_109	[p8l947t3114r1203b3174],
8	to	TO	O	to	_	0	SENT_109	[p8l1223t3127r1284b3173],
9	this	DT	O	this	det	10	SENT_109	[p8l1310t3114r1430b3172],
10	article	NN	O	article	prep_to	7	SENT_109	[p8l1454t3114r1655b3173],
11	was	VBD	O	be	auxpass	12	SENT_109	[p8l1675t3134r1797b3174],
12	reported	VBN	O	report	_	0	SENT_109	[p8l1823t3114r2116b3189],
13	.	.	O	.	_	0	SENT_109	[p8l1823t3114r2116b3189],

1	This	DT	O	this	det	2	SENT_110	[p8l9t3205r149b3266],
2	article	NN	O	article	nsubjpass	9	SENT_110	[p8l186t3205r392b3266],
3	(	CD	NUMBER	(	number	4	SENT_110	[p8l434t3209r1291b3285],
4	10.1056	CD	NUMBER	10.1056	num	2	SENT_110	[p8l434t3209r1291b3285],
5	/	:	O	/	punct	7	SENT_110	[p8l434t3209r1291b3285],
6	NEJMeO804521	NN	O	nejmeo804521	nn	7	SENT_110	[p8l434t3209r1291b3285],
7	)	NN	O	)	dep	2	SENT_110	[p8l434t3209r1291b3285],
8	was	VBD	O	be	auxpass	9	SENT_110	[p8l1330t3227r1455b3266],
9	published	VBN	O	publish	_	0	SENT_110	[p8l1495t3205r1819b3284],
10	at	IN	O	at	_	0	SENT_110	[p8l1858t3217r1917b3266],
11	www	NN	O	www	prep_at	9	SENT_110	[p8l1948t3228r2131b3266],
12	.	.	O	.	_	0	SENT_110	[p8l1948t3228r2131b3266],

1	nejm.org	NN	O	nejm.org	nn	2	SENT_111	[p8l15t3293r314b3367],
2	onjuly	NN	O	onjuly	_	0	SENT_111	[p8l337t3287r561b3367],
3	2,2008	CD	NUMBER	2,2008	dep	2	SENT_111	[p8l584t3291r846b3358],
4	.	.	O	.	_	0	SENT_111	[p8l584t3291r846b3358],

1	From	IN	O	from	dep	10	SENT_112	[p8l16t3387r182b3443],
2	the	DT	O	the	det	3	SENT_112	[p8l227t3382r333b3443],
3	Division	NN	O	division	pobj	1	SENT_112	[p8l382t3388r649b3443],
4	of	IN	O	of	_	0	SENT_112	[p8l697t3381r769b3443],
5	Hematology	NNP	O	Hematology	prep_of	3	SENT_112	[p8l807t3382r1220b3462],
6	and	CC	O	and	_	0	SENT_112	[p8l1264t3382r1381b3443],
7	Oncology	NNP	O	Oncology	prep_of	3	SENT_112	[p8l1430t3382r1769b3462],
8	,	,	O	,	_	0	SENT_112	[p8l1430t3382r1769b3462],
9	Simmons	NNP	ORGANIZATION	Simmons	nn	10	SENT_112	[p8l1818t3387r2136b3443],
10	Comprehensive	NNP	ORGANIZATION	Comprehensive	_	0	SENT_112	[p8l11t3477r539b3556],
11	Cancer	NNP	ORGANIZATION	Cancer	nn	12	SENT_112	[p8l568t3482r801b3538],
12	Center	NNP	ORGANIZATION	Center	dep	10	SENT_112	[p8l828t3482r1062b3548],
13	,	,	O	,	_	0	SENT_112	[p8l828t3482r1062b3548],
14	University	NNP	ORGANIZATION	University	nn	15	SENT_112	[p8l1097t3482r1435b3557],
15	ofTexas	NNP	ORGANIZATION	ofTexas	dep	10	SENT_112	[p8l1462t3476r1731b3538],
16	Southwestern	NNP	ORGANIZATION	Southwestern	nn	18	SENT_112	[p8l1763t3477r2139b3538, p8l11t3595r113b3634],
17	Medical	NNP	ORGANIZATION	Medical	nn	18	SENT_112	[p8l147t3573r404b3634],
18	Center	NNP	ORGANIZATION	Center	dep	15	SENT_112	[p8l433t3578r667b3644],
19	,	,	O	,	_	0	SENT_112	[p8l433t3578r667b3644],
20	Dallas	NNP	LOCATION	Dallas	dep	10	SENT_112	[p8l700t3573r920b3634],
21	.	.	O	.	_	0	SENT_112	[p8l700t3573r920b3634],

1	1	LS	NUMBER	1	_	0	SENT_113	[p9l12t93r62b144],
2	.	.	O	.	_	0	SENT_113	[p9l12t93r62b144],

1	Schiller	NNP	PERSON	Schiller	nn	2	SENT_114	[p9l141t85r390b144],
2	JH	NNP	O	JH	_	0	SENT_114	[p9l413t91r517b157],
3	,	,	O	,	_	0	SENT_114	[p9l413t91r517b157],
4	Harrington	NNP	PERSON	Harrington	nn	5	SENT_114	[p9l553t86r931b161],
5	D	NNP	O	D	appos	2	SENT_114	[p9l962t90r1029b157],
6	,	,	O	,	_	0	SENT_114	[p9l962t90r1029b157],
7	Belani	NNP	PERSON	Belani	nn	8	SENT_114	[p9l1065t85r1274b144],
8	CP	NNP	O	CP	appos	2	SENT_114	[p9l1305t90r1403b157],
9	,	,	O	,	_	0	SENT_114	[p9l1305t90r1403b157],
10	et	FW	O	et	nn	11	SENT_114	[p9l1440t98r1500b144],
11	al.	FW	O	al.	appos	2	SENT_114	[p9l1527t85r1602b144],
12	.	.	O	.	_	0	SENT_114	[p9l1527t85r1602b144],

1	Comparison	NN	O	comparison	_	0	SENT_115	[p9l1638t86r2044b160],
2	of	IN	O	of	_	0	SENT_115	[p9l2078t85r2153b144],
3	four	CD	NUMBER	four	num	5	SENT_115	[p9l9t181r148b240],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_115	[p9l177t181r646b256],
5	regimens	NNS	O	regimen	prep_of	1	SENT_115	[p9l674t182r980b257],
6	for	IN	O	for	_	0	SENT_115	[p9l1012t181r1107b240],
7	advanced	JJ	O	advanced	amod	9	SENT_115	[p9l1135t181r1439b240],
8	non	JJ	O	non	amod	9	SENT_115	[p9l1470t181r1964b240],
9	—	NN	O	—	prep_for	1	SENT_115	[p9l1470t181r1964b240],
10	small	JJ	O	small	amod	14	SENT_115	[p9l1470t181r1964b240],
11	—	NN	O	—	nn	14	SENT_115	[p9l1470t181r1964b240],
12	cell	NN	O	cell	nn	14	SENT_115	[p9l1470t181r1964b240],
13	lung	NN	O	lung	nn	14	SENT_115	[p9l1994t181r2142b257],
14	cancer	NN	O	cancer	dep	9	SENT_115	[p9l10t296r240b336],
15	.	.	O	.	_	0	SENT_115	[p9l10t296r240b336],

1	N	NN	O	n	nn	3	SENT_116	[p9l268t283r325b336],
2	Engl	NNP	O	Engl	nn	3	SENT_116	[p9l349t277r544b353],
3	]	NNP	O	]	nsubj	4	SENT_116	[p9l349t277r544b353],
4	Med	VBD	O	med	_	0	SENT_116	[p9l566t277r708b336],
5	2002	CD	DATE	2002	dobj	4	SENT_116	[p9l734t282r1215b348],
6	;	:	O	;	_	0	SENT_116	[p9l734t282r1215b348],
7	346:92	CD	NUMBER	346:92	number	8	SENT_116	[p9l734t282r1215b348],
8	—	CD	NUMBER	—	dep	5	SENT_116	[p9l734t282r1215b348],
9	8	CD	NUMBER	8	dep	8	SENT_116	[p9l734t282r1215b348],
10	.	.	O	.	_	0	SENT_116	[p9l734t282r1215b348],

1	2	LS	NUMBER	2	_	0	SENT_117	[p9l9t381r64b432],
2	.	.	O	.	_	0	SENT_117	[p9l9t381r64b432],

1	Hanahan	NN	PERSON	hanahan	nn	2	SENT_118	[p9l139t373r449b432],
2	D	NN	O	d	_	0	SENT_118	[p9l483t378r551b445],
3	,	,	O	,	_	0	SENT_118	[p9l483t378r551b445],
4	Weinberg	NNP	PERSON	Weinberg	nn	5	SENT_118	[p9l587t373r914b449],
5	RA	NN	O	ra	appos	2	SENT_118	[p9l945t378r1064b436],
6	.	.	O	.	_	0	SENT_118	[p9l945t378r1064b436],

1	The	DT	O	the	det	2	SENT_119	[p9l1101t373r1225b432],
2	hallmarks	NNS	O	hallmark	_	0	SENT_119	[p9l1260t373r1602b433],
3	of	IN	O	of	_	0	SENT_119	[p9l1638t373r1716b432],
4	cancer	NN	O	cancer	prep_of	2	SENT_119	[p9l1736t392r1971b432],
5	.	.	O	.	_	0	SENT_119	[p9l1736t392r1971b432],

1	Cell	NN	O	cell	_	0	SENT_120	[p9l2010t373r2140b432],
2	2000	CD	DATE	2000	num	1	SENT_120	[p9l10t474r524b540],
3	;	:	O	;	_	0	SENT_120	[p9l10t474r524b540],
4	100:57	CD	NUMBER	100:57	number	5	SENT_120	[p9l10t474r524b540],
5	-70	CD	NUMBER	-70	dep	1	SENT_120	[p9l10t474r524b540],
6	.	.	O	.	_	0	SENT_120	[p9l10t474r524b540],

1	3	LS	NUMBER	3	_	0	SENT_121	[p9l9t573r59b624],
2	.	.	O	.	_	0	SENT_121	[p9l9t573r59b624],

1	Jéinne	NNP	ORGANIZATION	Jéinne	nn	2	SENT_122	[p9l131t570r317b633],
2	PA	NN	ORGANIZATION	pa	_	0	SENT_122	[p9l338t570r439b637],
3	,	,	O	,	_	0	SENT_122	[p9l338t570r439b637],
4	Engelman	NNP	PERSON	Engelman	nn	5	SENT_122	[p9l464t565r793b641],
5	JA	NNP	O	JA	appos	2	SENT_122	[p9l808t571r900b637],
6	,	,	O	,	_	0	SENT_122	[p9l808t571r900b637],
7	Johnson	NNP	PERSON	Johnson	nsubj	8	SENT_122	[p9l919t565r1190b633],
8	BE	VB	O	be	dep	2	SENT_122	[p9l1211t570r1314b624],
9	.	.	O	.	_	0	SENT_122	[p9l1211t570r1314b624],

1	Epidermal	JJ	O	epidermal	amod	5	SENT_123	[p9l1339t565r1673b640],
2	growth	NN	O	growth	nn	5	SENT_123	[p9l1695t565r1932b641],
3	factor	NN	O	factor	nn	5	SENT_123	[p9l1954t565r2143b624],
4	receptor	NN	O	receptor	nn	5	SENT_123	[p9l9t674r283b736],
5	mutations	NNS	O	mutation	_	0	SENT_123	[p9l312t662r646b720],
6	in	IN	O	in	_	0	SENT_123	[p9l679t662r742b719],
7	non	JJ	O	non	amod	13	SENT_123	[p9l774t661r1252b720],
8	—	JJ	O	—	amod	13	SENT_123	[p9l774t661r1252b720],
9	small	JJ	O	small	amod	13	SENT_123	[p9l774t661r1252b720],
10	—	NN	O	—	nn	13	SENT_123	[p9l774t661r1252b720],
11	cell	NN	O	cell	nn	13	SENT_123	[p9l774t661r1252b720],
12	lung	NN	O	lung	nn	13	SENT_123	[p9l1282t661r1430b737],
13	cancer	NN	O	cancer	prep_in	5	SENT_123	[p9l1460t680r1692b720],
14	:	:	O	:	_	0	SENT_123	[p9l1460t680r1692b720],
15	implications	NNS	O	implication	dep	5	SENT_123	[p9l1726t661r2138b736],
16	for	IN	O	for	_	0	SENT_123	[p9l9t757r104b816],
17	treatment	NN	O	treatment	nn	20	SENT_123	[p9l128t770r454b816],
18	and	CC	O	and	_	0	SENT_123	[p9l475t757r596b816],
19	tumor	NN	O	tumor	nn	20	SENT_123	[p9l622t770r827b816],
20	biology	NN	O	biology	prep_for	15	SENT_123	[p9l851t757r1107b833],
21	.	.	O	.	_	0	SENT_123	[p9l851t757r1107b833],

1	J	NNP	O	J	nn	3	SENT_124	[p9l1130t763r1157b825],
2	Clin	NNP	O	Clin	nn	3	SENT_124	[p9l1182t757r1318b816],
3	Oncol	NNP	O	Oncol	_	0	SENT_124	[p9l1343t757r1538b816],
4	2005	CD	DATE	2005	num	3	SENT_124	[p9l1563t762r2120b828],
5	;	:	O	;	_	0	SENT_124	[p9l1563t762r2120b828],
6	23:3227	CD	NUMBER	23:3227	number	7	SENT_124	[p9l1563t762r2120b828],
7	—	CD	NUMBER	—	dep	3	SENT_124	[p9l1563t762r2120b828],
8	34	CD	NUMBER	34	dep	7	SENT_124	[p9l1563t762r2120b828],
9	.	.	O	.	_	0	SENT_124	[p9l1563t762r2120b828],

1	4	LS	NUMBER	4	_	0	SENT_125	[p9l8t861r62b912],
2	.	.	O	.	_	0	SENT_125	[p9l8t861r62b912],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_126	[p9l138t853r332b928],
2	T	NN	O	t	nn	3	SENT_126	[p9l355t858r442b925],
3	]	NN	O	]	_	0	SENT_126	[p9l355t858r442b925],
4	,	,	O	,	_	0	SENT_126	[p9l355t858r442b925],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_126	[p9l470t853r596b912],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_126	[p9l620t858r753b925],
7	,	,	O	,	_	0	SENT_126	[p9l620t858r753b925],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_126	[p9l784t853r1051b912],
9	R	NNP	PERSON	R	appos	3	SENT_126	[p9l1074t858r1140b925],
10	,	,	O	,	_	0	SENT_126	[p9l1074t858r1140b925],
11	et	FW	O	et	nn	12	SENT_126	[p9l1171t866r1230b912],
12	al.	FW	O	al.	appos	3	SENT_126	[p9l1251t853r1326b912],
13	.	.	O	.	_	0	SENT_126	[p9l1251t853r1326b912],

1	Activating	VBG	O	activate	amod	2	SENT_127	[p9l1353t854r1693b929],
2	mutations	NNS	O	mutation	_	0	SENT_127	[p9l1716t854r2050b913],
3	in	IN	O	in	_	0	SENT_127	[p9l2076t854r2140b911],
4	the	DT	O	the	det	7	SENT_127	[p9l10t949r112b1008],
5	epidermal	JJ	O	epidermal	amod	7	SENT_127	[p9l136t949r468b1024],
6	growth	NN	O	growth	nn	7	SENT_127	[p9l492t949r732b1025],
7	factor	NN	O	factor	prep_in	2	SENT_127	[p9l756t949r949b1008],
8	receptor	NN	O	receptor	nn	10	SENT_127	[p9l971t962r1244b1024],
9	underlying	VBG	O	underlie	amod	10	SENT_127	[p9l1265t949r1624b1025],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_127	[p9l1645t950r2138b1024],
11	of	IN	O	of	_	0	SENT_127	[p9l10t1045r86b1104],
12	non	JJ	O	non	amod	18	SENT_127	[p9l103t1045r597b1104],
13	—	JJ	O	—	amod	18	SENT_127	[p9l103t1045r597b1104],
14	small	JJ	O	small	amod	18	SENT_127	[p9l103t1045r597b1104],
15	—	NN	O	—	nn	18	SENT_127	[p9l103t1045r597b1104],
16	cell	NN	O	cell	nn	18	SENT_127	[p9l103t1045r597b1104],
17	lung	NN	O	lung	nn	18	SENT_127	[p9l626t1045r774b1121],
18	cancer	NN	O	cancer	prep_of	10	SENT_127	[p9l802t1064r1018b1104],
19	to	TO	O	to	_	0	SENT_127	[p9l1046t1058r1108b1104],
20	gefitinib	NN	O	gefitinib	prep_to	10	SENT_127	[p9l1139t1045r1443b1121],
21	.	.	O	.	_	0	SENT_127	[p9l1139t1045r1443b1121],

1	N	NN	O	n	nn	3	SENT_128	[p9l1476t1051r1532b1104],
2	Engl	NNP	O	Engl	nn	3	SENT_128	[p9l1560t1045r1709b1121],
3	J	NNP	O	J	nsubj	4	SENT_128	[p9l1731t1051r1760b1113],
4	Med	VBD	O	med	_	0	SENT_128	[p9l1786t1045r1928b1104],
5	2004	CD	DATE	2004	dobj	4	SENT_128	[p9l1959t1050r2136b1116],
6	;	:	O	;	_	0	SENT_128	[p9l1959t1050r2136b1116],
7	350:2129	CD	NUMBER	350:2129	num	8	SENT_128	[p9l11t1146r426b1200],
8	-39	CD	NUMBER	-39	dep	5	SENT_128	[p9l11t1146r426b1200],
9	.	.	O	.	_	0	SENT_128	[p9l11t1146r426b1200],

1	5	CD	NUMBER	5	_	0	SENT_129	[p9l11t1244r60b1295],
2	.	.	O	.	_	0	SENT_129	[p9l11t1244r60b1295],

1	Kobayashi	NNP	LOCATION	Kobayashi	nn	2	SENT_130	[p9l139t1236r477b1311],
2	S	NNP	LOCATION	S	_	0	SENT_130	[p9l514t1241r566b1308],
3	,	,	O	,	_	0	SENT_130	[p9l514t1241r566b1308],
4	Boggon	NNP	PERSON	Boggon	nn	6	SENT_130	[p9l604t1241r860b1312],
5	T	NN	O	t	nn	6	SENT_130	[p9l892t1241r979b1308],
6	]	NN	O	]	appos	2	SENT_130	[p9l892t1241r979b1308],
7	,	,	O	,	_	0	SENT_130	[p9l892t1241r979b1308],
8	Dayaram	NN	ORGANIZATION	dayaram	nn	9	SENT_130	[p9l1017t1241r1312b1311],
9	T	NN	ORGANIZATION	t	appos	2	SENT_130	[p9l1344t1241r1403b1308],
10	,	,	O	,	_	0	SENT_130	[p9l1344t1241r1403b1308],
11	et	FW	O	et	nn	12	SENT_130	[p9l1443t1249r1502b1295],
12	al.	FW	O	al.	appos	2	SENT_130	[p9l1533t1236r1608b1295],
13	.	.	O	.	_	0	SENT_130	[p9l1533t1236r1608b1295],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_131	[p9l1646t1241r1808b1296],
2	mutation	NN	O	mutation	_	0	SENT_131	[p9l1838t1237r2140b1295],
3	and	CC	O	and	_	0	SENT_131	[p9l9t1332r131b1391],
4	resistance	NN	O	resistance	conj_and	2	SENT_131	[p9l163t1333r500b1391],
5	of	IN	O	of	_	0	SENT_131	[p9l532t1332r609b1391],
6	non	JJ	O	non	amod	11	SENT_131	[p9l627t1332r1131b1391],
7	—	JJ	O	—	amod	11	SENT_131	[p9l627t1332r1131b1391],
8	small	JJ	O	small	amod	11	SENT_131	[p9l627t1332r1131b1391],
9	—	NN	O	—	nn	11	SENT_131	[p9l627t1332r1131b1391],
10	cell	NN	O	cell	nn	11	SENT_131	[p9l627t1332r1131b1391],
11	cancer	NN	O	cancer	prep_of	2	SENT_131	[p9l1163t1351r1382b1391],
12	to	TO	O	to	_	0	SENT_131	[p9l1412t1345r1475b1391],
13	gefitinib	NN	O	gefitinib	prep_to	2	SENT_131	[p9l1507t1332r1818b1408],
14	.	.	O	.	_	0	SENT_131	[p9l1507t1332r1818b1408],

1	N	NN	O	n	nn	3	SENT_132	[p9l1853t1338r1909b1391],
2	Engl	NNP	O	Engl	nn	3	SENT_132	[p9l1938t1332r2142b1408],
3	]	NNP	O	]	nsubj	4	SENT_132	[p9l1938t1332r2142b1408],
4	Med	VBD	O	med	_	0	SENT_132	[p9l7t1428r150b1487],
5	2005	CD	DATE	2005	dobj	4	SENT_132	[p9l175t1433r732b1499],
6	;	:	O	;	_	0	SENT_132	[p9l175t1433r732b1499],
7	352:786	CD	NUMBER	352:786	number	8	SENT_132	[p9l175t1433r732b1499],
8	—	CD	NUMBER	—	dep	5	SENT_132	[p9l175t1433r732b1499],
9	92	CD	NUMBER	92	dep	8	SENT_132	[p9l175t1433r732b1499],
10	.	.	O	.	_	0	SENT_132	[p9l175t1433r732b1499],

1	6	CD	NUMBER	6	_	0	SENT_133	[p9l10t1531r62b1583],
2	.	.	O	.	_	0	SENT_133	[p9l10t1531r62b1583],

1	Maheswaran	NNP	MISC	Maheswaran	nn	2	SENT_134	[p9l137t1524r561b1583],
2	S	NNP	O	S	_	0	SENT_134	[p9l601t1529r653b1596],
3	,	,	O	,	_	0	SENT_134	[p9l601t1529r653b1596],
4	Sequist	NNP	O	Sequist	nn	5	SENT_134	[p9l697t1525r937b1599],
5	LV	NNP	O	LV	appos	2	SENT_134	[p9l970t1530r1060b1596],
6	,	,	O	,	_	0	SENT_134	[p9l970t1530r1060b1596],
7	Nagrath	NNP	PERSON	Nagrath	nn	8	SENT_134	[p9l1101t1524r1373b1600],
8	S	NNP	O	S	appos	2	SENT_134	[p9l1413t1529r1465b1596],
9	,	,	O	,	_	0	SENT_134	[p9l1413t1529r1465b1596],
10	et	FW	O	et	nn	11	SENT_134	[p9l1508t1537r1567b1583],
11	al.	FW	O	al.	appos	2	SENT_134	[p9l1602t1524r1676b1583],
12	.	.	O	.	_	0	SENT_134	[p9l1602t1524r1676b1583],

1	Detection	NN	O	detection	_	0	SENT_135	[p9l1718t1525r2038b1583],
2	of	IN	O	of	_	0	SENT_135	[p9l2077t1524r2153b1583],
3	mutations	NNS	O	mutation	prep_of	1	SENT_135	[p9l10t1621r343b1679],
4	in	IN	O	in	_	0	SENT_135	[p9l368t1621r432b1678],
5	EGFR	NN	ORGANIZATION	egfr	prep_in	3	SENT_135	[p9l454t1625r616b1680],
6	in	IN	O	in	_	0	SENT_135	[p9l634t1621r698b1678],
7	circulating	VBG	O	circulate	prepc_in	5	SENT_135	[p9l722t1620r1082b1696],
8	lung	NN	O	lung	nn	11	SENT_135	[p9l1102t1620r1495b1696],
9	—	NN	O	—	nn	11	SENT_135	[p9l1102t1620r1495b1696],
10	cancer	NN	O	cancer	nn	11	SENT_135	[p9l1102t1620r1495b1696],
11	cells	NNS	O	cell	dobj	7	SENT_135	[p9l1518t1620r1681b1679],
12	.	.	O	.	_	0	SENT_135	[p9l1518t1620r1681b1679],

1	N	NN	O	n	nn	3	SENT_136	[p9l1707t1626r1764b1680],
2	Engl	NNP	O	Engl	nn	3	SENT_136	[p9l1785t1620r1978b1696],
3	]	NNP	O	]	nsubj	4	SENT_136	[p9l1785t1620r1978b1696],
4	Med	VBD	O	med	_	0	SENT_136	[p9l1998t1620r2140b1679],
5	2008	CD	DATE	2008	dobj	4	SENT_136	[p9l10t1721r562b1788],
6	;	:	O	;	_	0	SENT_136	[p9l10t1721r562b1788],
7	359:366	CD	NUMBER	359:366	num	8	SENT_136	[p9l10t1721r562b1788],
8	-77	CD	NUMBER	-77	dep	5	SENT_136	[p9l10t1721r562b1788],
9	.	.	O	.	_	0	SENT_136	[p9l10t1721r562b1788],

1	7	CD	NUMBER	7	_	0	SENT_137	[p9l11t1820r55b1871],
2	.	.	O	.	_	0	SENT_137	[p9l11t1820r55b1871],

1	Nagrath	NN	MISC	nagrath	nn	2	SENT_138	[p9l137t1812r408b1888],
2	S	NN	O	s	_	0	SENT_138	[p9l435t1817r487b1884],
3	,	,	O	,	_	0	SENT_138	[p9l435t1817r487b1884],
4	Sequist	NNP	O	Sequist	nn	5	SENT_138	[p9l518t1813r757b1887],
5	LV	NNP	O	LV	appos	2	SENT_138	[p9l777t1818r867b1884],
6	,	,	O	,	_	0	SENT_138	[p9l777t1818r867b1884],
7	Maheswaran	NNP	O	Maheswaran	nn	8	SENT_138	[p9l894t1812r1318b1872],
8	S	NNP	O	S	appos	2	SENT_138	[p9l1344t1817r1395b1884],
9	,	,	O	,	_	0	SENT_138	[p9l1344t1817r1395b1884],
10	et	FW	O	et	nn	11	SENT_138	[p9l1425t1825r1484b1871],
11	al.	FW	O	al.	appos	2	SENT_138	[p9l1505t1812r1579b1871],
12	.	.	O	.	_	0	SENT_138	[p9l1505t1812r1579b1871],

1	Isolation	NN	O	isolation	_	0	SENT_139	[p9l1607t1812r1899b1871],
2	of	IN	O	of	_	0	SENT_139	[p9l1924t1812r2000b1871],
3	rare	JJ	O	rare	acomp	4	SENT_139	[p9l2011t1831r2139b1871],
4	circulating	VBG	O	circulate	prepc_of	1	SENT_139	[p9l10t1908r370b1984],
5	tumour	NN	O	tumour	nn	6	SENT_139	[p9l401t1921r650b1967],
6	cells	NNS	O	cell	dobj	4	SENT_139	[p9l682t1908r826b1967],
7	in	IN	O	in	_	0	SENT_139	[p9l861t1909r924b1966],
8	cancer	NN	O	cancer	nn	9	SENT_139	[p9l959t1927r1174b1967],
9	patients	NNS	O	patient	prep_in	4	SENT_139	[p9l1205t1909r1467b1983],
10	by	IN	O	by	_	0	SENT_139	[p9l1503t1908r1577b1983],
11	microchip	NN	O	microchip	nn	12	SENT_139	[p9l1607t1908r1943b1983],
12	technology	NN	O	technology	prep_by	9	SENT_139	[p9l1978t1908r2139b1967, p9l10t2004r246b2080],
13	.	.	O	.	_	0	SENT_139	[p9l1978t1908r2139b1967, p9l10t2004r246b2080],

1	Nature	NNP	O	Nature	_	0	SENT_140	[p9l275t2010r500b2064],
2	2007	CD	DATE	2007	num	1	SENT_140	[p9l527t2009r1080b2075],
3	;	:	O	;	_	0	SENT_140	[p9l527t2009r1080b2075],
4	450:1235	CD	NUMBER	450:1235	number	5	SENT_140	[p9l527t2009r1080b2075],
5	—	CD	NUMBER	—	dep	1	SENT_140	[p9l527t2009r1080b2075],
6	9	CD	NUMBER	9	dep	5	SENT_140	[p9l527t2009r1080b2075],
7	.	.	O	.	_	0	SENT_140	[p9l527t2009r1080b2075],

1	8	CD	NUMBER	8	_	0	SENT_141	[p9l9t2106r62b2160],
2	.	.	O	.	_	0	SENT_141	[p9l9t2106r62b2160],

1	Krivacic	JJ	ORGANIZATION	krivacic	amod	2	SENT_142	[p9l139t2101r403b2161],
2	RT	NN	ORGANIZATION	rt	_	0	SENT_142	[p9l428t2105r533b2172],
3	,	,	O	,	_	0	SENT_142	[p9l428t2105r533b2172],
4	Ladanyi	NNP	PERSON	Ladanyi	nn	5	SENT_142	[p9l563t2100r822b2175],
5	A	NNP	O	A	appos	2	SENT_142	[p9l845t2106r913b2172],
6	,	,	O	,	_	0	SENT_142	[p9l845t2106r913b2172],
7	Curry	NNP	PERSON	Curry	appos	2	SENT_142	[p9l944t2105r1132b2175],
8	DN	JJ	O	dn	dep	7	SENT_142	[p9l1154t2105r1280b2172],
9	,	,	O	,	_	0	SENT_142	[p9l1154t2105r1280b2172],
10	et	FW	O	et	nn	11	SENT_142	[p9l1312t2113r1371b2159],
11	al.	FW	O	al.	appos	2	SENT_142	[p9l1394t2100r1469b2160],
12	.	.	O	.	_	0	SENT_142	[p9l1394t2100r1469b2160],

1	A	DT	O	a	det	5	SENT_143	[p9l1497t2106r1547b2158],
2	rare	JJ	O	rare	amod	5	SENT_143	[p9l1572t2100r1845b2159],
3	—	NN	O	—	nn	5	SENT_143	[p9l1572t2100r1845b2159],
4	cell	NN	O	cell	nn	5	SENT_143	[p9l1572t2100r1845b2159],
5	detector	NN	O	detector	_	0	SENT_143	[p9l1872t2100r2142b2160],
6	for	IN	O	for	_	0	SENT_143	[p9l10t2196r104b2255],
7	cancer	NN	O	cancer	prep_for	5	SENT_143	[p9l128t2215r358b2255],
8	.	.	O	.	_	0	SENT_143	[p9l128t2215r358b2255],

1	Proc	NNP	O	Proc	nn	7	SENT_144	[p9l387t2201r534b2255],
2	Natl	NNP	O	Natl	nn	7	SENT_144	[p9l557t2196r697b2256],
3	Acad	NNP	O	Acad	nn	7	SENT_144	[p9l720t2196r882b2255],
4	Sci	NNP	O	Sci	nn	7	SENT_144	[p9l909t2197r1001b2255],
5	U	NNP	O	U	nn	7	SENT_144	[p9l1025t2202r1077b2255],
6	S	NNP	O	S	nn	7	SENT_144	[p9l1104t2201r1135b2255],
7	A	NNP	O	A	_	0	SENT_144	[p9l1161t2202r1211b2254],
8	2004	CD	DATE	2004	num	7	SENT_144	[p9l1234t2201r1829b2267],
9	;	:	O	;	_	0	SENT_144	[p9l1234t2201r1829b2267],
10	101:10501	CD	NUMBER	101:10501	number	11	SENT_144	[p9l1234t2201r1829b2267],
11	—	CD	NUMBER	—	dep	7	SENT_144	[p9l1234t2201r1829b2267],
12	4	CD	NUMBER	4	dep	11	SENT_144	[p9l1234t2201r1829b2267],
13	.	.	O	.	_	0	SENT_144	[p9l1234t2201r1829b2267],

1	9	CD	NUMBER	9	_	0	SENT_145	[p9l9t2299r60b2351],
2	.	.	O	.	_	0	SENT_145	[p9l9t2299r60b2351],

1	Braun	NNP	PERSON	Braun	nn	2	SENT_146	[p9l138t2297r333b2351],
2	S	NNP	O	S	_	0	SENT_146	[p9l379t2297r431b2364],
3	,	,	O	,	_	0	SENT_146	[p9l379t2297r431b2364],
4	Marth	NNP	PERSON	Marth	nn	5	SENT_146	[p9l477t2292r682b2351],
5	C.	NNP	O	C.	appos	2	SENT_146	[p9l726t2297r790b2351],
6	Circulating	VBG	O	circulate	partmod	5	SENT_146	[p9l837t2292r1211b2368],
7	tumor	NN	O	tumor	nn	8	SENT_146	[p9l1253t2305r1458b2351],
8	cells	NNS	O	cell	dobj	6	SENT_146	[p9l1500t2292r1644b2351],
9	in	IN	O	in	_	0	SENT_146	[p9l1689t2293r1752b2350],
10	metastatic	JJ	O	metastatic	amod	12	SENT_146	[p9l1796t2293r2140b2351],
11	breast	NN	O	breast	nn	12	SENT_146	[p9l10t2388r212b2448],
12	cancer	NN	O	cancer	prep_in	6	SENT_146	[p9l234t2408r450b2448],
13	—	CD	NUMBER	—	dep	12	SENT_146	[p9l470t2422r551b2429],
14	toward	IN	O	toward	_	0	SENT_146	[p9l573t2388r803b2448],
15	individualized	JJ	O	individualized	amod	16	SENT_146	[p9l827t2388r1301b2448],
16	treatment	NN	O	treatment	prep_toward	13	SENT_146	[p9l1326t2387r1679b2448],
17	?	.	O	?	_	0	SENT_146	[p9l1326t2387r1679b2448],

1	N	NN	O	n	nn	3	SENT_147	[p9l1703t2394r1760b2448],
2	Engl	NNP	O	Engl	nn	3	SENT_147	[p9l1782t2388r1976b2465],
3	]	NNP	O	]	nsubj	4	SENT_147	[p9l1782t2388r1976b2465],
4	Med	VBD	O	med	_	0	SENT_147	[p9l1998t2388r2140b2448],
5	2004	CD	DATE	2004	dobj	4	SENT_147	[p9l10t2490r534b2556],
6	;	:	O	;	_	0	SENT_147	[p9l10t2490r534b2556],
7	351:824	CD	NUMBER	351:824	number	8	SENT_147	[p9l10t2490r534b2556],
8	—	CD	NUMBER	—	dep	5	SENT_147	[p9l10t2490r534b2556],
9	6	CD	NUMBER	6	dep	8	SENT_147	[p9l10t2490r534b2556],
10	.	.	O	.	_	0	SENT_147	[p9l10t2490r534b2556],

1	10	CD	NUMBER	10	_	0	SENT_148	[p9l12t2587r97b2640],
2	.	.	O	.	_	0	SENT_148	[p9l12t2587r97b2640],

1	Cristofanilli	NNP	PERSON	Cristofanilli	nn	2	SENT_149	[p9l139t2581r541b2640],
2	M	NNP	O	M	_	0	SENT_149	[p9l568t2587r651b2653],
3	,	,	O	,	_	0	SENT_149	[p9l568t2587r651b2653],
4	Budd	NNP	PERSON	Budd	nn	5	SENT_149	[p9l685t2581r853b2640],
5	GT	NN	O	gt	appos	2	SENT_149	[p9l884t2586r996b2653],
6	,	,	O	,	_	0	SENT_149	[p9l884t2586r996b2653],
7	Ellis	NNP	PERSON	Ellis	nn	9	SENT_149	[p9l1029t2581r1171b2640],
8	M	NNP	O	M	nn	9	SENT_149	[p9l1201t2587r1306b2653],
9	]	NN	O	]	appos	2	SENT_149	[p9l1201t2587r1306b2653],
10	,	,	O	,	_	0	SENT_149	[p9l1201t2587r1306b2653],
11	et	FW	O	et	nn	12	SENT_149	[p9l1340t2594r1400b2640],
12	al.	FW	O	al.	appos	2	SENT_149	[p9l1426t2581r1500b2640],
13	.	.	O	.	_	0	SENT_149	[p9l1426t2581r1500b2640],

1	Circulating	VBG	O	circulate	_	0	SENT_150	[p9l1535t2581r1909b2657],
2	tumor	NN	O	tumor	nn	3	SENT_150	[p9l1937t2594r2142b2640],
3	cells	NNS	O	cell	dobj	1	SENT_150	[p9l10t2677r174b2749],
4	,	,	O	,	_	0	SENT_150	[p9l10t2677r174b2749],
5	disease	NN	O	disease	nn	6	SENT_150	[p9l202t2677r440b2736],
6	progression	NN	O	progression	dobj	1	SENT_150	[p9l463t2678r874b2753],
7	,	,	O	,	_	0	SENT_150	[p9l463t2678r874b2753],
8	and	CC	O	and	_	0	SENT_150	[p9l902t2677r1022b2736],
9	survival	NN	O	survival	dobj	1	SENT_150	[p9l1047t2677r1302b2737],
10	in	IN	O	in	_	0	SENT_150	[p9l1324t2678r1387b2735],
11	metastatic	JJ	O	metastatic	amod	13	SENT_150	[p9l1411t2678r1755b2736],
12	breast	NN	O	breast	nn	13	SENT_150	[p9l1778t2677r1980b2736],
13	cancer	NN	O	cancer	prep_in	9	SENT_150	[p9l2000t2696r2139b2736, p9l10t2792r122b2832],
14	.	.	O	.	_	0	SENT_150	[p9l2000t2696r2139b2736, p9l10t2792r122b2832],

1	N	NN	O	n	nn	2	SENT_151	[p9l150t2779r206b2832],
2	EnglJ	NN	O	englj	nsubj	3	SENT_151	[p9l231t2773r425b2849],
3	Med	VBD	O	med	_	0	SENT_151	[p9l447t2773r589b2832],
4	2004	CD	DATE	2004	dobj	3	SENT_151	[p9l615t2778r1168b2844],
5	;	:	O	;	_	0	SENT_151	[p9l615t2778r1168b2844],
6	351:781	CD	NUMBER	351:781	number	7	SENT_151	[p9l615t2778r1168b2844],
7	—	CD	NUMBER	—	dep	4	SENT_151	[p9l615t2778r1168b2844],
8	91	CD	NUMBER	91	dep	7	SENT_151	[p9l615t2778r1168b2844],
9	.	.	O	.	_	0	SENT_151	[p9l615t2778r1168b2844],

1	11	CD	NUMBER	11	_	0	SENT_152	[p9l12t2877r97b2928],
2	.	.	O	.	_	0	SENT_152	[p9l12t2877r97b2928],

1	Cristofanilli	NNP	PERSON	Cristofanilli	nn	2	SENT_153	[p9l139t2869r541b2928],
2	M	NNP	O	M	_	0	SENT_153	[p9l562t2875r645b2941],
3	,	,	O	,	_	0	SENT_153	[p9l562t2875r645b2941],
4	Hayes	NNP	PERSON	Hayes	nn	5	SENT_153	[p9l673t2875r866b2944],
5	DF	NNP	O	DF	appos	2	SENT_153	[p9l891t2874r996b2941],
6	,	,	O	,	_	0	SENT_153	[p9l891t2874r996b2941],
7	Budd	NNP	PERSON	Budd	nn	8	SENT_153	[p9l1024t2869r1193b2928],
8	GT	NN	O	gt	appos	2	SENT_153	[p9l1217t2874r1329b2941],
9	,	,	O	,	_	0	SENT_153	[p9l1217t2874r1329b2941],
10	et	FW	O	et	nn	11	SENT_153	[p9l1359t2882r1417b2928],
11	al.	FW	O	al.	appos	2	SENT_153	[p9l1437t2869r1512b2928],
12	.	.	O	.	_	0	SENT_153	[p9l1437t2869r1512b2928],

1	Circulating	VBG	O	circulate	dep	8	SENT_154	[p9l1541t2869r1915b2945],
2	tumor	NN	O	tumor	nn	3	SENT_154	[p9l1937t2882r2142b2928],
3	cells	NNS	O	cell	dobj	1	SENT_154	[p9l10t2965r174b3024],
4	:	:	O	:	_	0	SENT_154	[p9l10t2965r174b3024],
5	a	DT	O	a	det	8	SENT_154	[p9l207t2985r241b3024],
6	novel	JJ	O	novel	amod	8	SENT_154	[p9l271t2965r443b3024],
7	prognostic	JJ	O	prognostic	amod	8	SENT_154	[p9l473t2966r830b3041],
8	factor	NN	O	factor	_	0	SENT_154	[p9l861t2965r1054b3024],
9	for	IN	O	for	prep	8	SENT_154	[p9l1082t2965r1177b3024],
10	newly	RB	O	newly	pcomp	9	SENT_154	[p9l1206t2965r1397b3040],
11	diagnosed	VBN	O	diagnose	partmod	8	SENT_154	[p9l1425t2965r1766b3041],
12	metastatic	JJ	O	metastatic	amod	14	SENT_154	[p9l1797t2966r2140b3024],
13	breast	NN	O	breast	nn	14	SENT_154	[p9l10t3060r212b3119],
14	cancer	NN	O	cancer	dobj	11	SENT_154	[p9l247t3079r477b3119],
15	.	.	O	.	_	0	SENT_154	[p9l247t3079r477b3119],

1	J	NNP	O	J	nn	3	SENT_155	[p9l512t3066r540b3128],
2	Clin	NNP	O	Clin	nn	3	SENT_155	[p9l577t3060r712b3119],
3	Oncol	NNP	O	Oncol	_	0	SENT_155	[p9l751t3060r945b3119],
4	2005	CD	DATE	2005	num	3	SENT_155	[p9l984t3065r1540b3131],
5	;	:	O	;	_	0	SENT_155	[p9l984t3065r1540b3131],
6	23:1420	CD	NUMBER	23:1420	number	7	SENT_155	[p9l984t3065r1540b3131],
7	—	CD	NUMBER	—	dep	3	SENT_155	[p9l984t3065r1540b3131],
8	30	CD	NUMBER	30	dep	7	SENT_155	[p9l984t3065r1540b3131],
9	.	.	O	.	_	0	SENT_155	[p9l984t3065r1540b3131],

1	[	NNP	O	[	_	0	SENT_156	[p9l1590t3065r1905b3132],
2	Erratum	NNP	O	Erratum	nn	6	SENT_156	[p9l1590t3065r1905b3132],
3	,	,	O	,	_	0	SENT_156	[p9l1590t3065r1905b3132],
4	J	NNP	O	J	appos	6	SENT_156	[p9l1939t3066r1968b3128],
5	Clin	NNP	O	Clin	nn	6	SENT_156	[p9l2004t3060r2140b3119],
6	Oncol	NNP	O	Oncol	dep	1	SENT_156	[p9l10t3156r205b3215],
7	2005	CD	DATE	2005	rcmod	6	SENT_156	[p9l230t3161r712b3227],
8	;	:	O	;	_	0	SENT_156	[p9l230t3161r712b3227],
9	23:4808	CD	NUMBER	23:4808	dep	7	SENT_156	[p9l230t3161r712b3227],
10	.	.	O	.	_	0	SENT_156	[p9l230t3161r712b3227],
11	]	SYM	O	]	dep	7	SENT_156	[p9l230t3161r712b3227],

1	Copyright	NN	O	copyright	_	0	SENT_157	[p9l12t3248r266b3313],
2	©	CD	NUMBER	©	num	6	SENT_157	[p9l290t3253r343b3308],
3	2008	CD	DATE	2008	num	6	SENT_157	[p9l370t3252r504b3298],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_157	[p9l527t3248r909b3297],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_157	[p9l933t3248r1142b3298],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_157	[p9l1162t3250r1359b3312],
7	.	.	O	.	_	0	SENT_157	[p9l1162t3250r1359b3312],

1	Sorafenib	NNP	ORGANIZATION	Sorafenib	_	0	SENT_158	[p9l466t3459r713b3508],
2	in	IN	O	in	_	0	SENT_158	[p9l733t3461r775b3507],
3	Liver	NN	O	liver	nn	4	SENT_158	[p9l800t3461r922b3508],
4	Cancer	NN	O	cancer	prep_in	1	SENT_158	[p9l938t3464r1120b3508],
5	—	CD	NUMBER	—	num	4	SENT_158	[p9l1134t3464r1315b3522],
6	just	RB	O	just	advmod	8	SENT_158	[p9l1134t3464r1315b3522],
7	the	DT	O	the	det	8	SENT_158	[p9l1330t3460r1413b3508],
8	Beginning	NN	O	beginning	dep	1	SENT_158	[p9l1434t3461r1695b3523],

1	Lewis	NNP	PERSON	Lewis	nn	3	SENT_159	[p9l772t3536r862b3564],
2	R.	NNP	PERSON	R.	nn	3	SENT_159	[p9l880t3536r908b3564],
3	Roberts	NNP	PERSON	Roberts	_	0	SENT_159	[p9l926t3533r1063b3570],
4	,	,	O	,	_	0	SENT_159	[p9l926t3533r1063b3570],
5	M.B.	NNP	O	M.B.	nn	7	SENT_159	[p9l1082t3536r1167b3570],
6	,	,	O	,	_	0	SENT_159	[p9l1082t3536r1167b3570],
7	Ch	NNP	O	Ch	appos	3	SENT_159	[p9l1184t3533r1282b3570],
8	.	.	O	.	_	0	SENT_159	[p9l1184t3533r1282b3570],

1	B.	NNP	O	B.	_	0	SENT_160	[p9l1184t3533r1282b3570],
2	,	,	O	,	_	0	SENT_160	[p9l1184t3533r1282b3570],
3	Ph.D.	NNP	O	Ph.D.	appos	1	SENT_160	[p9l1301t3533r1390b3564],
4	.	.	O	.	_	0	SENT_160	[p9l1301t3533r1390b3564],

1	Primary	JJ	O	primary	amod	3	SENT_161	[p10l6t97r364b197],
2	liver	NN	O	liver	nn	3	SENT_161	[p10l400t96r590b176],
3	cancer	NN	O	cancer	nsubj	9	SENT_161	[p10l629t122r917b175],
4	is	VBZ	O	be	cop	9	SENT_161	[p10l955t97r1023b175],
5	the	DT	O	the	det	9	SENT_161	[p10l1067t96r1203b175],
6	fifth	JJ	ORDINAL	fifth	amod	9	SENT_161	[p10l1245t96r1447b175],
7	most	RBS	O	most	advmod	8	SENT_161	[p10l1488t113r1709b175],
8	common	JJ	O	common	amod	9	SENT_161	[p10l1747t122r2135b175],
9	cancer	NN	O	cancer	_	0	SENT_161	[p10l8t250r295b303],
10	Worldwide	NNP	O	Worldwide	dep	9	SENT_161	[p10l332t224r792b304],
11	and	CC	O	and	_	0	SENT_161	[p10l837t224r997b303],
12	the	DT	O	the	det	16	SENT_161	[p10l1043t224r1178b303],
13	third	JJ	ORDINAL	third	amod	16	SENT_161	[p10l1224t224r1442b303],
14	most	RBS	O	most	advmod	15	SENT_161	[p10l1486t241r1706b303],
15	common	JJ	O	common	amod	16	SENT_161	[p10l1747t250r2135b303],
16	cause	NN	O	cause	conj_and	9	SENT_161	[p10l8t379r233b431],
17	of	IN	O	of	_	0	SENT_161	[p10l263t352r362b431],
18	death	NN	O	death	prep_of	16	SENT_161	[p10l373t352r602b431],
19	from	IN	O	from	_	0	SENT_161	[p10l632t352r836b431],
20	cancer	NN	O	cancer	prep_from	16	SENT_161	[p10l866t378r1153b448],
21	,	,	O	,	_	0	SENT_161	[p10l866t378r1153b448],
22	resulting	VBG	O	result	partmod	16	SENT_161	[p10l1188t352r1558b453],
23	in	IN	O	in	_	0	SENT_161	[p10l1584t353r1666b430],
24	more	JJR	O	more	mwe	25	SENT_161	[p10l1695t378r1908b431],
25	than	IN	O	than	quantmod	26	SENT_161	[p10l1938t352r2135b431],
26	600,000	CD	NUMBER	600,000	num	27	SENT_161	[p10l7t486r350b576],
27	deaths	NNS	O	death	prep_in	22	SENT_161	[p10l395t480r675b559],
28	per	IN	O	per	_	0	SENT_161	[p10l720t506r860b581],
29	year	NN	DURATION	year	prep_per	27	SENT_161	[p10l897t506r1095b581],
30	.	.	O	.	_	0	SENT_161	[p10l897t506r1095b581],

1	The	DT	O	the	det	4	SENT_162	[p10l1141t480r1302b559],
2	major	JJ	O	major	amod	4	SENT_162	[p10l1346t481r1597b581],
3	risk	NN	O	risk	nn	4	SENT_162	[p10l1638t480r1802b560],
4	factors	NNS	O	factor	nsubj	11	SENT_162	[p10l1841t480r2132b559],
5	for	IN	O	for	_	0	SENT_162	[p10l7t608r130b687],
6	hepatocellular	JJ	O	hepatocellular	amod	7	SENT_162	[p10l165t608r784b709],
7	carcinoma	NN	O	carcinoma	prep_for	4	SENT_162	[p10l819t609r1274b687],
8	are	VBP	O	be	cop	11	SENT_162	[p10l1308t634r1438b687],
9	chronic	JJ	O	chronic	amod	11	SENT_162	[p10l1476t608r1800b687],
10	hepatitis	NN	O	hepatitis	nn	11	SENT_162	[p10l1836t608r2134b709, p10l7t737r108b815],
11	B	NN	O	b	_	0	SENT_162	[p10l146t743r201b815],
12	or	CC	O	or	_	0	SENT_162	[p10l241t762r330b815],
13	hepatitis	NN	O	hepatitis	nn	16	SENT_162	[p10l364t736r735b837],
14	C	NN	O	c	nn	16	SENT_162	[p10l774t742r832b815],
15	virus	NN	O	virus	nn	16	SENT_162	[p10l867t737r1080b815],
16	infection	NN	O	infection	conj_or	11	SENT_162	[p10l1118t736r1529b832],
17	,	,	O	,	_	0	SENT_162	[p10l1118t736r1529b832],
18	alcoholic	JJ	O	alcoholic	amod	19	SENT_162	[p10l1571t736r1958b815],
19	cirrhosis	NN	O	cirrhosis	attr	11	SENT_162	[p10l1995t737r2134b815, p10l7t864r289b960],
20	,	,	O	,	_	0	SENT_162	[p10l1995t737r2134b815, p10l7t864r289b960],
21	and	CC	O	and	_	0	SENT_162	[p10l328t864r486b943],
22	nonalcoholic	JJ	O	nonalcoholic	amod	25	SENT_162	[p10l519t864r1077b943],
23	steatohepatitis	NN	O	steatohepatitis	nn	25	SENT_162	[p10l1112t864r1805b965],
24	}	NN	O	}	nn	25	SENT_162	[p10l1112t864r1805b965],
25	Cancer	NN	O	cancer	nsubj	27	SENT_162	[p10l1839t870r2138b943],
26	probably	RB	O	probably	advmod	27	SENT_162	[p10l6t992r368b1093],
27	develops	VBZ	O	develop	conj_and	11	SENT_162	[p10l395t992r747b1093],
28	in	IN	O	in	_	0	SENT_162	[p10l779t993r860b1070],
29	the	DT	O	the	det	31	SENT_162	[p10l892t992r1020b1071],
30	cirrhotic	JJ	O	cirrhotic	amod	31	SENT_162	[p10l1052t992r1402b1071],
31	liver	NN	O	liver	prep_in	27	SENT_162	[p10l1431t992r1607b1071],
32	through	IN	O	through	_	0	SENT_162	[p10l1635t992r1971b1093],
33	the	DT	O	the	det	34	SENT_162	[p10l2003t992r2135b1071],
34	induction	NN	O	induction	prep_through	27	SENT_162	[p10l6t1120r402b1199],
35	of	IN	O	of	_	0	SENT_162	[p10l434t1120r531b1199],
36	accelerated	VBN	O	accelerate	amod	37	SENT_162	[p10l543t1120r998b1199],
37	cycles	NNS	O	cycle	prep_of	34	SENT_162	[p10l1029t1120r1264b1221],
38	of	IN	O	of	_	0	SENT_162	[p10l1298t1120r1395b1199],
39	cell	NN	O	cell	nn	40	SENT_162	[p10l1408t1120r1548b1199],
40	injury	NN	O	injury	prep_of	37	SENT_162	[p10l1577t1121r1832b1221],
41	,	,	O	,	_	0	SENT_162	[p10l1577t1121r1832b1221],
42	death	NN	O	death	prep_of	37	SENT_162	[p10l1868t1120r2130b1216],
43	,	,	O	,	_	0	SENT_162	[p10l1868t1120r2130b1216],
44	and	CC	O	and	_	0	SENT_162	[p10l6t1248r160b1327],
45	regeneration	NN	O	regeneration	prep_of	37	SENT_162	[p10l191t1249r711b1349],
46	in	IN	O	in	_	0	SENT_162	[p10l742t1249r823b1326],
47	an	DT	O	a	det	52	SENT_162	[p10l853t1274r953b1327],
48	altered	JJ	O	altered	amod	52	SENT_162	[p10l983t1248r1263b1327],
49	fibrotic	JJ	O	fibrotic	amod	52	SENT_162	[p10l1294t1248r1598b1327],
50	and	CC	O	and	_	0	SENT_162	[p10l1628t1248r1782b1327],
51	inflammatory	JJ	O	inflammatory	amod	52	SENT_162	[p10l1811t1248r2134b1327, p10l7t1393r316b1477],
52	microenvironment	NN	O	microenvironment	prep_in	45	SENT_162	[p10l349t1377r1178b1455],
53	.	.	O	.	_	0	SENT_162	[p10l349t1377r1178b1455],

1	Abnormal	JJ	O	abnormal	amod	3	SENT_163	[p10l1218t1376r1655b1455],
2	immortal	JJ	O	immortal	amod	3	SENT_163	[p10l1692t1376r2134b1455],
3	—	NN	O	—	nsubj	7	SENT_163	[p10l1692t1376r2134b1455],
4	ized	VBN	O	ize	partmod	3	SENT_163	[p10l6t1504r181b1583],
5	cell	NN	O	cell	nn	6	SENT_163	[p10l221t1504r363b1583],
6	clones	NNS	O	clone	dobj	4	SENT_163	[p10l402t1504r663b1583],
7	arise	VBP	O	arise	_	0	SENT_163	[p10l704t1505r925b1600],
8	,	,	O	,	_	0	SENT_163	[p10l704t1505r925b1600],
9	and	CC	O	and	_	0	SENT_163	[p10l968t1504r1125b1583],
10	these	DT	O	these	det	11	SENT_163	[p10l1163t1504r1383b1583],
11	cells	NNS	O	cell	nsubj	12	SENT_163	[p10l1422t1504r1606b1583],
12	develop	VBP	O	develop	conj_and	7	SENT_163	[p10l1647t1504r1964b1605],
13	genetic	JJ	O	genetic	amod	16	SENT_163	[p10l2004t1531r2134b1605, p10l7t1633r220b1711],
14	and	CC	O	and	_	0	SENT_163	[p10l268t1632r429b1711],
15	epigenetic	JJ	O	epigenetic	amod	16	SENT_163	[p10l479t1633r928b1733],
16	alterations	NNS	O	alteration	dobj	12	SENT_163	[p10l976t1632r1445b1711],
17	that	WDT	O	that	nsubj	18	SENT_163	[p10l1497t1632r1674b1711],
18	provide	VBP	O	provide	rcmod	16	SENT_163	[p10l1717t1632r2043b1733],
19	a	DT	O	a	det	20	SENT_163	[p10l2092t1659r2137b1711],
20	survival	NN	O	survival	dobj	18	SENT_163	[p10l8t1760r341b1839],
21	and	CC	O	and	_	0	SENT_163	[p10l377t1760r536b1839],
22	proliferative	JJ	O	proliferative	amod	23	SENT_163	[p10l572t1760r1095b1861],
23	advantage	NN	O	advantage	dobj	18	SENT_163	[p10l1132t1760r1587b1861],
24	,	,	O	,	_	0	SENT_163	[p10l1132t1760r1587b1861],
25	resulting	VBG	O	result	partmod	18	SENT_163	[p10l1630t1760r2018b1861],
26	in	IN	O	in	_	0	SENT_163	[p10l2052t1761r2135b1838],
27	unconstrained	JJ	O	unconstrained	amod	28	SENT_163	[p10l7t1888r645b1967],
28	proliferation	NN	O	proliferation	prep_in	25	SENT_163	[p10l690t1888r1272b1989],
29	,	,	O	,	_	0	SENT_163	[p10l690t1888r1272b1989],
30	a	DT	O	a	det	32	SENT_163	[p10l1324t1915r1368b1967],
31	key	JJ	O	key	amod	32	SENT_163	[p10l1413t1888r1560b1989],
32	hallmark	NN	O	hallmark	appos	28	SENT_163	[p10l1602t1888r2009b1968],
33	of	IN	O	of	_	0	SENT_163	[p10l2052t1888r2153b1967],
34	cancer	NN	O	cancer	prep_of	32	SENT_163	[p10l8t2014r307b2067],
35	.	.	O	.	_	0	SENT_163	[p10l8t2014r307b2067],

1	Early	RB	O	early	advmod	3	SENT_164	[p10l136t2117r589b2219],
2	—	JJ	O	—	amod	3	SENT_164	[p10l136t2117r589b2219],
3	stage	NN	O	stage	nsubj	7	SENT_164	[p10l136t2117r589b2219],
4	hepatocellular	JJ	O	hepatocellular	amod	5	SENT_164	[p10l627t2117r1222b2219],
5	carcinoma	NN	O	carcinoma	dep	3	SENT_164	[p10l1257t2118r1697b2197],
6	is	VBZ	O	be	cop	7	SENT_164	[p10l1732t2118r1796b2197],
7	amenable	JJ	O	amenable	_	0	SENT_164	[p10l1835t2143r2148b2197, p10l7t2247r126b2327],
8	to	TO	O	to	_	0	SENT_164	[p10l164t2264r244b2327],
9	potentially	RB	O	potentially	advmod	10	SENT_164	[p10l281t2247r729b2349],
10	curative	JJ	O	curative	amod	11	SENT_164	[p10l761t2248r1085b2327],
11	therapies	NNS	O	therapy	prep_to	7	SENT_164	[p10l1123t2247r1521b2349],
12	;	:	O	;	_	0	SENT_164	[p10l1123t2247r1521b2349],
13	however	RB	O	however	advmod	26	SENT_164	[p10l1562t2247r1925b2344],
14	,	,	O	,	_	0	SENT_164	[p10l1562t2247r1925b2344],
15	only	RB	O	only	advmod	16	SENT_164	[p10l1968t2247r2154b2349],
16	about	IN	O	about	advmod	18	SENT_164	[p10l6t2377r244b2457],
17	30	CD	PERCENT	30	num	18	SENT_164	[p10l271t2383r455b2457],
18	%	NN	PERCENT	%	nsubj	26	SENT_164	[p10l271t2383r455b2457],
19	of	IN	O	of	_	0	SENT_164	[p10l488t2377r587b2457],
20	patients	NNS	O	patient	prep_of	18	SENT_164	[p10l598t2378r928b2479],
21	who	WP	O	who	nsubj	22	SENT_164	[p10l957t2377r1137b2458],
22	present	VBP	DATE	present	rcmod	20	SENT_164	[p10l1169t2394r1478b2479],
23	at	IN	O	at	_	0	SENT_164	[p10l1504t2394r1582b2457],
24	most	JJS	O	most	amod	25	SENT_164	[p10l1608t2394r1821b2457],
25	centers	NNS	O	center	prep_at	22	SENT_164	[p10l1848t2394r2146b2457],
26	have	VBP	O	have	parataxis	7	SENT_164	[p10l7t2507r195b2587],
27	early-stage	JJ	O	early-stage	amod	28	SENT_164	[p10l235t2507r688b2609],
28	disease	NN	O	disease	dobj	26	SENT_164	[p10l727t2507r1057b2587],
29	.	.	O	.	_	0	SENT_164	[p10l727t2507r1057b2587],

1	Liver	NN	O	liver	nn	2	SENT_165	[p10l1099t2508r1305b2587],
2	cancer	NN	O	cancer	nsubj	11	SENT_165	[p10l1342t2533r1620b2587],
3	in	IN	O	in	_	0	SENT_165	[p10l1655t2508r1738b2586],
4	an	DT	O	a	det	8	SENT_165	[p10l1776t2533r1879b2587],
5	intermediate	JJ	O	intermediate	amod	8	SENT_165	[p10l1917t2508r2148b2587, p10l7t2637r346b2717],
6	or	CC	O	or	_	0	SENT_165	[p10l381t2663r468b2717],
7	advanced	JJ	O	advanced	conj_or	5	SENT_165	[p10l499t2637r890b2717],
8	stage	NN	O	stage	prep_in	2	SENT_165	[p10l926t2654r1144b2739],
9	is	VBZ	O	be	cop	11	SENT_165	[p10l1176t2638r1242b2717],
10	particularly	RB	O	particularly	advmod	11	SENT_165	[p10l1276t2637r1772b2739],
11	difficult	JJ	O	difficult	_	0	SENT_165	[p10l1801t2637r2154b2717],
12	to	TO	O	to	aux	13	SENT_165	[p10l7t2784r87b2847],
13	treat	VB	O	treat	xcomp	11	SENT_165	[p10l123t2784r333b2864],
14	,	,	O	,	_	0	SENT_165	[p10l123t2784r333b2864],
15	for	IN	O	for	_	0	SENT_165	[p10l372t2767r492b2847],
16	several	JJ	O	several	amod	17	SENT_165	[p10l524t2767r805b2847],
17	reasons	NNS	O	reason	prep_for	11	SENT_165	[p10l838t2793r1177b2847],
18	.	.	O	.	_	0	SENT_165	[p10l838t2793r1177b2847],

1	Liver	NN	O	liver	nn	2	SENT_166	[p10l1215t2768r1416b2847],
2	cancers	NNS	O	cancer	nsubj	4	SENT_166	[p10l1447t2793r1757b2847],
3	typically	RB	O	typically	advmod	4	SENT_166	[p10l1794t2767r2153b2869],
4	retain	VBP	O	retain	_	0	SENT_166	[p10l7t2898r256b2977],
5	active	JJ	O	active	amod	7	SENT_166	[p10l290t2898r527b2977],
6	drug	NN	O	drug	nn	7	SENT_166	[p10l562t2897r1364b2999],
7	—	NN	O	—	dobj	4	SENT_166	[p10l562t2897r1364b2999],
8	metabolizing	VBG	O	metabolize	partmod	7	SENT_166	[p10l562t2897r1364b2999],
9	systems	NNS	O	system	dobj	8	SENT_166	[p10l1396t2914r1726b2999],
10	that	WDT	O	that	nsubj	11	SENT_166	[p10l1762t2897r1933b2977],
11	contribute	VBP	O	contribute	rcmod	9	SENT_166	[p10l1963t2923r2148b2977, p10l7t3027r289b3107],
12	to	TO	O	to	_	0	SENT_166	[p10l325t3044r406b3107],
13	an	DT	O	a	det	15	SENT_166	[p10l442t3053r545b3107],
14	intrinsic	JJ	O	intrinsic	amod	15	SENT_166	[p10l579t3028r935b3107],
15	resistance	NN	O	resistance	prep_to	11	SENT_166	[p10l969t3028r1392b3107],
16	to	TO	O	to	_	0	SENT_166	[p10l1428t3044r1509b3107],
17	chemotherapy	NN	O	chemotherapy	nn	18	SENT_166	[p10l1546t3027r2153b3129],
18	drugs	NNS	O	drug	prep_to	11	SENT_166	[p10l7t3157r278b3259],
19	.	.	O	.	_	0	SENT_166	[p10l7t3157r278b3259],

1	Liver	NN	O	liver	nn	2	SENT_167	[p10l322t3158r532b3237],
2	cancers	NNS	O	cancer	nsubj	5	SENT_167	[p10l570t3183r893b3237],
3	also	RB	O	also	advmod	5	SENT_167	[p10l934t3157r1107b3237],
4	have	VBP	O	have	aux	5	SENT_167	[p10l1148t3157r1339b3237],
5	enhanced	VBN	O	enhance	_	0	SENT_167	[p10l1380t3157r1798b3237],
6	expression	NN	O	expression	dobj	5	SENT_167	[p10l1838t3183r2148b3259, p10l9t3288r186b3367],
7	of	IN	O	of	_	0	SENT_167	[p10l228t3287r329b3367],
8	transporters	NNS	O	transporter	prep_of	6	SENT_167	[p10l354t3304r889b3389],
9	of	IN	O	of	_	0	SENT_167	[p10l934t3287r1035b3367],
10	the	DT	O	the	det	14	SENT_167	[p10l1059t3287r1192b3367],
11	multidrug	JJ	O	multidrug	amod	14	SENT_167	[p10l1235t3287r1677b3389],
12	resistance	NN	O	resistance	nn	14	SENT_167	[p10l1716t3288r2149b3367],
13	protein	NN	O	protein	nn	14	SENT_167	[p10l6t3418r320b3519],
14	family	NN	O	family	prep_of	8	SENT_167	[p10l356t3417r647b3519],
15	,	,	O	,	_	0	SENT_167	[p10l356t3417r647b3519],
16	which	WDT	O	which	nsubj	17	SENT_167	[p10l684t3417r949b3498],
17	mediate	VBP	O	mediate	rcmod	14	SENT_167	[p10l985t3417r1330b3497],
18	the	DT	O	the	det	19	SENT_167	[p10l1367t3417r1501b3497],
19	export	NN	O	export	dobj	17	SENT_167	[p10l1538t3434r1819b3519],
20	of	IN	O	of	_	0	SENT_167	[p10l1851t3417r1951b3497],
21	chemotherapeutic	JJ	O	chemotherapeutic	amod	22	SENT_167	[p10l1969t3417r2148b3497, p10l7t3547r655b3649],
22	drugs	NNS	O	drug	prep_of	19	SENT_167	[p10l706t3547r958b3649],
23	across	IN	O	across	_	0	SENT_167	[p10l1010t3573r1285b3627],
24	the	DT	O	the	det	26	SENT_167	[p10l1339t3547r1476b3627],
25	plasma	NN	O	plasma	nn	26	SENT_167	[p10l1525t3547r1845b3649],
26	membrane	NN	O	membrane	prep_across	22	SENT_167	[p10l1895t3573r2148b3627, p10l7t3677r263b3757],
27	.	.	O	.	_	0	SENT_167	[p10l1895t3573r2148b3627, p10l7t3677r263b3757],

1	Other	JJ	O	other	amod	2	SENT_168	[p10l300t3677r542b3757],
2	factors	NNS	O	factor	nsubj	4	SENT_168	[p10l571t3677r850b3757],
3	also	RB	O	also	advmod	4	SENT_168	[p10l883t3677r1050b3757],
4	militate	VBP	O	militate	_	0	SENT_168	[p10l1083t3677r1405b3757],
5	against	IN	O	against	_	0	SENT_168	[p10l1436t3678r1742b3779],
6	response	NN	O	response	prep_against	4	SENT_168	[p10l1768t3703r2148b3779],
7	to	TO	O	to	_	0	SENT_168	[p11l7t38r88b101],
8	therapy	NN	O	therapy	prep_to	4	SENT_168	[p11l132t21r462b123],
9	.	.	O	.	_	0	SENT_168	[p11l132t21r462b123],

1	Many	JJ	O	many	amod	2	SENT_169	[p11l507t29r747b123],
2	drugs	NNS	O	drug	nsubj	3	SENT_169	[p11l784t21r1027b123],
3	have	VBP	O	have	_	0	SENT_169	[p11l1071t21r1259b101],
4	intrinsic	JJ	O	intrinsic	amod	7	SENT_169	[p11l1300t22r1656b101],
5	hepatotox	NN	O	hepatotox	nn	7	SENT_169	[p11l1697t21r2148b123],
6	—	NN	O	—	nn	7	SENT_169	[p11l1697t21r2148b123],
7	icity	NN	O	icity	dobj	3	SENT_169	[p11l6t152r184b253],
8	that	WDT	O	that	nsubj	10	SENT_169	[p11l217t151r388b231],
9	may	MD	O	may	aux	10	SENT_169	[p11l420t177r598b253],
10	exacerbate	VB	O	exacerbate	rcmod	7	SENT_169	[p11l631t151r1075b231],
11	the	DT	O	the	det	14	SENT_169	[p11l1113t151r1244b231],
12	underlying	VBG	O	underlie	amod	14	SENT_169	[p11l1282t151r1742b253],
13	liver	NN	O	liver	nn	14	SENT_169	[p11l1775t151r1956b232],
14	disease	NN	O	disease	dobj	10	SENT_169	[p11l1990t151r2148b231, p11l8t308r209b361],
15	.	.	O	.	_	0	SENT_169	[p11l1990t151r2148b231, p11l8t308r209b361],

1	Leukopenia	NN	PERSON	leukopenia	_	0	SENT_170	[p11l252t281r751b383],
2	and	CC	O	and	_	0	SENT_170	[p11l787t281r944b361],
3	thrombocytopenia	NN	O	thrombocytopenia	conj_and	1	SENT_170	[p11l984t281r1777b383],
4	that	WDT	O	that	nsubj	5	SENT_170	[p11l1814t281r1985b361],
5	are	VBP	O	be	rcmod	1	SENT_170	[p11l2018t307r2149b361],

1	420	CD	NUMBER	420	num	4	SENT_171	[p11l148t458r206b480],
2	N	NN	O	n	nn	4	SENT_171	[p11l934t468r948b483],
3	ENGLJ	NN	O	englj	nn	4	SENT_171	[p11l963t468r1041b490],
4	MED359	NN	O	med359	_	0	SENT_171	[p11l1055t468r1183b490],
5	;	:	O	;	_	0	SENT_171	[p11l1055t468r1183b490],
6	4	CD	NUMBER	4	dep	4	SENT_171	[p11l1055t468r1183b490],
7	WWW	NNP	O	WWW	nn	10	SENT_171	[p11l1215t468r1416b490],
8	,	,	O	,	_	0	SENT_171	[p11l1215t468r1416b490],
9	NEJM.ORG	NNP	O	NEJM.ORG	appos	10	SENT_171	[p11l1215t468r1416b490],
10	JULY	NNP	DATE	JULY	dep	6	SENT_171	[p11l1447t468r1505b490],
11	24,2008	CD	NUMBER	24,2008	num	10	SENT_171	[p11l1515t462r1625b490],

1	The	DT	O	the	det	4	SENT_172	[p11l936t501r987b525],
2	New	NNP	O	New	nn	4	SENT_172	[p11l996t502r1058b525],
3	England	NNP	O	England	nn	4	SENT_172	[p11l1067t501r1178b532],
4	Journal	NNP	O	Journal	_	0	SENT_172	[p11l1187t501r1284b525],
5	of	IN	O	of	_	0	SENT_172	[p11l1294t501r1323b525],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_172	[p11l1330t501r1455b525],

1	Downloaded	VBN	O	download	_	0	SENT_173	[p11l378t542r548b565],
2	from	IN	O	from	_	0	SENT_173	[p11l557t542r622b565],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_173	[p11l630t542r749b572],
4	at	IN	O	at	_	0	SENT_173	[p11l759t546r782b565],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_173	[p11l790t542r973b565],
6	on	IN	O	on	_	0	SENT_173	[p11l982t549r1015b565],
7	January	NNP	DATE	January	prep_on	1	SENT_173	[p11l1023t542r1126b572],
8	5	CD	DATE	5	num	7	SENT_173	[p11l1136t542r1159b569],
9	,	,	DATE	,	_	0	SENT_173	[p11l1136t542r1159b569],
10	2014	CD	DATE	2014	num	7	SENT_173	[p11l1169t542r1242b565],
11	.	.	O	.	_	0	SENT_173	[p11l1169t542r1242b565],

1	For	IN	O	for	_	0	SENT_174	[p11l1252t542r1299b565],
2	personal	JJ	O	personal	amod	3	SENT_174	[p11l1307t542r1419b572],
3	use	NN	O	use	pobj	1	SENT_174	[p11l1428t549r1472b565],
4	only	RB	O	only	advmod	3	SENT_174	[p11l1481t542r1546b572],
5	.	.	O	.	_	0	SENT_174	[p11l1481t542r1546b572],

1	No	DT	O	no	det	3	SENT_175	[p11l1557t542r1596b565],
2	other	JJ	O	other	amod	3	SENT_175	[p11l1606t542r1674b565],
3	uses	NNS	O	use	_	0	SENT_175	[p11l1683t549r1739b565],
4	without	IN	O	without	_	0	SENT_175	[p11l1749t542r1850b565],
5	permission	NN	O	permission	prep_without	3	SENT_175	[p11l1858t542r2011b572],
6	.	.	O	.	_	0	SENT_175	[p11l1858t542r2011b572],

1	Copyright	NN	O	copyright	_	0	SENT_176	[p11l729t583r863b614],
2	©	CD	NUMBER	©	num	6	SENT_176	[p11l872t583r896b607],
3	2008	CD	DATE	2008	num	6	SENT_176	[p11l906t583r970b607],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_176	[p11l980t583r1171b607],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_176	[p11l1181t583r1289b607],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_176	[p11l1300t583r1405b614],
7	.	.	O	.	_	0	SENT_176	[p11l1300t583r1405b614],

1	All	DT	O	all	det	2	SENT_177	[p11l1416t583r1457b607],
2	rights	NNS	O	rights	nsubj	3	SENT_177	[p11l1466t583r1541b614],
3	reserved	VBN	O	reserve	_	0	SENT_177	[p11l1551t583r1669b607],
4	.	.	O	.	_	0	SENT_177	[p11l1551t583r1669b607],

